RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy7276
(101 letters)
>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular
signal-Regulated Kinase 1 and 2-like Serine/Threonine
Kinases. Serine/Threonine Kinases (STKs), Extracellular
signal-regulated kinases 1 and 2 (ERK1/2) and Fus3
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. This
ERK1/2-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
the mitogen-activated protein kinases (MAPKs) ERK1,
ERK2, baker's yeast Fus3, and similar proteins. MAPK
pathways are important mediators of cellular responses
to extracellular signals. ERK1/2 activation is
preferentially by mitogenic factors, differentiation
stimuli, and cytokines, through a kinase cascade
involving the MAPK kinases MEK1/2 and a MAPK kinase
kinase from the Raf family. ERK1/2 have numerous
substrates, many of which are nuclear and participate in
transcriptional regulation of many cellular processes.
They regulate cell growth, cell proliferation, and cell
cycle progression from G1 to S phase. Although the
distinct roles of ERK1 and ERK2 have not been fully
determined, it is known that ERK2 can maintain most
functions in the absence of ERK1, and that the deletion
of ERK2 is embryonically lethal. The MAPK, Fus3,
regulates yeast mating processes including
mating-specific gene expression, G1 arrest, mating
projection, and cell fusion.
Length = 336
Score = 116 bits (292), Expect = 6e-33
Identities = 45/55 (81%), Positives = 48/55 (87%), Gaps = 1/55 (1%)
Query: 27 SDSHRT-KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+D ++ K Q LSNDHI YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT CDLK
Sbjct: 92 TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLK 146
>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine
Kinase, Mitogen-Activated Protein Kinase.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase (MAPK) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The MAPK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. MAPKs serve as important
mediators of cellular responses to extracellular
signals. They control critical cellular functions
including differentiation, proliferation, migration, and
apoptosis. They are also implicated in the pathogenesis
of many diseases including multiple types of cancer,
stroke, diabetes, and chronic inflammation. Typical MAPK
pathways involve a triple kinase core cascade comprising
of the MAPK, which is phosphorylated and activated by a
MAPK kinase (MAP2K or MKK), which itself is
phosphorylated and activated by a MAPK kinase kinase
(MAP3K or MKKK). Each cascade is activated either by a
small GTP-binding protein or by an adaptor protein,
which transmits the signal either directly to a MAP3K to
start the triple kinase core cascade or indirectly
through a mediator kinase, a MAP4K. There are three main
typical MAPK subfamilies: Extracellular signal-Regulated
Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38.
Some MAPKs are atypical in that they are not regulated
by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7.
Length = 330
Score = 104 bits (262), Expect = 1e-28
Identities = 36/46 (78%), Positives = 43/46 (93%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
Q L++DHI YFLYQILRGLKY+HSANV+HRDLKPSN+L+N+ CDLK
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLK 143
>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the
Serine/Threonine Kinases, TEY Mitogen-Activated Protein
Kinases from Plants. Serine/Threonine Kinases (STKs),
Plant TEY Mitogen-Activated Protein Kinase (MAPK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The TEY
MAPK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKs are important mediators of cellular
responses to extracellular signals. In plants, MAPKs are
associated with physiological, developmental, hormonal,
and stress responses. Some plants show numerous gene
duplications of MAPKs. Arabidopsis thaliana harbors at
least 20 MAPKs, named AtMPK1-20. There are two subtypes
of plant MAPKs based on the conserved phosphorylation
motif present in the activation loop, TEY and TDY. This
subfamily represents the TEY subtype and is further
subdivided into three groups (A, B, and C). Group A is
represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4
(NtNTF4), among others. They are mostly involved in
environmental and hormonal responses. AtMPK3 and AtMPK6
are also key regulators for stomatal development and
patterning. Group B is represented by AtMPK4, AtMPK13,
and NtNTF6, among others. They may be involved in both
cell division and environmental stress response. AtMPK4
also participates in regulating innate immunity. Group C
is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa
MAPK4 (OsMAPK4), among others. They may also be involved
in stress responses. AtMPK1 and AtMPK2 are activated
following mechanical injury and in the presence of
stress chemicals such as jasmonic acid, hydrogen
peroxide and abscisic acid. OsMAPK4 is also called
OsMSRMK3 for Multiple Stress-Responsive MAPK3.
Length = 337
Score = 100 bits (250), Expect = 8e-27
Identities = 39/46 (84%), Positives = 41/46 (89%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
Q LS+DH YFLYQ+LRGLKYIHSANVLHRDLKPSNLLLN CDLK
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLK 148
>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine
Kinase, Extracellular signal-Regulated Kinase 5.
Serine/Threonine Kinases (STKs), Extracellular
signal-Regulated Kinase 5 (ERK5) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ERK5 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. ERK5, also called Big MAPK1
(BMK1) or MAPK7, has a unique C-terminal extension,
making it approximately twice as big as other MAPKs.
This extension contains transcriptional activation
capability which is inhibited by the N-terminal half.
ERK5 is activated in response to growth factors and
stress by a cascade that leads to its phosphorylation by
the MAP2K MEK5, which in turn is regulated by the MAP3Ks
MEKK2 and MEKK3. Activated ERK5 phosphorylates its
targets including myocyte enhancer factor 2 (MEF2),
Sap1a, c-Myc, and RSK. It plays a role in EGF-induced
cell proliferation during the G1/S phase transition.
Studies on knockout mice revealed that ERK5 is essential
for cardiovascular development and plays an important
role in angiogenesis. It is also critical for neural
differentiation and survival. The ERK5 pathway has been
implicated in the pathogenesis of many diseases
including cancer, cardiac hypertrophy, and
atherosclerosis.
Length = 334
Score = 97.4 bits (243), Expect = 7e-26
Identities = 37/56 (66%), Positives = 45/56 (80%), Gaps = 2/56 (3%)
Query: 27 SDSHRTKY--QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
SD H + Q L+ +HI YFLYQ+LRGLKYIHSANV+HRDLKPSNLL+N C+L+
Sbjct: 92 SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELR 147
>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase,
p38 Mitogen-Activated Protein Kinase. Serine/Threonine
Kinases (STKs), p38 subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The p38 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. p38 kinases are
mitogen-activated protein kinases (MAPKs), serving as
important mediators of cellular responses to
extracellular signals. They function in the regulation
of the cell cycle, cell development, cell
differentiation, senescence, tumorigenesis, apoptosis,
pain development and pain progression, and immune
responses. p38 kinases are activated by the MAPK kinases
MKK3 and MKK6, which in turn are activated by upstream
MAPK kinase kinases including TAK1, ASK1, and MLK3, in
response to cellular stresses or inflammatory cytokines.
p38 substrates include other protein kinases and factors
that regulate transcription, nuclear export, mRNA
stability and translation. p38 kinases are drug targets
for the inflammatory diseases psoriasis, rheumatoid
arthritis, and chronic pulmonary disease. Vertebrates
contain four isoforms of p38, named alpha, beta, gamma,
and delta, which show varying substrate specificity and
expression patterns. p38alpha and p38beta are
ubiquitously expressed, p38gamma is predominantly found
in skeletal muscle, and p38delta is found in the heart,
lung, testis, pancreas, and small intestine.
Length = 343
Score = 92.4 bits (230), Expect = 6e-24
Identities = 32/48 (66%), Positives = 41/48 (85%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K Q+LS+DHI + +YQILRGLKYIHSA ++HRDLKPSN+ +N C+LK
Sbjct: 111 KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 158
>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine
Kinase, Fungal Mitogen-Activated Protein Kinase MPK1.
Serine/Threonine Kinases (STKs), Fungal
Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MPK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily is
composed of the MAPKs MPK1 from Saccharomyces
cerevisiae, Pmk1 from Schizosaccharomyces pombe, and
similar proteins. MAPKs are important mediators of
cellular responses to extracellular signals. MPK1 (also
called Slt2) and Pmk1 (also called Spm1) are
stress-activated MAPKs that regulate the cell wall
integrity (CWI) pathway, and are therefore important in
the maintainance of cell shape, cell wall construction,
morphogenesis, and ion homeostasis. MPK1 is activated in
response to cell wall stress including heat stimulation,
osmotic shock, UV irradiation, and any agents that
interfere with cell wall biogenesis such as chitin
antagonists, caffeine, or zymolase. MPK1 is regulated by
the MAP2Ks Mkk1/2, which are regulated by the MAP3K
Bck1. Pmk1 is also activated by multiple stresses
including elevated temperatures, hyper- or hypotonic
stress, glucose deprivation, exposure to cell-wall
damaging compounds, and oxidative stress. It is
regulated by the MAP2K Pek1, which is regulated by the
MAP3K Mkh1.
Length = 332
Score = 87.5 bits (217), Expect = 4e-22
Identities = 32/46 (69%), Positives = 37/46 (80%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
Q L++ H F+YQIL GLKYIHSANVLHRDLKP NLL+N C+LK
Sbjct: 100 QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELK 145
>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase,
Nemo-Like Kinase. Serine/Threonine Kinases (STKs),
Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The NLK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Mitogen-activated protein
kinases (MAPKs) are important mediators of cellular
responses to extracellular signals. NLK is an atypical
MAPK that is not regulated by a MAPK kinase. It
functions downstream of the MAPK kinase kinase Tak1,
which also plays a role in activating the JNK and p38
MAPKs. The Tak1/NLK pathways are regulated by Wnts, a
family of secreted proteins that is critical in the
control of asymmetric division and cell polarity. NLK
can phosphorylate transcription factors from the TCF/LEF
family, inhibiting their ability to activate the
transcription of target genes. In prostate cancer cells,
NLK is involved in regulating androgen receptor-mediated
transcription and its expression is altered during
cancer progression.
Length = 372
Score = 83.3 bits (206), Expect = 2e-20
Identities = 32/46 (69%), Positives = 39/46 (84%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
Q LS+DH+ FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LK
Sbjct: 98 QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLK 143
>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), CMGC family, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CMGC family is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The CMGC family consists of Cyclin-Dependent
protein Kinases (CDKs), Mitogen-activated protein
kinases (MAPKs) such as Extracellular signal-regulated
kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38,
and similar proteins. CDKs belong to a large subfamily
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. MAPKs
serve as important mediators of cellular responses to
extracellular signals. They control critical cellular
functions including differentiation, proliferation,
migration, and apoptosis. They are also implicated in
the pathogenesis of many diseases including multiple
types of cancer, stroke, diabetes, and chronic
inflammation.
Length = 283
Score = 80.4 bits (199), Expect = 8e-20
Identities = 24/44 (54%), Positives = 30/44 (68%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L I +LYQ+L+GL + HS +LHRDLKP NLL+NT LK
Sbjct: 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLK 138
>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine
Kinases, Fungal Mitogen-Activated Protein Kinases Sty1
and Hog1. Serine/Threonine Kinases (STKs), Fungal
Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Sty1/Hog1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of the MAPKs Sty1
from Schizosaccharomyces pombe, Hog1 from Saccharomyces
cerevisiae, and similar proteins. MAPKs are important
mediators of cellular responses to extracellular
signals. Sty1 and Hog1 are stress-activated MAPKs that
partipate in transcriptional regulation in response to
stress. Sty1 is activated in response to oxidative
stress, osmotic stress, and UV radiation. Sty1 is
regulated by the MAP2K Wis1, which is activated by the
MAP3Ks Wis4 and Win1, which receive signals of the
stress condition from membrane-spanning histidine
kinases Mak1-3. Activated Sty1 stabilizes the Atf1
transcription factor and induces transcription of
Atf1-dependent genes of the core environmetal stress
response (CESR). Hog1 is the key element in the high
osmolarity glycerol (HOG) pathway and is activated upon
hyperosmotic stress. Activated Hog1 accumulates in the
nucleus and regulates stress-induced transcription. The
HOG pathway is mediated by two transmembrane
osmosensors, Sln1 and Sho1.
Length = 328
Score = 80.3 bits (198), Expect = 2e-19
Identities = 35/55 (63%), Positives = 41/55 (74%), Gaps = 1/55 (1%)
Query: 27 SDSHRT-KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+D HR + L I YFLYQILRGLKY+HSA V+HRDLKPSN+L+N CDLK
Sbjct: 94 TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLK 148
>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine
Kinases, Mitogen-Activated Protein Kinases 4 and 6.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAPK4/6 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. MAPK4 is also called ERK4 or
p63MAPK, while MAPK6 is also called ERK3 or p97MAPK.
MAPK4 and MAPK6 are atypical MAPKs that are not
regulated by MAP2Ks. MAPK6 is expressed ubiquitously
with highest amounts in brain and skeletal muscle. It
may be involved in the control of cell differentiation
by negatively regulating cell cycle progression in
certain conditions. It may also play a role in
glucose-induced insulin secretion. MAPK6 and MAPK4
cooperate to regulate the activity of MAPK-activated
protein kinase 5 (MK5), leading to its relocation to the
cytoplasm and exclusion from the nucleus. The MAPK6/MK5
and MAPK4/MK5 pathways may play critical roles in
embryonic and post-natal development.
Length = 342
Score = 78.3 bits (193), Expect = 1e-18
Identities = 28/41 (68%), Positives = 34/41 (82%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
LS +H F+YQ+LRGLKYIHSANVLHRDLKP+N+ +NT
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT 149
>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine
Kinase, Mitogen-Activated Protein Kinase 15.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase 15 (MAPK15) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAPK15 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. Human MAPK15 is also called
Extracellular signal Regulated Kinase 8 (ERK8) while the
rat protein is called ERK7. ERK7 and ERK8 display both
similar and different biochemical properties. They
autophosphorylate and activate themselves and do not
require upstream activating kinases. ERK7 is
constitutively active and is not affected by
extracellular stimuli whereas ERK8 shows low basal
activity and is activated by DNA-damaging agents. ERK7
and ERK8 also have different substrate profiles. Genome
analysis shows that they are orthologs with similar gene
structures. ERK7 and ERK 8 may be involved in the
signaling of some nuclear receptor transcription
factors. ERK7 regulates hormone-dependent degradation of
estrogen receptor alpha while ERK8 down-regulates the
transcriptional co-activation androgen and
glucocorticoid receptors.
Length = 337
Score = 77.6 bits (192), Expect = 2e-18
Identities = 27/44 (61%), Positives = 35/44 (79%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L + H Y +YQ+L+ LKYIHS NV+HRDLKPSN+LLN+ C +K
Sbjct: 104 LEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVK 147
>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the
Serine/Threonine Kinase, p38beta Mitogen-Activated
Protein Kinase. Serine/Threonine Kinases (STKs),
p38beta subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
p38beta subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. p38 kinases are mitogen-activated protein
kinases (MAPKs), serving as important mediators of
cellular responses to extracellular signals. They are
activated by the MAPK kinases MKK3 and MKK6, which in
turn are activated by upstream MAPK kinase kinases
including TAK1, ASK1, and MLK3, in response to cellular
stresses or inflammatory cytokines. Vertebrates contain
four isoforms of p38, named alpha, beta, gamma, and
delta. p38beta, also called MAPK11, is widely expressed
in tissues and shows more similarity with p38alpha than
with the other isoforms. Both are sensitive to
pyridinylimidazoles and share some common substrates
such as MAPK activated protein kinase 2 (MK2) and the
transcription factors ATF2, c-Fos and, ELK-1. p38beta is
involved in regulating the activation of the
cyclooxygenase-2 promoter and the expression of
TGFbeta-induced alpha-smooth muscle cell actin.
Length = 343
Score = 76.6 bits (188), Expect = 5e-18
Identities = 28/48 (58%), Positives = 41/48 (85%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K Q+LS++H+ + +YQ+LRGLKYIHSA ++HRDLKPSN+ +N C+L+
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR 158
>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the
Serine/Threonine Kinase, p38alpha Mitogen-Activated
Protein Kinase. Serine/Threonine Kinases (STKs),
p38alpha subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
p38alpha subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. p38 kinases are mitogen-activated protein
kinases (MAPKs), serving as important mediators of
cellular responses to extracellular signals. They are
activated by the MAPK kinases MKK3 and MKK6, which in
turn are activated by upstream MAPK kinase kinases
including TAK1, ASK1, and MLK3, in response to cellular
stresses or inflammatory cytokines. Vertebrates contain
four isoforms of p38, named alpha, beta, gamma, and
delta. p38alpha, also called MAPK14, is expressed in
most tissues and is the major isoform involved in the
immune and inflammatory response. It is the central p38
MAPK involved in myogenesis. It plays a role in
regulating cell cycle check-point transition and
promoting cell differentiation. p38alpha also regulates
cell proliferation and death through crosstalk with the
JNK pathway. Its substrates include MAPK activated
protein kinase 2 (MK2), MK5, and the transcription
factors ATF2 and Mitf.
Length = 345
Score = 76.2 bits (187), Expect = 6e-18
Identities = 31/48 (64%), Positives = 42/48 (87%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K Q+L++DH+ + +YQILRGLKYIHSA+++HRDLKPSNL +N C+LK
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 160
>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic
domain. Phosphotransferases. Serine or
threonine-specific kinase subfamily.
Length = 254
Score = 73.7 bits (182), Expect = 2e-17
Identities = 23/52 (44%), Positives = 32/52 (61%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K RLS D ++L QIL L+Y+HS ++HRDLKP N+LL+ +K
Sbjct: 86 DLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVK 137
>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the
Serine/Threonine Kinases, TDY Mitogen-Activated Protein
Kinases from Plants. Serine/Threonine Kinases (STKs),
Plant TDY Mitogen-Activated Protein Kinase (MAPK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The TDY
MAPK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKs are important mediators of cellular
responses to extracellular signals. In plants, MAPKs are
associated with physiological, developmental, hormonal,
and stress responses. Some plants show numerous gene
duplications of MAPKs. Arabidopsis thaliana harbors at
least 20 MAPKs, named AtMPK1-20. Oryza sativa contains
at least 17 MAPKs. There are two subtypes of plant MAPKs
based on the conserved phosphorylation motif present in
the activation loop, TEY and TDY. Arabidopsis thaliana
contains more TEY-type MAPKs than TDY-type, whereas the
reverse is true for Oryza sativa. This subfamily
represents the TDY subtype and is composed of Group D
plant MAPKs including Arabidopsis thaliana MPK18
(AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1
(OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1),
Zea mays MPK6, and the Medicago sativa TDY1 gene
product. OsBWMK1 enhances resistance to pathogenic
infections. It mediates stress-activated defense
responses by activating a transcription factor that
affects the expression of stress-related genes. AtMPK18
is involved in microtubule-related functions.
Length = 338
Score = 72.9 bits (179), Expect = 9e-17
Identities = 28/44 (63%), Positives = 34/44 (77%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L+ +H +FLYQ+LR LKYIH+ANV HRDLKP N+L N C LK
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLK 143
>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the
Serine/Threonine Kinase, p38gamma Mitogen-Activated
Protein Kinase. Serine/Threonine Kinases (STKs),
p38gamma subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
p38gamma subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. p38 kinases are mitogen-activated protein
kinases (MAPKs), serving as important mediators of
cellular responses to extracellular signals. They are
activated by the MAPK kinases MKK3 and MKK6, which in
turn are activated by upstream MAPK kinase kinases
including TAK1, ASK1, and MLK3, in response to cellular
stresses or inflammatory cytokines. Vertebrates contain
four isoforms of p38, named alpha, beta, gamma, and
delta. p38gamma, also called MAPK12, is predominantly
expressed in skeletal muscle. Unlike p38alpha and
p38beta, p38gamma is insensitive to pyridinylimidazoles.
It displays an antagonizing function compared to
p38alpha. p38gamma inhibits, while p38alpha stimulates,
c-Jun phosphorylation and AP-1 mediated transcription.
p38gamma also plays a role in the signaling between Ras
and the estrogen receptor and has been implicated to
increase cell invasion and breast cancer progression. In
Xenopus, p38gamma is critical in the meiotic maturation
of oocytes.
Length = 343
Score = 71.9 bits (176), Expect = 2e-16
Identities = 27/48 (56%), Positives = 39/48 (81%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K+++LS D I + +YQ+L+GLKYIH+A ++HRDLKP NL +N C+LK
Sbjct: 111 KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELK 158
>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain.
Length = 260
Score = 68.4 bits (168), Expect = 2e-15
Identities = 22/53 (41%), Positives = 32/53 (60%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ ++ LS D QILRGL+Y+HS ++HRDLKP N+LL+ +K
Sbjct: 86 FDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVK 138
>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent
protein Kinase-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase (CDK)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKs are partly
regulated by their subcellular localization, which
defines substrate phosphorylation and the resulting
specific function. CDK1, CDK2, CDK4, and CDK6 have
well-defined functions in the cell cycle, such as the
regulation of the early G1 phase by CDK4 or CDK6, the
G1/S phase transition by CDK2, or the entry of mitosis
by CDK1. They also exhibit overlapping cyclin
specificity and functions in certain conditions.
Knockout mice with a single CDK deleted remain viable
with specific phenotypes, showing that some CDKs can
compensate for each other. For example, CDK4 can
compensate for the loss of CDK6, however, double
knockout mice with both CDK4 and CDK6 deleted die in
utero. CDK8 and CDK9 are mainly involved in
transcription while CDK5 is implicated in neuronal
function. CDK7 plays essential roles in both the cell
cycle as a CDK-Activating Kinase (CAK) and in
transcription as a component of the general
transcription factor TFIIH.
Length = 282
Score = 67.1 bits (165), Expect = 8e-15
Identities = 26/57 (45%), Positives = 34/57 (59%), Gaps = 3/57 (5%)
Query: 24 REYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
++Y D LS + I +YQ+LRGL Y HS +LHRDLKP N+L+N LK
Sbjct: 85 KKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLK 138
>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the
Serine/Threonine Kinase, p38delta Mitogen-Activated
Protein Kinase. Serine/Threonine Kinases (STKs),
p38delta subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
p38delta subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. p38 kinases are mitogen-activated protein
kinases (MAPKs), serving as important mediators of
cellular responses to extracellular signals. They are
activated by the MAPK kinases MKK3 and MKK6, which in
turn are activated by upstream MAPK kinase kinases
including TAK1, ASK1, and MLK3, in response to cellular
stresses or inflammatory cytokines. Vertebrates contain
four isoforms of p38, named alpha, beta, gamma, and
delta. p38delta, also called MAPK13, is found in
skeletal muscle, heart, lung, testis, pancreas, and
small intestine. It regulates microtubule function by
phosphorylating Tau. It activates the c-jun promoter and
plays a role in G2 cell cycle arrest. It also controls
the degration of c-Myb, which is associated with myeloid
leukemia and poor prognosis in colorectal cancer.
p38delta is the main isoform involved in regulating the
differentiation and apoptosis of keratinocytes.
Length = 342
Score = 66.1 bits (161), Expect = 3e-14
Identities = 34/73 (46%), Positives = 45/73 (61%), Gaps = 11/73 (15%)
Query: 19 SLVSFREYSDSH------RTKYQR-----LSNDHICYFLYQILRGLKYIHSANVLHRDLK 67
S VS E+ D + +T Q+ LS D + Y +YQ+L GLKYIHSA ++HRDLK
Sbjct: 85 SAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLK 144
Query: 68 PSNLLLNTTCDLK 80
P NL +N C+LK
Sbjct: 145 PGNLAVNEDCELK 157
>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), PCTAIRE-like subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The PCTAIRE-like subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein STKs, protein tyrosine kinases, RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Members of this
subfamily share sequence similarity with
Cyclin-Dependent Kinases (CDKs), which belong to a large
family of STKs that are regulated by their cognate
cyclins. Together, CDKs and cyclins are involved in the
control of cell-cycle progression, transcription, and
neuronal function. The association of PCTAIRE-like
proteins with cyclins has not been widely studied,
although PFTAIRE-1 has been shown to function as a CDK
which is regulated by cyclin D3 as well as the
membrane-associated cyclin Y. PCTAIRE-like proteins show
unusual expression patterns with high levels in
post-mitotic tissues, suggesting that they may be
involved in regulating post-mitotic cellular events.
Length = 291
Score = 65.1 bits (159), Expect = 4e-14
Identities = 31/70 (44%), Positives = 42/70 (60%), Gaps = 5/70 (7%)
Query: 16 TKESLVSFREYSDSHRTKYQR-----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
TK++L EY D+ +Y LS ++ FL+Q+LRGL Y H VLHRDLKP N
Sbjct: 74 TKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQN 133
Query: 71 LLLNTTCDLK 80
LL++ +LK
Sbjct: 134 LLISERGELK 143
>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen-Activated Protein
Kinase Kinase Kinase. Serine/threonine kinases (STKs),
mitogen-activated protein kinase (MAPK) kinase kinase
(MAPKKK) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called
MAP/ERK kinase kinases (MEKKs) in some cases. They
phosphorylate and activate MAPK kinases (MAPKKs or MKKs
or MAP2Ks), which in turn phosphorylate and activate
MAPKs during signaling cascades that are important in
mediating cellular responses to extracellular signals.
This subfamily is composed of the Apoptosis
Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or
MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant
and fungal MAPKKKs. Also included in this subfamily are
the cell division control proteins Schizosaccharomyces
pombe Cdc7 and Saccharomyces cerevisiae Cdc15.
Length = 260
Score = 64.5 bits (158), Expect = 6e-14
Identities = 19/52 (36%), Positives = 32/52 (61%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
S K+ +L I + QIL GL Y+HS ++HRD+K +N+L+++ +K
Sbjct: 90 SLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVK 141
>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent
protein Kinase 9-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 9 (CDK9)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK9-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDK9 and CDK12 from higher eukaryotes, yeast
BUR1, C-type plant CDKs (CdkC), and similar proteins.
CDK9, BUR1, and CdkC are functionally equivalent. They
act as a kinase for the C-terminal domain of RNA
polymerase II and participate in regulating mutliple
steps of gene expression including transcription
elongation and RNA processing. CDK9 and CdkC associate
with T-type cyclins while BUR1 associates with the
cyclin BUR2. CDK12 is a unique CDK that contains an
arginine/serine-rich (RS) domain, which is predominantly
found in splicing factors. CDK12 interacts with cyclins
L1 and L2, and participates in regulating transcription
and alternative splicing.
Length = 287
Score = 63.7 bits (156), Expect = 1e-13
Identities = 19/51 (37%), Positives = 31/51 (60%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ + + I ++ Q+L GL+Y+HS +LHRD+K SN+L+N LK
Sbjct: 90 LDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLK 140
>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase,
c-Jun N-terminal Kinase. Serine/Threonine Kinases
(STKs), c-Jun N-terminal kinase (JNK) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The JNK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. JNKs are
mitogen-activated protein kinases (MAPKs) that are
involved in many stress-activated responses including
those during inflammation, neurodegeneration, apoptosis,
and persistent pain sensitization, among others. They
are also essential regulators of physiological and
pathological processes and are involved in the
pathogenesis of several diseases such as diabetes,
atherosclerosis, stroke, Parkinson's and Alzheimer's.
Vetebrates harbor three different JNK genes (Jnk1, Jnk2,
and Jnk3) that are alternatively spliced to produce at
least 10 isoforms. JNKs are specifically activated by
the MAPK kinases MKK4 and MKK7, which are in turn
activated by upstream MAPK kinase kinases as a result of
different stimuli including stresses such as ultraviolet
(UV) irradiation, hyperosmolarity, heat shock, or
cytokines. JNKs activate a large number of different
substrates based on specific stimulus, cell type, and
cellular condition, and may be implicated in seemingly
contradictory functions.
Length = 353
Score = 63.2 bits (154), Expect = 3e-13
Identities = 22/44 (50%), Positives = 35/44 (79%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L ++ + Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LK
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 158
>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 5.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 5 (CDK5) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK5 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK5
is unusual in that it is regulated by non-cyclin
proteins, p35 and p39. It is highly expressed in the
nervous system and is critical in normal neural
development and function. It plays a role in neuronal
migration and differentiation, and is also important in
synaptic plasticity and learning. CDK5 also participates
in protecting against cell death and promoting
angiogenesis. Impaired CDK5 activity is implicated in
Alzheimer's disease, amyotrophic lateral sclerosis,
Parkinson's disease, Huntington's disease and acute
neuronal injury.
Length = 284
Score = 62.1 bits (151), Expect = 7e-13
Identities = 32/76 (42%), Positives = 44/76 (57%), Gaps = 6/76 (7%)
Query: 10 IEIRHSTKESLVSFREYSDSHRTKY----QRLSNDHIC-YFLYQILRGLKYIHSANVLHR 64
++ HS K+ + F EY D KY + I F++Q+L+GL + HS NVLHR
Sbjct: 65 YDVLHSDKKLTLVF-EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 65 DLKPSNLLLNTTCDLK 80
DLKP NLL+N +LK
Sbjct: 124 DLKPQNLLINKNGELK 139
>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases. Protein Kinases
(PKs), catalytic (c) domain. PKs catalyze the transfer
of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The PK family is part of a larger
superfamily that includes the catalytic domains of RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, phosphoinositide 3-kinase (PI3K), and
actin-fragmin kinase. PKs make up a large family of
serine/threonine kinases, protein tyrosine kinases
(PTKs), and dual-specificity PKs that phosphorylate both
serine/threonine and tyrosine residues of target
proteins. Majority of protein phosphorylation, about
95%, occurs on serine residues while only 1% occurs on
tyrosine residues. Protein phosphorylation is a
mechanism by which a wide variety of cellular proteins,
such as enzymes and membrane channels, are reversibly
regulated in response to certain stimuli. PKs often
function as components of signal transduction pathways
in which one kinase activates a second kinase, which in
turn, may act on other kinases; this sequential action
transmits a signal from the cell surface to target
proteins, which results in cellular responses. The PK
family is one of the largest known protein families with
more than 100 homologous yeast enzymes and 550 human
proteins. A fraction of PK family members are
pseudokinases that lack crucial residues for catalytic
activity. The mutiplicity of kinases allows for specific
regulation according to substrate, tissue distribution,
and cellular localization. PKs regulate many cellular
processes including proliferation, division,
differentiation, motility, survival, metabolism,
cell-cycle progression, cytoskeletal rearrangement,
immunity, and neuronal functions. Many kinases are
implicated in the development of various human diseases
including different types of cancer.
Length = 215
Score = 60.7 bits (148), Expect = 1e-12
Identities = 22/48 (45%), Positives = 31/48 (64%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 78
+ +LS D I L QIL GL+Y+HS ++HRDLKP N+LL++
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG 130
>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like
protein kinase 3-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), mammalian Ste20-like
protein kinase 3 (MST3)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MST3-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of MST3, MST4,
STK25, Schizosaccharomyces pombe Nak1 and Sid1,
Saccharomyces cerevisiae sporulation-specific protein 1
(SPS1), and related proteins. Nak1 is required by
fission yeast for polarizing the tips of actin
cytoskeleton and is involved in cell growth, cell
separation, cell morphology and cell-cycle progression.
Sid1 is a component in the septation initiation network
(SIN) signaling pathway, and plays a role in
cytokinesis. SPS1 plays a role in regulating proteins
required for spore wall formation. MST4 plays a role in
mitogen-activated protein kinase (MAPK) signaling during
cytoskeletal rearrangement, morphogenesis, and
apoptosis. MST3 phosphorylates the STK NDR and may play
a role in cell cycle progression and cell morphology.
STK25 may play a role in the regulation of cell
migration and polarization.
Length = 274
Score = 60.3 bits (147), Expect = 2e-12
Identities = 21/60 (35%), Positives = 34/60 (56%), Gaps = 4/60 (6%)
Query: 25 EY----SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
EY S K +L +I + L ++L GL+Y+H +HRD+K +N+LL+ D+K
Sbjct: 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVK 138
>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent
protein Kinase 1-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 1 (CDK1)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. This subfamily is composed of CDK1 from higher
eukaryotes, plants, and yeasts, as well as CDK2 and
CDK3. CDK1 is also called Cell division control protein
2 (Cdc2) or p34 protein kinase, and is regulated by
cyclins A, B, and E. The CDK1/cyclin A complex controls
G2 phase entry and progression while the CDK1/cyclin B
complex is critical for G2 to M phase transition. CDK2
is regulated by cyclin E or cyclin A. Upon activation by
cyclin E, it phosphorylates the retinoblastoma (pRb)
protein which activates E2F mediated transcription and
allows cells to move into S phase. The CDK2/cyclin A
complex plays a role in regulating DNA replication.
Studies in knockout mice revealed that CDK1 can
compensate for the loss of the cdk2 gene as it can also
bind cyclin E and drive G1 to S phase transition. CDK3
is regulated by cyclin C and it phosphorylates pRB
specifically during the G0/G1 transition. This
phosphorylation is required for cells to exit G0
efficiently and enter the G1 phase.
Length = 283
Score = 59.6 bits (145), Expect = 4e-12
Identities = 21/36 (58%), Positives = 27/36 (75%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+LYQ+L+G+ Y HS VLHRDLKP NLL++ LK
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALK 139
>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine
Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases
(STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PFTAIRE-1 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PFTAIRE-1 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PFTAIRE-1 is
widely expressed except in the spleen and thymus. It is
highly expressed in the brain, heart, pancreas, testis,
and ovary, and is localized in the cytoplasm. It is
regulated by cyclin D3 and is inhibited by the p21 cell
cycle inhibitor. It has also been shown to interact with
the membrane-associated cyclin Y, which recruits the
protein to the plasma membrane.
Length = 303
Score = 58.6 bits (141), Expect = 1e-11
Identities = 31/71 (43%), Positives = 43/71 (60%), Gaps = 5/71 (7%)
Query: 16 TKESLVSFREYSDSHRTKYQR-----LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
TKE+L EY + +Y L +++ FL+Q+LRGL YIH +LHRDLKP N
Sbjct: 74 TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQN 133
Query: 71 LLLNTTCDLKF 81
LL++ T +LK
Sbjct: 134 LLISDTGELKL 144
>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III
myosin-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), Class III myosin-like
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
class III myosin-like subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Class III myosins are motor
proteins with an N-terminal kinase catalytic domain and
a C-terminal actin-binding motor domain. Class III
myosins are present in the photoreceptors of
invertebrates and vertebrates and in the auditory hair
cells of mammals. The kinase domain of myosin III can
phosphorylate several cytoskeletal proteins,
conventional myosin regulatory light chains, and can
autophosphorylate the C-terminal motor domain. Myosin
III may play an important role in maintaining the
structural integrity of photoreceptor cell microvilli.
It may also function as a cargo carrier during
light-dependent translocation, in photoreceptor cells,
of proteins such as transducin and arrestin. The
Drosophila class III myosin, called NinaC (Neither
inactivation nor afterpotential protein C), is critical
in normal adaptation and termination of photoresponse.
Vertebrates contain two isoforms of class III myosin,
IIIA and IIIB. This subfamily also includes mammalian
NIK-like embryo-specific kinase (NESK), Traf2- and
Nck-interacting kinase (TNIK), mitogen-activated protein
kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or
MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in
some MAPK signaling pathways by activating a MAPK kinase
kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is
activated either by a small GTP-binding protein or by an
adaptor protein, which transmits the signal either
directly to a MAP3K to start the triple kinase core
cascade or indirectly through a mediator kinase, a
MAP4K. MAPK signaling cascades are important in
mediating cellular responses to extracellular signals.
Length = 275
Score = 58.4 bits (142), Expect = 1e-11
Identities = 22/50 (44%), Positives = 31/50 (62%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
R K +RL + I Y L + LRGL Y+H V+HRD+K N+LL ++K
Sbjct: 104 RKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153
>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-2 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-2 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-2 is
specifically expressed in neurons in the central nervous
system, mainly in terminally differentiated neurons. It
associates with Trap (Tudor repeat associator with
PCTAIRE-2) and could play a role in regulating
mitochondrial function in neurons.
Length = 309
Score = 58.5 bits (141), Expect = 1e-11
Identities = 35/83 (42%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 4 HQDQITIEIRHSTKESLVSFREYSDSHRTKYQR-----LSNDHICYFLYQILRGLKYIHS 58
H + +T+ T +SL EY D +Y +S ++ FLYQILRGL Y H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 59 ANVLHRDLKPSNLLLNTTCDLKF 81
VLHRDLKP NLL+N +LK
Sbjct: 123 RKVLHRDLKPQNLLINERGELKL 145
>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine
Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases
(STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PFTAIRE-2 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PFTAIRE-2 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PFTAIRE-2 is also
referred to as ALS2CR7 (amyotrophic lateral sclerosis 2
(juvenile) chromosome region candidate 7). It may be
associated with amyotrophic lateral sclerosis 2 (ALS2),
an autosomal recessive form of juvenile ALS. The
function of PFTAIRE-2 is not yet known.
Length = 291
Score = 58.4 bits (141), Expect = 1e-11
Identities = 30/71 (42%), Positives = 41/71 (57%), Gaps = 5/71 (7%)
Query: 16 TKESLVSFREYSDSHRTKY--QRLSNDHIC---YFLYQILRGLKYIHSANVLHRDLKPSN 70
TKE+L EY + +Y Q H F++Q+LRGL YIH ++LHRDLKP N
Sbjct: 74 TKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQN 133
Query: 71 LLLNTTCDLKF 81
LL++ +LK
Sbjct: 134 LLISYLGELKL 144
>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases.
Protein Kinases (PKs), STE family, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The STE family is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases (STKs), protein
tyrosine kinases (PTKs), RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). This family is composed of STKs, and
some dual-specificity PKs that phosphorylate both
threonine and tyrosine residues of target proteins. Most
members are kinases involved in mitogen-activated
protein kinase (MAPK) signaling cascades, acting as MAPK
kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK
kinase kinase kinases (MAP4Ks). The MAPK signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising of the MAPK, which is
phosphorylated and activated by a MAPKK, which itself is
phosphorylated and activated by a MAPKKK. Each MAPK
cascade is activated either by a small GTP-binding
protein or by an adaptor protein, which transmits the
signal either directly to a MAPKKK to start the triple
kinase core cascade or indirectly through a mediator
kinase, a MAP4K. Other STE family members include
p21-activated kinases (PAKs) and class III myosins,
among others. PAKs are Rho family GTPase-regulated
kinases that serve as important mediators in the
function of Cdc42 (cell division cycle 42) and Rac.
Class III myosins are motor proteins containing an
N-terminal kinase catalytic domain and a C-terminal
actin-binding domain, which can phosphorylate several
cytoskeletal proteins, conventional myosin regulatory
light chains, as well as autophosphorylate the
C-terminal motor domain. They play an important role in
maintaining the structural integrity of photoreceptor
cell microvilli.
Length = 253
Score = 57.6 bits (140), Expect = 2e-11
Identities = 18/50 (36%), Positives = 34/50 (68%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
++ Q L+ I Y ++L+GL+Y+HS ++HRD+K +N+LL + ++K
Sbjct: 89 KSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVK 138
>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine
Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine
Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
JNK2 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. JNKs are mitogen-activated protein kinases
(MAPKs) that are involved in many stress-activated
responses including those during inflammation,
neurodegeneration, apoptosis, and persistent pain
sensitization, among others. Vetebrates harbor three
different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like
JNK2, is expressed in every cell and tissue type.
Initially it was thought that JNK1 and JNK2 were
functionally redundant as mice deficient in either genes
(Jnk1 or Jnk2) could survive but disruption of both
genes resulted in lethality. However, recent studies
have shown that JNK1 and JNK2 perform distinct functions
through specific binding partners and substrates. JNK2
is specifically translocated to the mitochondria during
dopaminergic cell death. Specific substrates include the
microtubule-associated proteins DCX and Tau, as well as
TIF-IA which is involved in ribosomal RNA synthesis
regulation. Mice deficient in Jnk2 show protection
against arthritis, type 1 diabetes, atherosclerosis,
abdominal aortic aneurysm, cardiac cell death,
TNF-induced liver damage, and tumor growth, indicating
that JNK2 may play roles in the pathogenesis of these
diseases.
Length = 359
Score = 57.7 bits (139), Expect = 3e-11
Identities = 22/49 (44%), Positives = 36/49 (73%)
Query: 34 YQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFF 82
+ L ++ + Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LK
Sbjct: 117 HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 165
>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 7.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 7 (CDK7) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK7 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK7
plays essential roles in the cell cycle and in
transcription. It associates with cyclin H and MAT1 and
acts as a CDK-Activating Kinase (CAK) by phosphorylating
and activating cell cycle CDKs (CDK1/2/4/6). In the
brain, it activates CDK5. CDK7 is also a component of
the general transcription factor TFIIH, which
phosphorylates the C-terminal domain (CTD) of RNA
polymerase II when it is bound with unphosphorylated
DNA, as present in the pre-initiation complex. Following
phosphorylation, the CTD dissociates from the DNA which
allows transcription initiation.
Length = 298
Score = 57.2 bits (139), Expect = 3e-11
Identities = 21/45 (46%), Positives = 30/45 (66%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L+ I ++ LRGL+Y+HS +LHRDLKP+NLL+ + LK
Sbjct: 98 VLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLK 142
>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine
Kinase, Never In Mitosis gene A-related kinase.
Serine/Threonine Kinases (STKs), Never In Mitosis gene A
(NIMA)-related kinase (Nek) family, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. The Nek family is
composed of 11 different mammalian members (Nek1-11)
with similarity to the catalytic domain of Aspergillus
nidulans NIMA kinase, the founding member of the Nek
family which was identified in a screen for cell cycle
mutants that were prevented from entering mitosis. Neks
contain a conserved N-terminal catalytic domain and a
more divergent C-terminal regulatory region of various
sizes and structures. They are involved in the
regulation of downstream processes following the
activation of Cdc2, and many of their functions are cell
cycle-related. They play critical roles in microtubule
dynamics during ciliogenesis and mitosis.
Length = 258
Score = 56.7 bits (138), Expect = 4e-11
Identities = 16/52 (30%), Positives = 28/52 (53%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ + + + I + Q+ LKY+HS +LHRD+KP N+ L + +K
Sbjct: 92 KQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVK 143
>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine
Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine
Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
JNK1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. JNKs are mitogen-activated protein kinases
(MAPKs) that are involved in many stress-activated
responses including those during inflammation,
neurodegeneration, apoptosis, and persistent pain
sensitization, among others. Vetebrates harbor three
different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like
JNK2, is expressed in every cell and tissue type.
Initially it was thought that JNK1 and JNK2 were
functionally redundant as mice deficient in either genes
(Jnk1 or Jnk2) could survive but disruption of both
genes resulted in lethality. However, recent studies
have shown that JNK1 and JNK2 perform distinct functions
through specific binding partners and substrates. JNK1
specifically binds with JAMP (JNK1-associated membrane
protein), which regulates the duration of JNK1 activity
in response to stimuli. Specific JNK1 substrates include
Itch and SG10, which are implicated in Th2 responses and
airway inflammation, and microtubule dynamics and
axodendritic length, respectively. Mice deficient in
Jnk1 are protected against arthritis, obesity, type 2
diabetes, cardiac cell death, and non-alcoholic liver
disease, suggesting that JNK1 may play roles in the
pathogenesis of these diseases.
Length = 364
Score = 57.0 bits (137), Expect = 5e-11
Identities = 22/46 (47%), Positives = 35/46 (76%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFF 82
L ++ + Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LK
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine
Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine
Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
JNK3 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. JNKs are mitogen-activated protein kinases
(MAPKs) that are involved in many stress-activated
responses including those during inflammation,
neurodegeneration, apoptosis, and persistent pain
sensitization, among others. Vetebrates harbor three
different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is
expressed primarily in the brain, and to a lesser extent
in the heart and testis. Mice deficient in Jnk3 are
protected against kainic acid-induced seizures, stroke,
sciatic axotomy neural death, and neuronal death due to
NGF deprivation, oxidative stress, or exposure to
beta-amyloid peptide. This suggests that JNK3 may play
roles in the pathogenesis of these diseases.
Length = 355
Score = 56.6 bits (136), Expect = 7e-11
Identities = 22/46 (47%), Positives = 35/46 (76%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFF 82
L ++ + Y LYQ+L G+K++HSA ++HRDLKPSN+++ + C LK
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine
Kinase, p21-activated kinase. Serine/threonine kinases
(STKs), p21-activated kinase (PAK) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PAK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PAKs are Rho
family GTPase-regulated kinases that serve as important
mediators in the function of Cdc42 (cell division cycle
42) and Rac. PAKs are implicated in the regulation of
many cellular processes including growth factor
receptor-mediated proliferation, cell polarity, cell
motility, cell death and survival, and actin
cytoskeleton organization. PAK deregulation is
associated with tumor development. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
Group I PAKs contain a PBD (p21-binding domain)
overlapping with an AID (autoinhibitory domain), a
C-terminal catalytic domain, SH3 binding sites and a
non-classical SH3 binding site for PIX (PAK-interacting
exchange factor). Group II PAKs contain a PBD and a
catalytic domain, but lack other motifs found in group I
PAKs. Since group II PAKs do not contain an obvious AID,
they may be regulated differently from group I PAKs.
Group I PAKs interact with the SH3 containing proteins
Nck, Grb2 and PIX; no such binding has been demonstrated
for group II PAKs.
Length = 286
Score = 55.7 bits (135), Expect = 1e-10
Identities = 19/45 (42%), Positives = 31/45 (68%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
R++ I Y ++L+GL+Y+HS NV+HRD+K N+LL+ +K
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVK 156
>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-3 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-3 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-3 shows a
restricted pattern of expression and is present in
brain, kidney, and intestine. It is elevated in
Alzheimer's disease (AD) and has been shown to associate
with paired helical filaments (PHFs) and stimulate Tau
phosphorylation. As AD progresses, phosphorylated Tau
aggregates and forms PHFs, which leads to the formation
of neurofibrillary tangles (NFTs). In human glioma
cells, PCTAIRE-3 induces cell cycle arrest and cell
death.
Length = 288
Score = 55.4 bits (133), Expect = 2e-10
Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 4 HQDQITIEIRHSTKESLVSFREYSDSHRTKY-----QRLSNDHICYFLYQILRGLKYIHS 58
H + +T+ T+ L EY DS +Y +S ++ F++Q+LRGL Y H
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 59 ANVLHRDLKPSNLLLNTTCDLKF 81
+LHRDLKP NLL+N +LK
Sbjct: 122 RKILHRDLKPQNLLINEKGELKL 144
>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-1 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-1 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-1 is
expressed ubiquitously and is localized in the
cytoplasm. Its kinase activity is cell cycle dependent
and peaks at the S and G2 phases. PCTAIRE-1 is highly
expressed in the brain and may play a role in regulating
neurite outgrowth. It can also associate with Trap
(Tudor repeat associator with PCTAIRE-2), a
physiological partner of PCTAIRE-2; with p11, a small
dimeric protein with similarity to S100; and with 14-3-3
proteins, mediators of phosphorylation-dependent
interactions in many different proteins.
Length = 301
Score = 55.4 bits (133), Expect = 2e-10
Identities = 32/83 (38%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 4 HQDQITIEIRHSTKESLVSFREYSDSHRTKY-----QRLSNDHICYFLYQILRGLKYIHS 58
H + +T+ T++SL EY D +Y ++ ++ FL+Q+LRGL Y H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 59 ANVLHRDLKPSNLLLNTTCDLKF 81
VLHRDLKP NLL+N +LK
Sbjct: 123 RKVLHRDLKPQNLLINERGELKL 145
>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional.
Length = 294
Score = 54.4 bits (131), Expect = 3e-10
Identities = 30/70 (42%), Positives = 39/70 (55%), Gaps = 7/70 (10%)
Query: 11 EIRHSTKESLVSFREYSD----SHRTKYQRLSNDH--ICYFLYQILRGLKYIHSANVLHR 64
++ HS K + F EY D H + + I +LYQILRG+ Y HS VLHR
Sbjct: 68 DVVHSEKRLYLVF-EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR 126
Query: 65 DLKPSNLLLN 74
DLKP NLL++
Sbjct: 127 DLKPQNLLID 136
>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant
dual-specificity MAP kinase kinases and similar
proteins. Protein kinases (PKs), MAP kinase kinase
(MAPKK) subfamily, Plant MAPKKs and similar proteins,
catalytic (c) domain. PKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine or
tyrosine residues on protein substrates. The MAPKK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein serine/threonine
kinases, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The mitogen-activated protein
(MAP) kinase signaling pathways are important mediators
of cellular responses to extracellular signals. The
pathways involve a triple kinase core cascade comprising
of the MAP kinase (MAPK), which is phosphorylated and
activated by a MAPK kinase (MAPKK or MKK), which itself
is phosphorylated and activated by a MAPK kinase kinase
(MAPKKK or MKKK). Members of this group include MAPKKs
from plants, kinetoplastids, alveolates, and mycetozoa.
The MAPKK, LmxPK4, from Leishmania mexicana, is
important in differentiation and virulence.
Dictyostelium discoideum MEK1 is required for proper
chemotaxis. MEK1 null mutants display severe defects in
cell polarization and directional movement. Plants
contain multiple MAPKKs like other eukaryotes. The
Arabidopsis genome encodes for 10 MAPKKs while poplar
and rice contain 13 MAPKKs each. The functions of these
proteins have not been fully elucidated. There is
evidence to suggest that MAPK cascades are involved in
plant stress responses. In Arabidopsis, MKK3 plays a
role in pathogen signaling, MKK2 is involved in cold and
salt stress signaling, MKK4/MKK5 participates in innate
immunity, and MKK7 regulates basal and systemic acquired
resistance.
Length = 264
Score = 54.1 bits (131), Expect = 4e-10
Identities = 19/38 (50%), Positives = 30/38 (78%), Gaps = 1/38 (2%)
Query: 44 YFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLK 80
Y QIL+GL Y+H+ +++HRD+KPSNLL+N+ ++K
Sbjct: 103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVK 140
>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine
Kinase, Cell Cycle-Related Kinase. Serine/Threonine
Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CCRK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CCRK was previously called p42. It is a
Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK)
which is essential for the activation of CDK2. It is
indispensable for cell growth and has been implicated in
the progression of glioblastoma multiforme. In the
heart, a splice variant of CCRK with a different
C-terminal half is expressed, this variant promotes
cardiac cell growth and survival and is significantly
down-regulated during the development of heart failure.
Length = 286
Score = 54.2 bits (131), Expect = 4e-10
Identities = 15/36 (41%), Positives = 27/36 (75%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
++ +L+G+ Y+H+ ++HRDLKP+NLL++ LK
Sbjct: 104 YMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK 139
>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein
Serine/Threonine Kinases, Mammalian Ste20-like protein
kinase 1 and 2. Serine/threonine kinases (STKs),
mammalian Ste20-like protein kinase 1 (MST1) and MST2
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MST1/2 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of MST1, MST2, and
related proteins including Drosophila Hippo and
Dictyostelium discoideum Krs1 (kinase responsive to
stress 1). MST1/2 and Hippo are involved in a conserved
pathway that governs cell contact inhibition, organ size
control, and tumor development. MST1 activates the
mitogen-activated protein kinases (MAPKs) p38 and c-Jun
N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and
MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase
kinase kinase (MAPKKKK). Activation of JNK by MST1 leads
to caspase activation and apoptosis. MST1 has also been
implicated in cell proliferation and differentiation.
Krs1 may regulate cell growth arrest and apoptosis in
response to cellular stress.
Length = 256
Score = 53.4 bits (129), Expect = 6e-10
Identities = 20/45 (44%), Positives = 28/45 (62%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L+ + I LYQ L+GL+Y+HS +HRD+K N+LLN K
Sbjct: 95 TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAK 139
>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 12.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 12 (CDK12) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK12 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK12 is also called Cdc2-related protein
kinase 7 (CRK7) or Cdc2-related kinase
arginine/serine-rich (CrkRS). It is a unique CDK that
contains an arginine/serine-rich (RS) domain, which is
predominantly found in splicing factors. CDK12 is widely
expressed in tissues. It interacts with cyclins L1 and
L2, and plays roles in regulating transcription and
alternative splicing.
Length = 302
Score = 54.0 bits (130), Expect = 6e-10
Identities = 23/43 (53%), Positives = 28/43 (65%)
Query: 38 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
S DHI F+ Q+L GL Y H N LHRD+K SN+LLN +K
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156
>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine
Kinase, Fungal Cyclin-Dependent protein Kinase Pho85.
Serine/Threonine Kinases (STKs), Pho85 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Pho85 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Pho85 is a
multifunctional Cyclin-Dependent protein Kinase (CDK) in
yeast. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. Pho85 is regulated
by 10 different cyclins (Pcls) and plays a role in G1
progression, cell polarity, phosphate and glycogen
metabolism, gene expression, and in signaling changes in
the environment. It is not essential for yeast viability
and is the functional homolog of mammalian CDK5, which
plays a role in central nervous system development.
Length = 284
Score = 53.6 bits (129), Expect = 7e-10
Identities = 27/72 (37%), Positives = 36/72 (50%), Gaps = 7/72 (9%)
Query: 16 TKESLVSFREYSDSHRTKYQRLSNDH-------ICYFLYQILRGLKYIHSANVLHRDLKP 68
T+ L+ EY D KY + F YQ+L+G+ + H VLHRDLKP
Sbjct: 69 TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKP 128
Query: 69 SNLLLNTTCDLK 80
NLL+N +LK
Sbjct: 129 QNLLINKRGELK 140
>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ
cell-Associated Kinase-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Male germ
cell-Associated Kinase (MAK)-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of human MAK and
MAK-related kinase (MRK), Saccharomyces cerevisiae
Ime2p, Schizosaccharomyces pombe Mei4-dependent protein
3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5,
Arabidopsis thaliana MHK, and similar proteins. These
proteins play important roles during meiosis. MAK is
highly expressed in testicular cells specifically in the
meiotic phase, but is not essential for spermatogenesis
and fertility. It functions as a coactivator of the
androgen receptor in prostate cells. MRK, also called
Intestinal Cell Kinase (ICK), is expressed ubiquitously,
with highest expression in the ovary and uterus. A
missense mutation in MRK causes
endocrine-cerebro-osteodysplasia (ECO), suggesting that
this protein plays an important role in the development
of many organs. MAK and MRK may be involved in
regulating cell cycle and cell fate. Ime2p is a
meiosis-specific kinase that is important during meiotic
initiation and during the later stages of meiosis. Mde3
functions downstream of the transcription factor Mei-4
which is essential for meiotic prophase I.
Length = 283
Score = 53.3 bits (129), Expect = 8e-10
Identities = 20/44 (45%), Positives = 26/44 (59%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
K + S I +YQIL+GL +IH HRDLKP NLL++
Sbjct: 92 KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135
>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine
Kinase, Fungal Cyclin-Dependent protein Kinase Bypass
UAS Requirement 1 and similar proteins.
Serine/Threonine Kinases (STKs), Bypass UAS Requirement
1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
BUR1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. BUR1, also called
SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK)
that is functionally equivalent to mammalian CDK9. It
associates with the cyclin BUR2. BUR genes were
orginally identified in a genetic screen as factors
involved in general transcription. The BUR1/BUR2 complex
phosphorylates the C-terminal domain of RNA polymerase
II. In addition, this complex regulates histone
modification by phosporylating Rad6 and mediating the
association of the Paf1 complex with chromatin.
Length = 311
Score = 52.3 bits (126), Expect = 2e-09
Identities = 16/45 (35%), Positives = 30/45 (66%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+L+ I ++ Q+L G+ Y+H ++LHRD+K +N+L++ LK
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILK 155
>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine
Kinase, cAMP-dependent protein kinase. Serine/Threonine
Kinases (STKs), cAMP-dependent protein kinase (PKA)
subfamily, catalytic (c) subunit. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PKA
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). This subfamily is composed of the
cAMP-dependent proteins kinases, PKA and PRKX. The
inactive PKA holoenzyme is a heterotetramer composed of
two phosphorylated and active catalytic (C) subunits
with a dimer of regulatory (R) subunits. Activation is
achieved through the binding of the important second
messenger cAMP to the R subunits, which leads to the
dissociation of PKA into the R dimer and two active C
subunits. PKA is present ubiquitously in cells and
interacts with many different downstream targets. It
plays a role in the regulation of diverse processes such
as growth, development, memory, metabolism, gene
expression, immunity, and lipolysis.
Length = 290
Score = 52.2 bits (126), Expect = 2e-09
Identities = 19/52 (36%), Positives = 32/52 (61%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
SH K R ++ Q++ L+Y+HS ++++RDLKP NLLL++ +K
Sbjct: 90 SHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIK 141
>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine
Kinase, Cell Division Cycle 2-like 1. Serine/Threonine
Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CDC2L1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDC2L1, also
called PITSLRE, exists in different isoforms which are
named using the alias CDK11(p). The CDC2L1 gene produces
two protein products, CDK11(p110) and CDK11(p58). CDC2L1
is also represented by the caspase-processed CDK11(p46).
CDK11(p110), the major isoform, associates with cyclin L
and is expressed throughout the cell cycle. It is
involved in RNA processing and the regulation of
transcription. CDK11(p58) associates with cyclin D3 and
is expressed during the G2/M phase of the cell cycle. It
plays roles in spindle morphogenesis, centrosome
maturation, sister chromatid cohesion, and the
completion of mitosis. CDK11(p46) is formed from the
larger isoforms by caspases during TNFalpha- and
Fas-induced apoptosis. It functions as a downstream
effector kinase in apoptotic signaling pathways and
interacts with eukaryotic initiation factor 3f (eIF3f),
p21-activated kinase (PAK1), and Ran-binding protein
(RanBPM).
Length = 293
Score = 52.2 bits (126), Expect = 2e-09
Identities = 18/36 (50%), Positives = 24/36 (66%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ Q+L G+ ++H +LHRDLK SNLLLN LK
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILK 146
>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control
protein 7-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), (Cdc7)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Cdc7-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this subfamily include
Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae
Cdc15, Arabidopsis thaliana mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK) epsilon, and
related proteins. MAPKKKs phosphorylate and activate
MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. Fission yeast Cdc7
is essential for cell division by playing a key role in
the initiation of septum formation and cytokinesis.
Budding yeast Cdc15 functions to coordinate mitotic exit
with cytokinesis. Arabidopsis MAPKKK epsilon is required
for pollen development in the plasma membrane.
Length = 254
Score = 51.1 bits (123), Expect = 4e-09
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 5/64 (7%)
Query: 16 TKESLVSFREYSD--SHRT---KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
T +SL EY++ S R K+ + ++YQ+L+GL Y+H V+HRD+K +N
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAAN 129
Query: 71 LLLN 74
+L
Sbjct: 130 ILTT 133
>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal
Bck1-like MAP Kinase Kinase Kinases. Serine/threonine
kinases (STKs), mitogen-activated protein kinase (MAPK)
kinase kinase (MAPKKK) subfamily, fungal Bck1-like
proteins, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include the MAPKKKs
Saccharomyces cerevisiae Bck1 and Schizosaccharomyces
pombe Mkh1, and related proteins. MAPKKKs phosphorylate
and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks),
which in turn phosphorylate and activate MAPKs during
signaling cascades that are important in mediating
cellular responses to extracellular signals. Budding
yeast Bck1 is part of the cell integrity MAPK pathway,
which is activated by stresses and aggressions to the
cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and
the MAPK Slt2 make up the cascade that is important in
the maintenance of cell wall homeostasis. Fission yeast
Mkh1 is involved in MAPK cascades regulating cell
morphology, cell wall integrity, salt resistance, and
filamentous growth in response to stress.
Length = 272
Score = 51.0 bits (122), Expect = 6e-09
Identities = 21/52 (40%), Positives = 29/52 (55%), Gaps = 2/52 (3%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKFF 82
Y R + +F Q+L GL Y+HS +LHRDLK NLL++ C + F
Sbjct: 101 TYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF 152
>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like
Protein Serine/Threonine Kinases. Serine/threonine
kinases (STKs), Nak1 subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The Nak1 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae
Kic1p (kinase that interacts with Cdc31p) and related
proteins. Nak1 (also known as N-rich kinase 1), is
required by fission yeast for polarizing the tips of
actin cytoskeleton and is involved in cell growth, cell
separation, cell morphology and cell-cycle progression.
Kic1p is required by budding yeast for cell integrity
and morphogenesis. Kic1p interacts with Cdc31p, the
yeast homologue of centrin, and phosphorylates
substrates in a Cdc31p-dependent manner.
Length = 277
Score = 50.9 bits (122), Expect = 7e-09
Identities = 21/57 (36%), Positives = 32/57 (56%), Gaps = 7/57 (12%)
Query: 29 SHRT--KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CD 78
S RT K ++ +I + ++L LKYIH V+HRD+K +N+L+ T CD
Sbjct: 88 SVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCD 144
>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase 2 and 3.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 2 (CDK2) and CDK3 subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK2/3 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK2 is regulated by cyclin E or cyclin A.
Upon activation by cyclin E, it phosphorylates the
retinoblastoma (pRb) protein which activates E2F
mediated transcription and allows cells to move into S
phase. The CDK2/cyclin A complex plays a role in
regulating DNA replication. CDK2, together with CDK4,
also regulates embryonic cell proliferation. Despite
these important roles, mice deleted for the cdk2 gene
are viable and normal except for being sterile. This may
be due to compensation provided by CDK1 (also called
Cdc2), which can also bind cyclin E and drive the G1 to
S phase transition. CDK3 is regulated by cyclin C and it
phosphorylates pRB specifically during the G0/G1
transition. This phosphorylation is required for cells
to exit G0 efficiently and enter the G1 phase.
Length = 284
Score = 50.2 bits (120), Expect = 1e-08
Identities = 21/36 (58%), Positives = 28/36 (77%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+L+Q+L+GL + HS VLHRDLKP NLL+NT +K
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIK 140
>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein
Kinase Like Serine/Threonine Kinases. Serine/Threonine
Kinases (STKs), Cyclin-dependent protein kinase like
(CDKL) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CDKL subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDKL1-5 and similar proteins. Some CDKLs,
like CDKL1 and CDKL3, may be implicated in
transformation and others, like CDKL3 and CDKL5, are
associated with mental retardation when impaired. CDKL2
plays a role in learning and memory.
Length = 288
Score = 49.2 bits (118), Expect = 2e-08
Identities = 16/41 (39%), Positives = 28/41 (68%), Gaps = 5/41 (12%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CDLKF 81
++Q+L+ + Y HS N++HRD+KP N+L++ + CD F
Sbjct: 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGF 146
>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity.
Phosphotransferases. The specificity of this class of
kinases can not be predicted. Possible dual-specificity
Ser/Thr/Tyr kinase.
Length = 258
Score = 49.1 bits (118), Expect = 3e-08
Identities = 16/45 (35%), Positives = 25/45 (55%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+ + + LS + F QI RG++Y+ S N +HRDL N L+
Sbjct: 93 RKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG 137
>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase;
Provisional.
Length = 353
Score = 49.1 bits (117), Expect = 3e-08
Identities = 17/33 (51%), Positives = 27/33 (81%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
QIL G+ Y+H +++HRD+KPSNLL+N+ ++K
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK 208
>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent
protein Kinase 8-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 8 (CDK8)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK8-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDK8, CDC2L6, and similar proteins. CDK8
functions as a negative or positive regulator of
transcription, depending on the scenario. Together with
its regulator, cyclin C, it reversibly associates with
the multi-subunit core Mediator complex, a cofactor that
is involved in regulating RNA polymerase II (RNAP
II)-dependent transcription. CDC2L6 also associates with
Mediator in complexes lacking CDK8. In VP16-dependent
transcriptional activation, CDK8 and CDC2L6 exerts
opposing effects by positive and negative regulation,
respectively, in similar conditions.
Length = 316
Score = 48.8 bits (117), Expect = 3e-08
Identities = 18/28 (64%), Positives = 24/28 (85%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLL 73
L+QIL G+ Y+HS VLHRDLKP+N+L+
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILV 141
>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like
dual-specificity MAP kinase kinases. Protein kinases
(PKs), MAP kinase kinase(MAPKK) subfamily, fungal
Pek1-like proteins, catalytic (c) domain. PKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The MAPKK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases, protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
mitogen-activated protein (MAP) kinase signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising of the MAP kinase (MAPK),
which is phosphorylated and activated by a MAPK kinase
(MAPKK or MKK), which itself is phosphorylated and
activated by a MAPK kinase kinase (MAPKKK or MKKK).
Members of this group include the MAPKKs Pek1/Skh1 from
Schizosaccharomyces pombe and MKK2 from Saccharomyces
cerevisiae, and related proteins. Both fission yeast
Pek1 and baker's yeast MKK2 are components of the cell
integrity MAPK pathway. In fission yeast, Pek1
phosphorylates and activates the MAPK Pmk1/Spm1 and is
regulated by the MAPKKK Mkh1. In baker's yeast, the
pathway involves the MAPK Slt2, the MAPKKs MKK1 and
MKK2, and the MAPKKK Bck1. The cell integrity MAPK
cascade is activated by multiple stress conditions, and
is essential in cell wall construction, morphogenesis,
cytokinesis, and ion homeostasis.
Length = 287
Score = 49.0 bits (117), Expect = 4e-08
Identities = 17/35 (48%), Positives = 24/35 (68%), Gaps = 5/35 (14%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLNTT-----CD 78
+L+GL Y+HS ++HRD+KPSN+LL CD
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCD 148
>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated
serine/threonine kinase-like proteins. Serine/Threonine
Kinases (STKs), Microtubule-associated serine/threonine
(MAST) kinase subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MAST kinase subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The MAST kinase subfamily
includes MAST kinases, MAST-like (MASTL) kinases, and
fungal kinases with similarity to Saccharomyces
cerevisiae Rim15 and Schizosaccharomyces pombe cek1.
MAST kinases contain an N-terminal domain of unknown
function, a central catalytic domain, and a C-terminal
PDZ domain that mediates protein-protein interactions.
MASTL kinases carry only a catalytic domain which
contains a long insert relative to other kinases. The
fungal kinases in this subfamily harbor other domains in
addition to a central catalytic domain, which also
contains an insert relative to MAST kinases like MASTL.
Rim15 contains a C-terminal signal receiver (REC) domain
while cek1 contains an N-terminal PAS domain. MAST
kinases are cytoskeletal associated kinases of unknown
function that are also expressed at neuromuscular
junctions and postsynaptic densities. The fungal
proteins Rim15 and cek1 are involved in the regulation
of meiosis and mitosis, respectively.
Length = 265
Score = 48.8 bits (117), Expect = 4e-08
Identities = 15/38 (39%), Positives = 26/38 (68%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L D ++ +I+ L+Y+HS ++HRDLKP N+L++
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127
>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase Like 2 and 3.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 2 (CDKL2) and CDKL3 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL2 and CDKL3
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKL2, also called
p56 KKIAMRE, is expressed in testis, kidney, lung, and
brain. It functions mainly in mature neurons and plays
an important role in learning and memory. Inactivation
of CDKL3, also called NKIAMRE (NKIATRE in rat), by
translocation is associated with mild mental
retardation. It has been reported that CDKL3 is lost in
leukemic cells having a chromosome arm 5q deletion, and
may contribute to the transformed phenotype.
Length = 286
Score = 48.5 bits (116), Expect = 4e-08
Identities = 19/42 (45%), Positives = 31/42 (73%), Gaps = 5/42 (11%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CDLKF 81
+L+QILRG+++ HS N++HRD+KP N+L++ + CD F
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 146
>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 1 from higher
eukaryotes-like. Serine/Threonine Kinases (STKs),
Cyclin-Dependent protein Kinase 1 (CDK1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. This subfamily is composed of CDK1 from higher
eukaryotes. CDK1 is also called Cell division control
protein 2 (Cdc2) or p34 protein kinase, and is regulated
by cyclins A, B, and E. The CDK1/cyclin A complex
controls G2 phase entry and progression. CDK1/cyclin A2
has also been implicated as an important regulator of S
phase events. The CDK1/cyclin B complex is critical for
G2 to M phase transition. It induces mitosis by
activating nuclear enzymes that regulate chromatin
condensation, nuclear membrane degradation,
mitosis-specific microtubule and cytoskeletal
reorganization. CDK1 also associates with cyclin E and
plays a role in the entry into S phase. CDK1
transcription is stable throughout the cell cycle but is
modulated in some pathological conditions. It may play a
role in regulating apoptosis under these conditions. In
breast cancer cells, HER2 can mediate apoptosis by
inactivating CDK1. Activation of CDK1 may contribute to
HIV-1 induced apoptosis and neuronal apoptosis in
neurodegenerative diseases.
Length = 285
Score = 48.6 bits (116), Expect = 4e-08
Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+LYQIL+G+ + HS VLHRDLKP NLL++
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLID 135
>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent
protein Kinase 4 and 6-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 4 (CDK4) and CDK6-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK4/6-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDK4 and CDK6
partner with D-type cyclins to regulate the early G1
phase of the cell cycle. They are the first kinase
activated by mitogenic signals to release cells from the
G0 arrested state. CDK4 and CDK6 are both expressed
ubiquitously, associate with all three D cyclins (D1, D2
and D3), and phosphorylate the retinoblastoma (pRb)
protein. They are also regulated by the INK4 family of
inhibitors which associate with either the CDK alone or
the CDK/cyclin complex. CDK4 and CDK6 show differences
in subcellular localization, sensitivity to some
inhibitors, timing in activation, tumor selectivity, and
possibly substrate profiles. Although CDK4 and CDK6 seem
to show some redundancy, they also have discrete,
nonoverlapping functions. CDK6 plays an important role
in cell differentiation.
Length = 287
Score = 48.4 bits (116), Expect = 5e-08
Identities = 17/44 (38%), Positives = 29/44 (65%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L + I + Q+LRG+ ++HS ++HRDLKP N+L+ + +K
Sbjct: 104 LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVK 147
>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine
Kinase, Plant B-type Cyclin-Dependent protein Kinase.
Serine/Threonine Kinases (STKs), Plant B-type
Cyclin-Dependent protein Kinase (CdkB) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CdkB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. The plant-specific B-type CDKs are expressed
from the late S to the M phase of the cell cycle. They
are characterized by the cyclin binding motif
PPT[A/T]LRE. They play a role in controlling mitosis and
integrating developmental pathways, such as stomata and
leaf development. CdkB has been shown to associate with
both cyclin B, which controls G2/M transition, and
cyclin D, which acts as a mediator in linking
extracellular signals to the cell cycle.
Length = 295
Score = 48.3 bits (115), Expect = 5e-08
Identities = 21/52 (40%), Positives = 33/52 (63%), Gaps = 1/52 (1%)
Query: 24 REYSDSHRTKYQR-LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+++ DS+ R L I F+YQ+L+G+ + H V+HRDLKP NLL++
Sbjct: 93 KKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD 144
>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated
protein kinase kinase kinase kinase-like Protein
Serine/Threonine Kinases. Serine/threonine kinases
(STKs), mitogen-activated protein kinase (MAPK) kinase
kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAP4K3-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily includes MAP4K3, MAP4K1,
MAP4K2, MAP4K5, and related proteins. Vertebrate members
contain an N-terminal catalytic domain and a C-terminal
citron homology (CNH) regulatory domain, similar to
MAP4K4/6. MAP4Ks are involved in some MAPK signaling
pathways that are important in mediating cellular
responses to extracellular signals by activating a MAPK
kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK
cascade is activated either by a small GTP-binding
protein or by an adaptor protein, which transmits the
signal either directly to a MAP3K to start the triple
kinase core cascade or indirectly through a mediator
kinase, a MAP4K. MAP4K1, also called haematopoietic
progenitor kinase 1 (HPK1), is a hematopoietic-specific
STK involved in many cellular signaling cascades
including MAPK, antigen receptor, apoptosis, growth
factor, and cytokine signaling. It participates in the
regulation of T cell receptor signaling and T
cell-mediated immune responses. MAP4K2 was referred to
as germinal center (GC) kinase because of its preferred
location in GC B cells. MAP4K3 plays a role in the
nutrient-responsive pathway of mTOR (mammalian target of
rapamycin) signaling. It is required in the activation
of S6 kinase by amino acids and for the phosphorylation
of the mTOR-regulated inhibitor of eukaryotic initiation
factor 4E. MAP4K5, also called germinal center
kinase-related enzyme (GCKR), has been shown to activate
the MAPK c-Jun N-terminal kinase (JNK).
Length = 262
Score = 48.1 bits (115), Expect = 6e-08
Identities = 18/44 (40%), Positives = 26/44 (59%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
LS I Y + L+GL Y+H +HRD+K +N+LL D+K
Sbjct: 98 LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVK 141
>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain.
Phosphotransferases. Tyrosine-specific kinase subfamily.
Length = 257
Score = 47.9 bits (115), Expect = 6e-08
Identities = 17/45 (37%), Positives = 25/45 (55%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+LS + F QI RG++Y+ S N +HRDL N L+ +K
Sbjct: 98 KLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK 142
>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 4.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4
(MEKK4) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK4 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK4 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates MAPK kinases (MAPKKs or
MKKs or MAP2Ks), which in turn phosphorylate and
activate MAPKs during signaling cascades that are
important in mediating cellular responses to
extracellular signals. MEKK4 activates the c-Jun
N-terminal kinase (JNK) and p38 MAPK signaling pathways
by directly activating their respective MAPKKs,
MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively
known as stress-activated MAPKs, as they are activated
in response to a variety of environmental stresses and
pro-inflammatory cytokines. MEKK4 also plays roles in
the re-polarization of the actin cytoskeleton in
response to osmotic stress, in the proper closure of the
neural tube, in cardiovascular development, and in
immune responses.
Length = 264
Score = 47.7 bits (114), Expect = 8e-08
Identities = 15/34 (44%), Positives = 24/34 (70%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
Q+L GL Y+HS ++HRD+KP+N+ L+ +K
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKL 140
>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine
Kinase, Apoptosis signal-regulating kinase.
Serine/threonine kinases (STKs), Apoptosis
signal-regulating kinase (ASK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ASK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Subfamily members
are mitogen-activated protein kinase (MAPK) kinase
kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1,
ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate
MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. ASK1 (also called
MAPKKK5) functions in the c-Jun N-terminal kinase (JNK)
and p38 MAPK signaling pathways by directly activating
their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It
plays important roles in cytokine and stress responses,
as well as in reactive oxygen species (ROS)-mediated
cellular responses. ASK1 is implicated in various
diseases mediated by oxidative stress including
inschemic heart disease, hypertension, vessel injury,
brain ischemia, Fanconi anemia, asthma, and pulmonary
edema, among others. ASK2 (also called MAPKKK6)
functions only in a heteromeric complex with ASK1, and
can activate ASK1 by direct phosphorylation. The
function of MAPKKK15 is still unknown.
Length = 268
Score = 47.1 bits (112), Expect = 1e-07
Identities = 21/51 (41%), Positives = 32/51 (62%), Gaps = 2/51 (3%)
Query: 27 SDSHRTKYQRLSN--DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
S R+K+ L + I ++ QIL GLKY+H ++HRD+K N+L+NT
Sbjct: 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein
Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1.
Serine/threonine kinases (STKs), plant MAP/ERK kinase
kinase 1 (MEKK1)-like subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The plant MEKK1 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein STKs, protein tyrosine kinases, RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily is
composed of plant mitogen-activated protein kinase
(MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks)
including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1
is a MAPKKK that phosphorylates and activates MAPK
kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. Arabidopsis thaliana
MEKK1 activates MPK4, a MAPK that regulates systemic
acquired resistance. MEKK1 also participates in the
regulation of temperature-sensitive and tissue-specific
cell death.
Length = 258
Score = 47.0 bits (112), Expect = 1e-07
Identities = 19/48 (39%), Positives = 29/48 (60%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
KY I + QIL GL+Y+H N +HRD+K +N+L++T +K
Sbjct: 95 KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVK 142
>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 10.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein Kinase 10 (CDK10) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK10 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK10, also called PISSLRE, is essential for
cell growth and proliferation, and acts through the G2/M
phase of the cell cycle. CDK10 has also been identified
as an important factor in endocrine therapy resistance
in breast cancer. CDK10 silencing increases the
transcription of c-RAF and the activation of the p42/p44
MAPK pathway, which leads to antiestrogen resistance.
Patients who express low levels of CDK10 relapse early
on tamoxifen.
Length = 309
Score = 47.0 bits (112), Expect = 1e-07
Identities = 19/33 (57%), Positives = 24/33 (72%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
Q+LRGL+Y+H ++HRDLK SNLLL LK
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLK 148
>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 9. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek9 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek9, also called
Nercc1, is primarily a cytoplasmic protein but can also
localize in the nucleus. It is involved in modulating
chromosome alignment and splitting during mitosis. It
interacts with the gamma-tubulin ring complex and the
Ran GTPase, and is implicated in microtubule
organization. Nek9 associates with FACT (FAcilitates
Chromatin Transcription) and modulates interphase
progression. It also interacts with Nek6, and Nek7,
during mitosis, resulting in their activation.
Length = 256
Score = 47.1 bits (112), Expect = 1e-07
Identities = 17/46 (36%), Positives = 27/46 (58%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
R K Q + + ++L+QI+ + YIH A +LHRD+K N+ L
Sbjct: 92 RQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137
>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein
Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2,
and similar domains. Serine/Threonine Kinases (STKs),
Chlamydomonas reinhardtii Never In Mitosis gene A
(NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Chlamydomonas
reinhardtii CNK2-like subfamily belongs to the
(NIMA)-related kinase (Nek) family. The Nek family
includes seven different Chlamydomonas Neks (CNKs 1-6
and Fa2). This subfamily includes CNK1, and -2. The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Chlamydomonas reinhardtii CNK2 has both
cilliary and cell cycle functions. It influences
flagellar length through promoting flagellar
disassembly, and it regulates cell size, through
influencing the size threshold at which cells commit to
mitosis.
Length = 256
Score = 47.1 bits (112), Expect = 2e-07
Identities = 17/44 (38%), Positives = 25/44 (56%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ I Q+LRGL+ +H +LHRDLK +N+LL +K
Sbjct: 100 IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVK 143
>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein
Serine/Threonine Kinase, Phosphoinositide-dependent
kinase 1. Serine/Threonine Kinases (STKs),
Phosphoinositide-dependent kinase 1 (PDK1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase (PI3K). PDK1
carries an N-terminal catalytic domain and a C-terminal
pleckstrin homology (PH) domain that binds
phosphoinositides. It phosphorylates the activation loop
of AGC kinases that are regulated by PI3K such as PKB,
SGK, and PKC, among others, and is crucial for their
activation. Thus, it contributes in regulating many
processes including metabolism, growth, proliferation,
and survival. PDK1 also has the ability to
autophosphorylate and is constitutively active in
mammalian cells. PDK1 is essential for normal embryo
development and is important in regulating cell volume.
Length = 280
Score = 46.8 bits (112), Expect = 2e-07
Identities = 18/43 (41%), Positives = 27/43 (62%)
Query: 32 TKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
KY L ++ +IL L+Y+HS ++HRDLKP N+LL+
Sbjct: 94 RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD 136
>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein
Serine/Threonine Kinases, Mitogen-Activated Protein
Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine
kinases (STKs), mitogen-activated protein kinase (MAPK)
kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6
(or MAP4K6) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MAP4K4/MAP4K6 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Members of this subfamily
contain an N-terminal catalytic domain and a C-terminal
citron homology (CNH) regulatory domain. MAP4Ks (or
MAPKKKKs) are involved in MAPK signaling pathways that
are important in mediating cellular responses to
extracellular signals by activating a MAPK kinase kinase
(MAPKKK or MAP3K or MKKK). Each MAPK cascade is
activated either by a small GTP-binding protein or by an
adaptor protein, which transmits the signal either
directly to a MAP3K to start the triple kinase core
cascade or indirectly through a mediator kinase, a
MAP4K. MAP4K4 is also called Nck Interacting kinase
(NIK). It facilitates the activation of the MAPKs,
extracellular signal-regulated kinase (ERK) 1, ERK2, and
c-Jun N-terminal kinase (JNK), by phosphorylating and
activating MEKK1. MAP4K4 plays a role in tumor necrosis
factor (TNF) alpha-induced insulin resistance. MAP4K4
silencing in skeletal muscle cells from type II diabetic
patients restores insulin-mediated glucose uptake.
MAP4K4, through JNK, also plays a broad role in cell
motility, which impacts inflammation, homeostasis, as
well as the invasion and spread of cancer. MAP4K4 is
found to be highly expressed in most tumor cell lines
relative to normal tissue. MAP4K6 (also called MINK for
Misshapen/NIKs-related kinase) is activated after Ras
induction and mediates activation of p38 MAPK. MAP4K6
plays a role in cell cycle arrest, cytoskeleton
organization, cell adhesion, and cell motility.
Length = 282
Score = 46.5 bits (110), Expect = 2e-07
Identities = 21/51 (41%), Positives = 30/51 (58%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
TK L D I Y +ILRGL ++H+ V+HRD+K N+LL ++K
Sbjct: 112 NTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKL 162
>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 6.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 6 (CDK6) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK6 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK6
is regulated by D-type cyclins and INK4 inhibitors. It
is active towards the retinoblastoma (pRb) protein,
implicating it to function in regulating the early G1
phase of the cell cycle. It is expressed ubiquitously
and is localized in the cytoplasm. It is also present in
the ruffling edge of spreading fibroblasts and may play
a role in cell spreading. It binds to the p21 inhibitor
without any effect on its own activity and it is
overexpressed in squamous cell carcinomas and
neuroblastomas. CDK6 has also been shown to inhibit cell
differentiation in many cell types.
Length = 290
Score = 46.5 bits (110), Expect = 2e-07
Identities = 17/36 (47%), Positives = 28/36 (77%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
++Q+LRGL ++HS V+HRDLKP N+L+ ++ +K
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 151
>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 1.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1
(MEKK1) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK1 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates MAPK kinases (MAPKKs or
MKKs or MAP2Ks), which in turn phosphorylate and
activate MAPKs during signaling cascades that are
important in mediating cellular responses to
extracellular signals. MEKK1 activates the extracellular
signal-regulated kinase 1/2 (ERK1/2) and c-Jun
N-terminal kinase (JNK) pathways by activating their
respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively.
MEKK1 is important in regulating cell survival and
apoptosis. MEKK1 also plays a role in cell migration,
tissue maintenance and homeostasis, and wound healing.
Length = 268
Score = 46.4 bits (110), Expect = 2e-07
Identities = 18/44 (40%), Positives = 28/44 (63%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
KY I + Q+LRGL Y+H ++HRD+K +NLL+++T
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST 139
>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), AGC (Protein Kinases A, G and C) family,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The AGC family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and Phosphoinositide 3-Kinase (PI3K). Members of
this family include cAMP-dependent Protein Kinase (PKA),
cGMP-dependent Protein Kinase (PKG), Protein Kinase C
(PKC), Protein Kinase B (PKB), G protein-coupled
Receptor Kinase (GRK), Serum- and Glucocorticoid-induced
Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase
(p70S6K or S6K), among others. AGC kinases share an
activation mechanism based on the phosphorylation of up
to three sites: the activation loop (A-loop), the
hydrophobic motif (HM) and the turn motif.
Phosphorylation at the A-loop is required of most AGC
kinases, which results in a disorder-to-order transition
of the A-loop. The ordered conformation results in the
access of substrates and ATP to the active site. A
subset of AGC kinases with C-terminal extensions
containing the HM also requires phosphorylation at this
site. Phosphorylation at the HM allows the C-terminal
extension to form an ordered structure that packs into
the hydrophobic pocket of the catalytic domain, which
then reconfigures the kinase into an active bi-lobed
state. In addition, growth factor-activated AGC kinases
such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require
phosphorylation at the turn motif (also called tail or
zipper site), located N-terminal to the HM at the
C-terminal extension. AGC kinases regulate many cellular
processes including division, growth, survival,
metabolism, motility, and differentiation. Many are
implicated in the development of various human diseases.
Length = 250
Score = 46.0 bits (110), Expect = 3e-07
Identities = 23/64 (35%), Positives = 38/64 (59%), Gaps = 5/64 (7%)
Query: 16 TKESLVSFREYSD-----SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
T+E L EY+ SH +K R S + ++ +I+ L+Y+HS +++RDLKP N
Sbjct: 64 TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPEN 123
Query: 71 LLLN 74
+LL+
Sbjct: 124 ILLD 127
>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 9.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 9 (CDK9) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK9 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK9
together with a cyclin partner (cyclin T1, T2a, T2b, or
K) is the main component of distinct positive
transcription elongation factors (P-TEFb), which
function as Ser2 C-terminal domain kinases of RNA
polymerase II. P-TEFb participates in multiple steps of
gene expression including transcription elongation, mRNA
synthesis, processing, export, and translation. It also
plays a role in mediating cytokine induced transcription
networks such as IL6-induced STAT3 signaling. In
addition, the CDK9/cyclin T2a complex promotes muscle
differentiation and enhances the function of some
myogenic regulatory factors.
Length = 310
Score = 45.8 bits (109), Expect = 4e-07
Identities = 17/48 (35%), Positives = 26/48 (54%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K + + I + +L GL YIH +LHRD+K +N+L+ LK
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILK 159
>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like
Protein Serine/Threonine Kinases. Serine/threonine
kinases (STKs), Ste20-like kinase (SLK)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The SLK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of the subfamily include SLK, STK10
(also called LOK for lymphocyte-oriented kinase), SmSLK
(Schistosoma mansoni SLK), and related proteins. SLK
promotes apoptosis through apoptosis signal-regulating
kinase 1 (ASK1) and the mitogen-activated protein kinase
(MAPK) p38. It also plays a role in mediating actin
reorganization. STK10 is responsible in regulating the
CD28 responsive element in T cells, as well as leukocyte
function associated antigen (LFA-1)-mediated lymphocyte
adhesion. SmSLK is capable of activating the MAPK Jun
N-terminal kinase (JNK) pathway in human embryonic
kidney (HEK) cells as well as in Xenopus oocytes. It may
participate in regulating MAPK cascades during
host-parasite interactions.
Length = 280
Score = 45.9 bits (109), Expect = 4e-07
Identities = 19/44 (43%), Positives = 26/44 (59%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L+ I Y Q+L L ++HS V+HRDLK N+LL D+K
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVK 143
>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 8. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek8 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek8 contains an
N-terminal kinase catalytic domain and a C-terminal RCC1
(regulator of chromosome condensation) domain. A double
point mutation in Nek8 causes cystic kidney disease in
mice that genetically resembles human autosomal
recessive polycystic kidney disease (ARPKD). Nek8 is
also associated with a rare form of juvenile renal
cystic disease, nephronophthisis type 9. It has been
suggested that a defect in the ciliary localization of
Nek8 contributes to the development of cysts manifested
by these diseases.
Length = 256
Score = 45.6 bits (108), Expect = 5e-07
Identities = 18/38 (47%), Positives = 25/38 (65%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L D I +F QIL L ++H+ +LHRDLK N+LL+
Sbjct: 98 LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135
>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase
3-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
(MEKK3)-like subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MEKK3-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
MEKK3, MEKK2, and related proteins, all containing an
N-terminal PB1 domain, which mediates oligomerization,
and a C-terminal catalytic domain. MEKK2 and MEKK3 are
mitogen-activated protein kinase (MAPK) kinase kinases
(MAPKKKs or MKKKs or MAP3Ks), proteins that
phosphorylate and activate MAPK kinases (MAPKKs or MKKs
or MAP2Ks), which in turn phosphorylate and activate
MAPKs during signaling cascades that are important in
mediating cellular responses to extracellular signals.
MEKK2 and MEKK3 activate MEK5 (also called MKK5), which
activates extracellular signal-regulated kinase 5
(ERK5). The ERK5 cascade plays roles in promoting cell
proliferation, differentiation, neuronal survival, and
neuroprotection. MEKK3 plays an essential role in
embryonic angiogenesis and early heart development.
MEKK2 and MEKK3 can also activate the MAPKs, c-Jun
N-terminal kinase (JNK) and p38, through their
respective MAPKKs.
Length = 263
Score = 45.6 bits (108), Expect = 5e-07
Identities = 22/68 (32%), Positives = 37/68 (54%), Gaps = 5/68 (7%)
Query: 18 ESLVSFREYSDSHRTK-----YQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 72
E+L F EY K Y L+ + QIL G++Y+HS ++HRD+K +N+L
Sbjct: 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL 136
Query: 73 LNTTCDLK 80
++ ++K
Sbjct: 137 RDSAGNVK 144
>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like
Protein Serine/Threonine Kinases. Serine/Threonine
Kinases (STKs), Microtubule-associated serine/threonine
(MAST) kinase subfamily, fungal Rim15-like kinases,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAST kinase
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include Saccharomyces
cerevisiae Rim15, Schizosaccharomyces pombe cek1, and
similar fungal proteins. They contain a central
catalytic domain, which contains an insert relative to
MAST kinases. In addition, Rim15 contains a C-terminal
signal receiver (REC) domain while cek1 contains an
N-terminal PAS domain. Rim15 (or Rim15p) functions as a
regulator of meiosis. It acts as a downstream effector
of PKA and regulates entry into stationary phase (G0).
Thus, it plays a crucial role in regulating yeast
proliferation, differentiation, and aging. Cek1 may
facilitate progression of mitotic anaphase.
Length = 260
Score = 45.2 bits (107), Expect = 6e-07
Identities = 15/44 (34%), Positives = 28/44 (63%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L D ++ +++ G++ +H ++HRD+KP NLL++ T LK
Sbjct: 94 LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137
>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein
Serine/Threonine Kinase, Class IIIB myosin.
Serine/threonine kinases (STKs), class IIIB myosin
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
class III myosin subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Class III myosins are motor
proteins containing an N-terminal kinase catalytic
domain and a C-terminal actin-binding domain. Class III
myosins may play an important role in maintaining the
structural integrity of photoreceptor cell microvilli.
They may also function as cargo carriers during
light-dependent translocation, in photoreceptor cells,
of proteins such as transducin and arrestin. Class IIIB
myosin is expressed highly in retina. It is also present
in the brain and testis. The human class IIIB myosin
gene maps to a region that overlaps the locus for
Bardet-Biedl syndrome, which is characterized by
dysmorphic extremities, retinal dystrophy, obesity, male
hypogenitalism, and renal abnormalities.
Length = 291
Score = 45.4 bits (107), Expect = 6e-07
Identities = 20/47 (42%), Positives = 30/47 (63%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
QRL I Y LY L GL+++H+ ++HRD+K +N+LL T +K
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169
>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein
Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2
and similar domains. Serine/Threonine Kinases (STKs),
Chlamydomonas reinhardtii FA2-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Chlamydomonas
reinhardtii FA2-like subfamily belongs to the
(NIMA)-related kinase (Nek) family. The Nek family
includes seven different Chlamydomonas Neks (CNKs 1-6
and Fa2). This subfamily includes FA2 and CNK4. The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Chlamydomonas reinhardtii FA2 was discovered
in a genetic screen for deflagellation-defective
mutants. It is essential for
basal-body/centriole-associated microtubule severing,
and plays a role in cell cycle progression. No cellular
function has yet been ascribed to CNK4.
Length = 256
Score = 45.2 bits (107), Expect = 7e-07
Identities = 18/45 (40%), Positives = 26/45 (57%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+ + L D + F QIL GL ++HS +LHRD+K NL L+
Sbjct: 91 KMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135
>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function
prediction only / Signal transduction mechanisms /
Transcription / DNA replication, recombination, and
repair].
Length = 384
Score = 45.1 bits (105), Expect = 8e-07
Identities = 18/46 (39%), Positives = 27/46 (58%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+ LS + L QIL L+Y+HS ++HRD+KP N+LL+
Sbjct: 90 KKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD 135
>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein
Serine/Threonine Kinase, Traf2- and Nck-interacting
kinase. Serine/threonine kinases (STKs), Traf2- and
Nck-interacting kinase (TNIK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The TNIK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Members of this
subfamily contain an N-terminal catalytic domain and a
C-terminal citron homology (CNH) regulatory domain,
similar to mitogen-activated protein kinase (MAPK),
kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks
participate in some MAPK signaling pathways by
activating a MAPK kinase kinase (MAPKKK or MAP3K or
MKKK). TNIK is an effector of Rap2, a small GTP-binding
protein from the Ras family. TNIK specifically activates
the c-Jun N-terminal kinase (JNK) pathway and plays a
role in regulating the actin cytoskeleton.
Length = 272
Score = 44.7 bits (105), Expect = 1e-06
Identities = 20/50 (40%), Positives = 29/50 (58%)
Query: 32 TKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
TK L + I Y +ILRGL ++H V+HRD+K N+LL ++K
Sbjct: 103 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 152
>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity
Protein Kinase, Mitogen-Activated Protein Kinase Kinase.
Protein kinases (PKs), MAP kinase kinase (MAPKK)
subfamily, catalytic (c) domain. PKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The MAPKK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases, protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
mitogen-activated protein (MAP) kinase signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising the MAP kinase (MAPK),
which is phosphorylated and activated by a MAPK kinase
(MAPKK or MKK or MAP2K), which itself is phosphorylated
and activated by a MAPK kinase kinase (MAPKKK or MKKK or
MAP3K). MAPKKs are dual-specificity PKs that
phosphorylate their downstream targets, MAPKs, at
specific threonine and tyrosine residues. There are
three MAPK subfamilies: extracellular signal-regulated
kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In
mammalian cells, there are seven MAPKKs (named MKK1-7)
and 20 MAPKKKs. Each MAPK subfamily can be activated by
at least two cognate MAPKKs and by multiple MAPKKKs.
Length = 265
Score = 44.6 bits (106), Expect = 1e-06
Identities = 14/30 (46%), Positives = 23/30 (76%), Gaps = 1/30 (3%)
Query: 47 YQILRGLKYIHSA-NVLHRDLKPSNLLLNT 75
+L+GL Y+H ++HRD+KPSN+L+N+
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136
>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase,
MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine
Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The MOK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MOK, also called Renal tumor antigen 1
(RAGE-1), is widely expressed and is enriched in testis,
kidney, lung, and brain. It is expressed in
approximately 50% of renal cell carcinomas (RCC) and is
a potential target for immunotherapy. MOK is stabilized
by its association with the HSP90 molecular chaperone.
It is induced by the transcription factor Cdx2 and may
be involved in regulating intestinal epithelial
development and differentiation.
Length = 282
Score = 43.8 bits (104), Expect = 2e-06
Identities = 12/30 (40%), Positives = 22/30 (73%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++YQ+L+ L ++H + HRD+KP N+L+
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILIK 134
>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase,
Cell Division Cycle 2-like 6. Serine/Threonine Kinases
(STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDC2L6 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDC2L6 is also called CDK8-like and was
previously referred to as CDK11. However, this is a
confusing nomenclature as CDC2L6 is distinct from
CDC2L1, which is represented by the two protein products
from its gene, called CDK11(p110) and CDK11(p58), as
well as the caspase-processed CDK11(p46). CDK11(p110),
CDK11(p58), and CDK11(p46)do not belong to this
subfamily. CDC2L6 is an associated protein of Mediator,
a multiprotein complex that provides a platform to
connect transcriptional and chromatin regulators and
cofactors, in order to activate and mediate RNA
polymerase II transcription. CDC2L6 is localized mainly
in the nucleus amd exerts an opposing effect to CDK8 in
VP16-dependent transcriptional activation by being a
negative regulator.
Length = 317
Score = 43.9 bits (103), Expect = 2e-06
Identities = 22/54 (40%), Positives = 34/54 (62%), Gaps = 1/54 (1%)
Query: 20 LVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
++ F S +++ Q L + LYQIL G+ Y+H+ VLHRDLKP+N+L+
Sbjct: 89 IIKFHRASKANKKPMQ-LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141
>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional.
Length = 335
Score = 43.6 bits (103), Expect = 2e-06
Identities = 16/40 (40%), Positives = 24/40 (60%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
RL+ + L QIL GL +H +HRDL P+N+ +N+
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS 154
>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein
Serine/Threonine Kinase, STK25 or Yeast
Sps1/Ste20-related kinase 1. Serine/threonine kinases
(STKs), STK25 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The STK25 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. STK25 is also called Ste20/oxidant stress
response kinase 1 (SOK1) or yeast Sps1/Ste20-related
kinase 1 (YSK1). STK25 is localized in the Golgi
apparatus through its interaction with the Golgi matrix
protein GM130. It may play a role in the regulation of
cell migration and polarization. STK25 binds and
phosphorylates CCM3 (cerebral cavernous malformation 3),
also called PCD10 (programmed cell death 10), and may
play a role in apoptosis. Human STK25 is a candidate
gene responsible for pseudopseudohypoparathyroidism
(PPHP), a disease that shares features with the Albright
hereditary osteodystrophy (AHO) phenotype.
Length = 277
Score = 43.5 bits (102), Expect = 3e-06
Identities = 19/45 (42%), Positives = 29/45 (64%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
L +I L +IL+GL Y+HS +HRD+K +N+LL+ D+K
Sbjct: 98 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKL 142
>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 8.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 8 (CDK8) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK8 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK8
can act as a negative or positive regulator of
transcription, depending on the scenario. Together with
its regulator, cyclin C, it reversibly associates with
the multi-subunit core Mediator complex, a cofactor that
is involved in regulating RNA polymerase II (RNAP
II)-dependent transcription. CDK8 phosphorylates cyclin
H, a subunit of the general transcription factor TFIIH,
which results in the inhibition of TFIIH-dependent
phosphorylation of the C-terminal domain (CTD) of RNAP
II, facilitating the inhibition of transcription. It has
also been shown to promote transcription by a mechanism
that is likely to involve RNAP II phosphorylation. CDK8
also functions as a stimulus-specific positive
coregulator of p53 transcriptional responses.
Length = 317
Score = 43.1 bits (101), Expect = 4e-06
Identities = 22/54 (40%), Positives = 34/54 (62%), Gaps = 1/54 (1%)
Query: 20 LVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
++ F S +++ Q L + LYQIL G+ Y+H+ VLHRDLKP+N+L+
Sbjct: 89 IIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141
>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase Like 1 and 4.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 1 (CDKL1) and CDKL4 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL1 and CDKL4
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKL1, also called
p42 KKIALRE, is a glial protein that is upregulated in
gliosis. It is present in neuroblastoma and A431 human
carcinoma cells, and may be implicated in neoplastic
transformation. The function of CDKL4 is unknown.
Length = 286
Score = 43.1 bits (102), Expect = 4e-06
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 5/50 (10%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CDLKF 81
+ I ++Q L+ + + H N +HRD+KP N+L+ CD F
Sbjct: 97 VPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGF 146
>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 1. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK1
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors, which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK1, also called rhodopsin kinase,
belongs to the visual group of GRKs and is expressed in
retinal cells. It phosphorylates rhodopsin in rod cells,
which leads to termination of the phototransduction
cascade. Mutations in GRK1 are associated to a
recessively inherited form of stationary nightblindness
called Oguchi disease.
Length = 280
Score = 42.9 bits (101), Expect = 5e-06
Identities = 14/32 (43%), Positives = 25/32 (78%)
Query: 43 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
C++ QI+ GL+++H +++RDLKP N+LL+
Sbjct: 100 CFYTAQIISGLEHLHQRRIIYRDLKPENVLLD 131
>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein
Serine/Threonine Kinases, Oxidative stress response
kinase and Ste20-related proline alanine-rich kinase.
Serine/threonine kinases (STKs), oxidative stress
response kinase (OSR1) and Ste20-related proline
alanine-rich kinase (SPAK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The OSR1 and SPAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. SPAK is also referred to as STK39 or PASK
(proline-alanine-rich STE20-related kinase). OSR1 and
SPAK regulate the activity of cation-chloride
cotransporters through direct interaction and
phosphorylation. They are also implicated in
cytoskeletal rearrangement, cell differentiation,
transformation and proliferation. OSR1 and SPAK contain
a conserved C-terminal (CCT) domain, which recognizes a
unique motif ([RK]FX[VI]) present in their activating
kinases (WNK1/WNK4) and their substrates.
Length = 267
Score = 42.3 bits (100), Expect = 6e-06
Identities = 16/39 (41%), Positives = 25/39 (64%)
Query: 42 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
I L ++L+GL+Y+HS +HRD+K N+LL +K
Sbjct: 104 IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVK 142
>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein
Serine/Threonine Kinase, Yank1. Serine/Threonine
Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Yank1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily
contains uncharacterized STKs with similarity to the
human protein designated Yank1 or STK32A.
Length = 258
Score = 42.3 bits (100), Expect = 6e-06
Identities = 15/44 (34%), Positives = 31/44 (70%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
H ++ + S + + +++ +I+ L+Y+HS ++HRD+KP N+LL
Sbjct: 90 HLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133
>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein
Serine/Threonine Kinases, Never In Mitosis gene
A-related kinase 6 and 7. Serine/Threonine Kinases
(STKs), Never In Mitosis gene A (NIMA)-related kinase 6
(Nek6) and Nek7 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The Nek6/7 subfamily is part of a family of 11 different
Neks (Nek1-11) that are involved in cell cycle control.
The Nek family is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Nek6 and Nek7 are the shortest Neks,
consisting only of the catalytic domain and a very short
N-terminal extension. They show distinct expression
patterns and both appear to be downstream substrates of
Nek9. They are required for mitotic spindle formation
and cytokinesis. They may also be regulators of the p70
ribosomal S6 kinase.
Length = 267
Score = 42.0 bits (99), Expect = 8e-06
Identities = 14/37 (37%), Positives = 25/37 (67%), Gaps = 1/37 (2%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
YF Q+ L+++HS ++HRD+KP+N+ + T +K
Sbjct: 111 YF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVK 146
>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein.
This model represents proteins of 1350 in length, in
multiple species of Burkholderia, in Acidovorax avenae
subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1,
and in multiple copies in Sorangium cellulosum, in
genomic neighborhoods that include a
cyclodehydratase/docking scaffold fusion protein
(TIGR03882) and a member of the thiazole/oxazole
modified metabolite (TOMM) precursor family TIGR03795.
It has a kinase domain in the N-terminal 300 amino
acids, followed by a cyclase homology domain, followed
by regions without named domain definitions. It is a
probable bacteriocin-like metabolite biosynthesis
protein [Cellular processes, Toxin production and
resistance].
Length = 1266
Score = 42.5 bits (100), Expect = 8e-06
Identities = 16/52 (30%), Positives = 27/52 (51%), Gaps = 6/52 (11%)
Query: 31 RTKYQRLSNDHIC------YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
RT + L+ D + Q+L L H+ ++HRDLKP N++++ T
Sbjct: 64 RTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQT 115
>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein
Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP
kinase kinase 5 (MKK5) subfamily, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The MKK5 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising of the MAP
kinase (MAPK), which is phosphorylated and activated by
a MAPK kinase (MAPKK or MKK), which itself is
phosphorylated and activated by a MAPK kinase kinase
(MAPKKK or MKKK). MKK5, also referred to as MEK5, is a
dual-specificity PK that phosphorylates its downstream
target, extracellular signal-regulated kinase 5 (ERK5),
on specific threonine and tyrosine residues. MKK5 is
activated by MEKK2 and MEKK3 in response to mitogenic
and stress stimuli. The ERK5 cascade promotes cell
proliferation, differentiation, neuronal survival, and
neuroprotection. This cascade plays an essential role in
heart development. Mice deficient in either ERK5 or MKK5
die around embryonic day 10 due to cardiovascular
defects including underdevelopment of the myocardium. In
addition, MKK5 is associated with metastasis and
unfavorable prognosis in prostate cancer.
Length = 279
Score = 42.2 bits (99), Expect = 8e-06
Identities = 16/33 (48%), Positives = 25/33 (75%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+++GL Y+ S +LHRD+KPSN+L+NT +K
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKL 136
>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity
Protein Kinases, MAP kinase kinases 3 and 6. Protein
kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6
subfamily, catalytic (c) domain. PKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The MKK3 and MKK6 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising the MAP kinase
(MAPK), which is phosphorylated and activated by a MAPK
kinase (MAPKK or MKK), which itself is phosphorylated
and activated by a MAPK kinase kinase (MAPKKK or MKKK).
MKK3 and MKK6 are dual-specificity PKs that
phosphorylate and activate their downstream target, p38
MAPK, on specific threonine and tyrosine residues.
MKK3/6 plays roles in the regulation of cell cycle
progression, cytokine- and stress-induced apoptosis,
oncogenic transformation, and adult tissue regeneration.
In addition, MKK6 plays a critical role in osteoclast
survival in inflammatory disease while MKK3 is
associated with tumor invasion, progression, and poor
patient survival in glioma.
Length = 283
Score = 42.0 bits (99), Expect = 9e-06
Identities = 15/27 (55%), Positives = 24/27 (88%), Gaps = 1/27 (3%)
Query: 49 ILRGLKYIHSA-NVLHRDLKPSNLLLN 74
I++ L+Y+HS +V+HRD+KPSN+L+N
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN 138
>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 3.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
(MEKK3) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK3 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK3 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates the MAPK kinase MEK5 (or
MKK5), which in turn phosphorylates and activates
extracellular signal-regulated kinase 5 (ERK5). The ERK5
cascade plays roles in promoting cell proliferation,
differentiation, neuronal survival, and neuroprotection.
MEKK3 plays an essential role in embryonic angiogenesis
and early heart development. In addition, MEKK3 is
involved in interleukin-1 receptor and Toll-like
receptor 4 signaling. It is also a specific regulator of
the proinflammatory cytokines IL-6 and GM-CSF in some
immune cells. MEKK3 also regulates calcineurin, which
plays a critical role in T cell activation, apoptosis,
skeletal myocyte differentiation, and cardiac
hypertrophy.
Length = 266
Score = 42.0 bits (98), Expect = 1e-05
Identities = 21/67 (31%), Positives = 37/67 (55%), Gaps = 11/67 (16%)
Query: 15 STKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
S K+ L ++ ++S KY R QIL G+ Y+HS ++HRD+K +N+L +
Sbjct: 92 SVKDQLKAYGALTESVTRKYTR-----------QILEGMSYLHSNMIVHRDIKGANILRD 140
Query: 75 TTCDLKF 81
+ ++K
Sbjct: 141 SAGNVKL 147
>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal
Byr2-like MAP Kinase Kinase Kinases. Serine/threonine
kinases (STKs), mitogen-activated protein kinase (MAPK)
kinase kinase (MAPKKK) subfamily, fungal Byr2-like
proteins, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include the MAPKKKs
Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae
and Cryptococcus neoformans Ste11, and related proteins.
They contain an N-terminal SAM (sterile alpha-motif)
domain, which mediates protein-protein interaction, and
a C-terminal catalytic domain. MAPKKKs phosphorylate and
activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which
in turn phosphorylate and activate MAPKs during
signaling cascades that are important in mediating
cellular responses to extracellular signals. Fission
yeast Byr2 is regulated by Ras1. It responds to
pheromone signaling and controls mating through the MAPK
pathway. Budding yeast Ste11 functions in MAPK cascades
that regulate mating, high osmolarity glycerol, and
filamentous growth responses.
Length = 267
Score = 41.8 bits (98), Expect = 1e-05
Identities = 15/36 (41%), Positives = 27/36 (75%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
F+ QIL+GL Y+H+ ++HRD+K +N+L++ +K
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIK 146
>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 4.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 4 (CDK4) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK4 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK4
partners with all three D-type cyclins (D1, D2, and D3)
and is also regulated by INK4 inhibitors. It is active
towards the retinoblastoma (pRb) protein and plays a
role in regulating the early G1 phase of the cell cycle.
It is expressed ubiquitously and is localized in the
nucleus. CDK4 also shows kinase activity towards Smad3,
a signal transducer of transforming growth factor
(TGF)-beta signaling which modulates transcription and
plays a role in cell proliferation and apoptosis. CDK4
is inhibited by the p21 inhibitor and is specifically
mutated in human melanoma.
Length = 288
Score = 41.5 bits (97), Expect = 2e-05
Identities = 17/45 (37%), Positives = 28/45 (62%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
L + I + Q LRGL ++H+ ++HRDLKP N+L+ + +K
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKL 149
>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 10. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 10 (Nek10)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Nek10 subfamily is one of a family of 11 different Neks
(Nek1-11) that are involved in cell cycle control. The
Nek family is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. No function has yet been ascribed to Nek10.
The gene encoding Nek10 is a putative causative gene for
breast cancer; it is located within a breast cancer
susceptibility loci on chromosome 3p24.
Length = 269
Score = 41.3 bits (97), Expect = 2e-05
Identities = 17/55 (30%), Positives = 31/55 (56%), Gaps = 1/55 (1%)
Query: 22 SFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNT 75
E+ +S + K QR + + I Q++ L+Y+H ++HRDL P+N++L
Sbjct: 95 PLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE 149
>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional.
Length = 357
Score = 41.4 bits (97), Expect = 2e-05
Identities = 13/27 (48%), Positives = 21/27 (77%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLN 74
QIL GL+Y+H+ ++HRD+K N+ +N
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFIN 191
>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein
Serine/Threonine Kinase, Mammalian Ste20-like protein
kinase 3. Serine/threonine kinases (STKs), mammalian
Ste20-like protein kinase 3 (MST3) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MST3 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MST3
phosphorylates the STK NDR and may play a role in cell
cycle progression and cell morphology. It may also
regulate paxillin and consequently, cell migration. MST3
is present in human placenta, where it plays an
essential role in the oxidative stress-induced apoptosis
of trophoblasts in normal spontaneous delivery.
Dysregulation of trophoblast apoptosis may result in
pregnancy complications such as preeclampsia and
intrauterine growth retardation.
Length = 277
Score = 41.2 bits (96), Expect = 2e-05
Identities = 18/45 (40%), Positives = 28/45 (62%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
L I L +IL+GL Y+HS +HRD+K +N+LL+ ++K
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKL 142
>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen-activated protein
kinase kinase kinase kinase 5. Serine/threonine kinases
(STKs), mitogen-activated protein kinase (MAPK) kinase
kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAP4K5 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Members of this
subfamily contain an N-terminal catalytic domain and a
C-terminal citron homology (CNH) regulatory domain,
similar to MAP4K4/6. MAP4Ks are involved in some MAPK
signaling pathways that are important in mediating
cellular responses to extracellular signals by
activating a MAPK kinase kinase (MAPKKK or MAP3K or
MKKK). Each MAPK cascade is activated either by a small
GTP-binding protein or by an adaptor protein, which
transmits the signal either directly to a MAP3K to start
the triple kinase core cascade or indirectly through a
mediator kinase, a MAP4K. MAP4K5, also called germinal
center kinase-related enzyme (GCKR), has been shown to
activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5
also facilitates Wnt signaling in B cells, and may
therefore be implicated in the control of cell fate,
proliferation, and polarity.
Length = 267
Score = 41.2 bits (96), Expect = 2e-05
Identities = 19/45 (42%), Positives = 27/45 (60%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
LS I Y + L+GL Y+HS +HRD+K +N+LL D+K
Sbjct: 103 LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKL 147
>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit;
Provisional.
Length = 329
Score = 41.3 bits (97), Expect = 2e-05
Identities = 18/52 (34%), Positives = 32/52 (61%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+H K R ND ++ +++ +Y+HS ++++RDLKP NLLL+ +K
Sbjct: 107 THLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVK 158
>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein
Serine/Threonine Kinase, Class IIIA myosin.
Serine/threonine kinases (STKs), class IIIA myosin
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
class III myosin subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Class III myosins are motor
proteins containing an N-terminal kinase catalytic
domain and a C-terminal actin-binding domain. Class III
myosins may play an important role in maintaining the
structural integrity of photoreceptor cell microvilli.
In photoreceptor cells, they may also function as cargo
carriers during light-dependent translocation of
proteins such as transducin and arrestin. Class IIIA
myosin is highly expressed in retina and in inner ear
hair cells. It is localized to the distal ends of
actin-bundled structures. Mutations in human myosin IIIA
are responsible for progressive nonsyndromic hearing
loss. Human myosin IIIA possesses ATPase and kinase
activities, and the ability to move actin filaments in a
motility assay. It may function as a cellular
transporter capable of moving along actin bundles in
sensory cells.
Length = 286
Score = 41.2 bits (96), Expect = 2e-05
Identities = 17/47 (36%), Positives = 29/47 (61%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+R+ I Y L++ L GL+++H +HRD+K +N+LL T +K
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165
>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase
kinase 3-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
(MEKK3)-like subfamily, catalytic (c) domain,
functionally uncharacterized subgroup 1. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK3-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The MEKK3-like subfamily is
composed of MEKK3, MEKK2, and related proteins, all
containing an N-terminal PB1 domain, which mediates
oligomerization, and a C-terminal catalytic domain.
MEKK2 and MEKK3 are mitogen-activated protein kinase
(MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks),
proteins that phosphorylate and activate MAPK kinases
(MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
and activate MAPKs during signaling cascades that are
important in mediating cellular responses to
extracellular signals. MEKK2 and MEKK3 activate MEK5
(also called MKK5), which activates extracellular
signal-regulated kinase 5 (ERK5). The ERK5 cascade plays
roles in promoting cell proliferation, differentiation,
neuronal survival, and neuroprotection. MEKK3 plays an
essential role in embryonic angiogenesis and early heart
development. MEKK2 and MEKK3 can also activate the
MAPKs, c-Jun N-terminal kinase (JNK) and p38, through
their respective MAPKKs.
Length = 264
Score = 41.2 bits (96), Expect = 2e-05
Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 5/75 (6%)
Query: 12 IRHSTKESLVSFREYSDSHRTK-----YQRLSNDHICYFLYQILRGLKYIHSANVLHRDL 66
+R ++ L F EY K Y L+ + + QIL+G+ Y+HS ++HRD+
Sbjct: 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDI 132
Query: 67 KPSNLLLNTTCDLKF 81
K +N+L ++ ++K
Sbjct: 133 KGANILRDSAGNVKL 147
>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional.
Length = 440
Score = 41.2 bits (96), Expect = 2e-05
Identities = 17/30 (56%), Positives = 22/30 (73%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+ YQ+ R L YIHS + HRDLKP NLL++
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLID 204
>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 2.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2
(MEKK2) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK2 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK2 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates the MAPK kinase MEK5 (or
MKK5), which in turn phosphorylates and activates
extracellular signal-regulated kinase 5 (ERK5). The ERK5
cascade plays roles in promoting cell proliferation,
differentiation, neuronal survival, and neuroprotection.
MEKK2 also activates ERK1/2, c-Jun N-terminal kinase
(JNK) and p38 through their respective MAPKKs MEK1/2,
JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays
roles in T cell receptor signaling, immune synapse
formation, cytokine gene expression, as well as in EGF
and FGF receptor signaling.
Length = 265
Score = 40.8 bits (95), Expect = 2e-05
Identities = 21/75 (28%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 12 IRHSTKESLVSFREYSDSHRTK-----YQRLSNDHICYFLYQILRGLKYIHSANVLHRDL 66
+R + +L F E+ K Y L+ + + QIL G+ Y+HS ++HRD+
Sbjct: 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDI 132
Query: 67 KPSNLLLNTTCDLKF 81
K +N+L ++ ++K
Sbjct: 133 KGANILRDSVGNVKL 147
>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein
Serine/Threonine Kinase, STK10 or Lymphocyte-oriented
kinase. Serine/threonine kinases (STKs), STK10
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
STK10 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Other names for STK10 include
lymphocyte-oriented kinase (LOK) and Xenopus polo-like
kinase kinase 1 (xPlkk1). STK10 is highly expressed in
lymphocytes and is responsible in regulating leukocyte
function associated antigen (LFA-1)-mediated lymphocyte
adhesion. It plays a role in regulating the CD28
responsive element in T cells, and may also function as
a regulator of polo-like kinase 1 (Plk1), a protein
which is overexpressed in multiple tumor types.
Length = 292
Score = 40.8 bits (95), Expect = 2e-05
Identities = 16/34 (47%), Positives = 23/34 (67%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
Q+L L+Y+HS ++HRDLK N+LL D+K
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKL 151
>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein
Serine/Threonine Kinase, Mammalian Ste20-like protein
kinase 4. Serine/threonine kinases (STKs), mammalian
Ste20-like protein kinase 4 (MST4) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MST4 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MST4 is sometimes
referred to as MASK (MST3 and SOK1-related kinase). It
plays a role in mitogen-activated protein kinase (MAPK)
signaling during cytoskeletal rearrangement,
morphogenesis, and apoptosis. It influences cell growth
and transformation by modulating the extracellular
signal-regulated kinase (ERK) pathway. MST4 may also
play a role in tumor formation and progression. It
localizes in the Golgi apparatus by interacting with the
Golgi matrix protein GM130 and may play a role in cell
migration.
Length = 277
Score = 40.8 bits (95), Expect = 2e-05
Identities = 18/41 (43%), Positives = 27/41 (65%)
Query: 41 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
I L +IL+GL Y+HS +HRD+K +N+LL+ D+K
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKL 142
>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein
Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase
4. Serine/threonine kinases (STKs), yeast
Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The YSK4 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. YSK4 is a
putative MAPKKK, whose mammalian gene has been isolated.
MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate
MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals.
Length = 265
Score = 40.7 bits (95), Expect = 3e-05
Identities = 14/32 (43%), Positives = 23/32 (71%)
Query: 42 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
C + QIL G+ Y+H+ V+HRD+K +N++L
Sbjct: 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVML 135
>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein
Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK
kinase (MEK) subfamily, catalytic (c) domain. PKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine or tyrosine residues on protein
substrates. The MEK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases, protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
mitogen-activated protein (MAP) kinase signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising the MAP kinase (MAPK),
which is phosphorylated and activated by a MAPK kinase
(MAPKK or MKK), which itself is phosphorylated and
activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1
and MEK2 are dual-specificity PKs that phosphorylate and
activate the downstream targets, ERK(extracellular
signal-regulated kinase) 1 and ERK2, on specific
threonine and tyrosine residues. The ERK cascade starts
with extracellular signals including growth factors,
hormones, and neurotransmitters, which act through
receptors and ion channels to initiate intracellular
signaling that leads to the activation at the MAPKKK
(Raf-1 or MOS) level, which leads to the transmission of
signals to MEK1/2, and finally to ERK1/2. The ERK
cascade plays an important role in cell proliferation,
differentiation, oncogenic transformation, and cell
cycle control, as well as in apoptosis and cell survival
under certain conditions. This cascade has also been
implicated in synaptic plasticity, migration,
morphological determination, and stress response
immunological reactions. Gain-of-function mutations in
genes encoding ERK cascade proteins, including MEK1/2,
cause cardiofaciocutaneous (CFC) syndrome, a condition
leading to multiple congenital anomalies and mental
retardation in patients.
Length = 308
Score = 40.5 bits (95), Expect = 3e-05
Identities = 16/37 (43%), Positives = 26/37 (70%), Gaps = 5/37 (13%)
Query: 47 YQILRGLKYI---HSANVLHRDLKPSNLLLNTTCDLK 80
+LRGL Y+ H ++HRD+KPSN+L+N+ ++K
Sbjct: 106 IAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIK 140
>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), cAMP-dependent protein kinase (PKA) subfamily,
PRKX-like kinases, catalytic (c) subunit. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PKA
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include human PRKX (X
chromosome-encoded protein kinase), Drosophila DC2, and
similar proteins. PRKX is present in many tissues
including fetal and adult brain, kidney, and lung. The
PRKX gene is located in the Xp22.3 subregion and has a
homolog called PRKY on the Y chromosome. An abnormal
interchange between PRKX aand PRKY leads to the sex
reversal disorder of XX males and XY females. PRKX is
implicated in granulocyte/macrophage lineage
differentiation, renal cell epithelial migration, and
tubular morphogenesis in the developing kidney.
Length = 291
Score = 40.5 bits (95), Expect = 3e-05
Identities = 17/45 (37%), Positives = 29/45 (64%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
R SN ++ +I+ L+Y+HS +++RDLKP N+LL+ +K
Sbjct: 97 RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIK 141
>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic
subunit; Provisional.
Length = 340
Score = 40.3 bits (94), Expect = 3e-05
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+R ND C++ QI+ +Y+ S N+++RDLKP NLLL+
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD 165
>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 11. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 11 (Nek11)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Nek11 subfamily is one of a family of 11 different Neks
(Nek1-11) that are involved in cell cycle control. The
Nek family is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Nek11 is involved, through direct
phosphorylation, in regulating the degradation of Cdc25A
(Cell Division Cycle 25 homolog A), which plays a role
in cell cycle progression and in activating cyclin
dependent kinases. Nek11 is activated by CHK1
(CHeckpoint Kinase 1) and may be involved in the G2/M
checkpoint. Nek11 may also play a role in the S-phase
checkpoint as well as in DNA replication and genotoxic
stress responses.
Length = 260
Score = 40.3 bits (94), Expect = 4e-05
Identities = 16/39 (41%), Positives = 25/39 (64%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+ LS + +C + Q+L G+ Y+H +LHRDLK N+ L
Sbjct: 101 KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL 139
>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase.
Length = 258
Score = 39.8 bits (94), Expect = 4e-05
Identities = 14/44 (31%), Positives = 24/44 (54%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
R ++L+ + QI +G++Y+ S N +HRDL N L+
Sbjct: 93 RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT 136
>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein
Serine/Threonine Kinase, 70 kDa ribosomal protein S6
kinase. Serine/Threonine Kinases (STKs), 70 kDa
ribosomal protein S6 kinase (p70S6K) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The p70S6K subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. p70S6K (or S6K)
contains only one catalytic kinase domain, unlike p90
ribosomal S6 kinases (RSKs). It acts as a downstream
effector of the STK mTOR (mammalian Target of Rapamycin)
and plays a role in the regulation of the translation
machinery during protein synthesis. p70S6K also plays a
pivotal role in regulating cell size and glucose
homeostasis. Its targets include S6, the translation
initiation factor eIF3, and the insulin receptor
substrate IRS-1, among others. Mammals contain two
isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta).
Length = 323
Score = 40.2 bits (94), Expect = 5e-05
Identities = 14/35 (40%), Positives = 25/35 (71%)
Query: 40 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
D C++L +I L+++H +++RDLKP N+LL+
Sbjct: 100 DTACFYLSEISLALEHLHQQGIIYRDLKPENILLD 134
>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase;
Provisional.
Length = 507
Score = 40.1 bits (93), Expect = 5e-05
Identities = 14/35 (40%), Positives = 23/35 (65%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ Q+L GL+ +H ++HRD+KP NLL+ +K
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVK 349
>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein
Serine/Threonine Kinase, Group II p21-activated kinase.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) subfamily, Group II, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PAK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
Group II PAKs, also called non-conventional PAKs,
include PAK4, PAK5, and PAK6. Group II PAKs contain PBD
(p21-binding domain) and catalytic domains, but lack
other motifs found in group I PAKs, such as an AID
(autoinhibitory domain) and SH3 binding sites. Since
group II PAKs do not contain an obvious AID, they may be
regulated differently from group I PAKs. While group I
PAKs interact with the SH3 containing proteins Nck, Grb2
and PIX, no such binding has been demonstrated for group
II PAKs. Some known substrates of group II PAKs are also
substrates of group I PAKs such as Raf, BAD, LIMK and
GEFH1. Unique group II substrates include MARK/Par-1 and
PDZ-RhoGEF. Group II PAKs play important roles in
filopodia formation, neuron extension, cytoskeletal
organization, and cell survival.
Length = 285
Score = 39.7 bits (93), Expect = 6e-05
Identities = 12/38 (31%), Positives = 24/38 (63%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
R++ + I +L+ L ++H+ V+HRD+K ++LL
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148
>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein
Kinase, MAP/ERK Kinase 2. Protein kinases (PKs),
MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The MEK subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising the MAP kinase
(MAPK), which is phosphorylated and activated by a MAPK
kinase (MAPKK or MKK), which itself is phosphorylated
and activated by a MAPK kinase kinase (MAPKKK or MKKK).
MEK2 is a dual-specificity PK that phosphorylates and
activates the downstream targets, extracellular
signal-regulated kinase (ERK) 1 and ERK2, on specific
threonine and tyrosine residues. The ERK cascade starts
with extracellular signals including growth factors,
hormones, and neurotransmitters, which act through
receptors and ion channels to initiate intracellular
signaling that leads to the activation at the MAPKKK
(Raf-1 or MOS) level, which leads to the transmission of
signals to MEK2, and finally to ERK1/2. The ERK cascade
plays an important role in cell proliferation,
differentiation, oncogenic transformation, and cell
cycle control, as well as in apoptosis and cell survival
under certain conditions. Gain-of-function mutations in
genes encoding ERK cascade proteins, including MEK2,
cause cardiofaciocutaneous (CFC) syndrome, a condition
leading to multiple congenital anomalies and mental
retardation in patients.
Length = 331
Score = 39.6 bits (92), Expect = 6e-05
Identities = 24/82 (29%), Positives = 44/82 (53%), Gaps = 9/82 (10%)
Query: 2 GFHQD-QITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSAN 60
F+ D +I+I + H SL D + +R+ + + +LRGL Y+ +
Sbjct: 71 AFYSDGEISICMEHMDGGSL-------DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 61 -VLHRDLKPSNLLLNTTCDLKF 81
++HRD+KPSN+L+N+ ++K
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKL 145
>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed.
Length = 932
Score = 39.4 bits (92), Expect = 8e-05
Identities = 15/26 (57%), Positives = 20/26 (76%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLL 73
+I ++Y+HS VLHRDLKP N+LL
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILL 146
>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase Like 5.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 5 (CDKL5) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL5 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. Mutations in the gene encoding CDKL5,
previously called STK9, are associated with early onset
epilepsy and severe mental retardation [X-linked
infantile spasm syndrome (ISSX) or West syndrome]. In
addition, CDKL5 mutations also sometimes cause a
phenotype similar to Rett syndrome (RTT), a progressive
neurodevelopmental disorder. These pathogenic mutations
are located in the N-terminal portion of the protein
within the kinase domain.
Length = 287
Score = 39.2 bits (91), Expect = 8e-05
Identities = 14/47 (29%), Positives = 29/47 (61%), Gaps = 5/47 (10%)
Query: 40 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-----CDLKF 81
+ + ++YQ+++ + + H +++HRD+KP NLL++ CD F
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGF 146
>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of
Phototropin-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Phototropin-like
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
phototropin-like subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Included in this subfamily
are plant phototropins and predominantly uncharacterized
fungal STKs whose catalytic domains resemble the
phototropin kinase domain. One protein from Neurospora
crassa is called nrc-2. Phototropins are blue-light
receptors that control responses such as phototropism,
stromatal opening, and chloroplast movement in order to
optimize the photosynthetic efficiency of plants. They
are light-activated STKs that contain an N-terminal
photosensory domain and a C-terminal catalytic domain.
The N-terminal domain contains two LOV (Light, Oxygen or
Voltage) domains that binds FMN. Photoexcitation of the
LOV domains results in autophosphorylation at multiple
sites and activation of the catalytic domain. Neurospora
crassa nrc-2 plays a role in growth and development by
controlling entry into the conidiation program.
Length = 316
Score = 38.8 bits (91), Expect = 1e-04
Identities = 14/39 (35%), Positives = 26/39 (66%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
LS + ++ ++L L+Y+H +++RDLKP N+LL+
Sbjct: 99 CLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137
>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 2. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
2 (DDR2) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR2 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR2 binds mostly to fibrillar collagens. More recently,
it has been reported to also bind collagen X. DDR2 is
widely expressed in many tissues with the highest levels
found in skeletal muscle, skin, kidney and lung. It is
important in cell proliferation and development. Mice,
with a deletion of DDR2, suffer from dwarfism and
delayed healing of epidermal wounds. DDR2 also
contributes to collagen (type I) regulation by
inhibiting fibrillogenesis and altering the morphology
of collagen fibers. It is also expressed in immature
dendritic cells (DCs), where it plays a role in DC
activation and function.
Length = 296
Score = 38.7 bits (90), Expect = 1e-04
Identities = 20/68 (29%), Positives = 29/68 (42%), Gaps = 9/68 (13%)
Query: 13 RHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 72
RH +E+ +D Y L + QI G+KY+ S N +HRDL N L
Sbjct: 112 RHEPQEAAEK----ADVVTISYSTL-----IFMATQIASGMKYLSSLNFVHRDLATRNCL 162
Query: 73 LNTTCDLK 80
+ +K
Sbjct: 163 VGKNYTIK 170
>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 4. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek4 subfamily is
one of a family of 11 different Neks (Nek1-11). The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Neks are involved in the regulation of
downstream processes following the activation of Cdc2,
and many of their functions are cell cycle-related. They
play critical roles in microtubule dynamics during
ciliogenesis and mitosis. Nek4 is highly abundant in the
testis. Its specific function is unknown.
Length = 257
Score = 38.8 bits (90), Expect = 1e-04
Identities = 19/54 (35%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 30 HRTKYQR---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
H+ K Q+ L + + + QI L+Y+H ++LHRDLK N+ L T +K
Sbjct: 89 HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIK 142
>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 5. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek5 subfamily is
one of a family of 11 different Neks (Nek1-11). The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Neks are involved in the regulation of
downstream processes following the activation of Cdc2,
and many of their functions are cell cycle-related. They
play critical roles in microtubule dynamics during
ciliogenesis and mitosis. The specific function of Nek5
is unknown.
Length = 257
Score = 38.8 bits (90), Expect = 1e-04
Identities = 23/57 (40%), Positives = 29/57 (50%), Gaps = 7/57 (12%)
Query: 25 EYSDS----HRTKYQR---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
EY D R QR S D I + QI GLK+IH +LHRD+K N+ L+
Sbjct: 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135
>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 3. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek3 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek3 is primarily
localized in the cytoplasm and shows no cell
cycle-dependent changes in its activity. It is present
in the axons of neurons and affects morphogenesis and
polarity through its regulation of microtubule
acetylation. Nek3 modulates the signaling of the
prolactin receptor through its activation of Vav2 and
contributes to prolactin-mediated motility of breast
cancer cells.
Length = 255
Score = 38.8 bits (90), Expect = 1e-04
Identities = 21/64 (32%), Positives = 30/64 (46%), Gaps = 7/64 (10%)
Query: 25 EYSDS----HRTKYQR---LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC 77
EY D + K QR D I + Q+ G+++IH VLHRD+K N+ L
Sbjct: 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
Query: 78 DLKF 81
+K
Sbjct: 138 KVKL 141
>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 5.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 5, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK5 belongs to group II. Group II PAKs contain a PBD
(p21-binding domain) and a C-terminal catalytic domain,
but do not harbor an AID (autoinhibitory domain) or SH3
binding sites. PAK5 is mainly expressed in the brain. It
is not required for viability, but together with PAK6,
it is required for normal levels of locomotion and
activity, and for learning and memory. PAK5 cooperates
with Inca (induced in neural crest by AP2) in the
regulation of cell adhesion and cytoskeletal
organization in the embryo and in neural crest cells
during craniofacial development. PAK5 may also play a
role in controlling the signaling of Raf-1, an effector
of Ras, at the mitochondria.
Length = 292
Score = 38.5 bits (89), Expect = 2e-04
Identities = 15/48 (31%), Positives = 28/48 (58%)
Query: 34 YQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+ R++ + I +LR L Y+H+ V+HRD+K ++LL + +K
Sbjct: 112 HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKL 159
>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional.
Length = 461
Score = 38.7 bits (90), Expect = 2e-04
Identities = 13/32 (40%), Positives = 21/32 (65%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDL 79
Q+L + YIH ++HRD+K N+L+N D+
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDI 299
>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases.
Protein Tyrosine Kinase (PTK) family, catalytic domain.
This PTKc family is part of a larger superfamily that
includes the catalytic domains of protein
serine/threonine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. They can be classified
into receptor and non-receptor tyr kinases. PTKs play
important roles in many cellular processes including,
lymphocyte activation, epithelium growth and
maintenance, metabolism control, organogenesis
regulation, survival, proliferation, differentiation,
migration, adhesion, motility, and morphogenesis.
Receptor tyr kinases (RTKs) are integral membrane
proteins which contain an extracellular ligand-binding
region, a transmembrane segment, and an intracellular
tyr kinase domain. RTKs are usually activated through
ligand binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain, leading to intracellular signaling.
Some RTKs are orphan receptors with no known ligands.
Non-receptor (or cytoplasmic) tyr kinases are
distributed in different intracellular compartments and
are usually multi-domain proteins containing a catalytic
tyr kinase domain as well as various regulatory domains
such as SH3 and SH2. PTKs are usually autoinhibited and
require a mechanism for activation. In many PTKs, the
phosphorylation of tyr residues in the activation loop
is essential for optimal activity. Aberrant expression
of PTKs is associated with many development
abnormalities and cancers.
Length = 262
Score = 38.3 bits (90), Expect = 2e-04
Identities = 14/41 (34%), Positives = 21/41 (51%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
LS + F QI +G++Y+ S +HRDL N L+
Sbjct: 100 STLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE 140
>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine
Kinases, Fibroblast Growth Factor Receptors. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor (FGFR) subfamily; catalytic (c) domain. The
FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K).PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. FGFR subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with three
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
FGFRs to their ligands, the FGFs, and to heparin/heparan
sulfate (HS) results in the formation of a ternary
complex, which leads to receptor dimerization and
activation, and intracellular signaling. There are at
least 23 FGFs and four types of FGFRs. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. FGF/FGFR signaling is
important in the regulation of embryonic development,
homeostasis, and regenerative processes. Depending on
the cell type and stage, FGFR signaling produces diverse
cellular responses including proliferation, growth
arrest, differentiation, and apoptosis. Aberrant
signaling leads to many human diseases such as skeletal,
olfactory, and metabolic disorders, as well as cancer.
Length = 293
Score = 38.2 bits (89), Expect = 2e-04
Identities = 15/46 (32%), Positives = 25/46 (54%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 72
D R + L+ + F YQ+ RG++++ S +HRDL N+L
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164
>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein
Serine/Threonine Kinase, cGMP-dependent protein kinase.
Serine/Threonine Kinases (STKs), cGMP-dependent protein
kinase (cGK or PKG) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The cGK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Mammals have two cGK isoforms
from different genes, cGKI and cGKII. cGKI exists as two
splice variants, cGKI-alpha and cGKI-beta. cGK consists
of an N-terminal regulatory domain containing a
dimerization and an autoinhibitory pseudosubstrate
region, two cGMP-binding domains, and a C-terminal
catalytic domain. Binding of cGMP to both binding sites
releases the inhibition of the catalytic center by the
pseudosubstrate region, allowing autophosphorylation and
activation of the kinase. cGKI is a soluble protein
expressed in all smooth muscles, platelets, cerebellum,
and kidney. It is also expressed at lower concentrations
in other tissues. cGKII is a membrane-bound protein that
is most abundantly expressed in the intestine. It is
also present in the brain nuclei, adrenal cortex,
kidney, lung, and prostate. cGKI is involved in the
regulation of smooth muscle tone, smooth cell
proliferation, and platelet activation. cGKII plays a
role in the regulation of secretion, such as renin
secretion by the kidney and aldosterone secretion by the
adrenal. It also regulates bone growth and the circadian
rhythm.
Length = 262
Score = 38.4 bits (90), Expect = 2e-04
Identities = 11/40 (27%), Positives = 24/40 (60%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
+++ ++ +Y+H+ +++RDLKP NLLL++
Sbjct: 89 LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS 128
>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled
Receptor Kinase 4-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), G protein-coupled
Receptor Kinase (GRK) subfamily, GRK4-like group,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The GRK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. GRKs
phosphorylate and regulate G protein-coupled receptors
(GPCRs), the largest superfamily of cell surface
receptors which regulate some part of nearly all
physiological functions. Phosphorylated GPCRs bind to
arrestins, which prevents further G protein signaling
despite the presence of activating ligand. There are
seven types of GRKs, named GRK1 to GRK7. Members of the
GRK4-like group include GRK4, GRK5, GRK6, and similar
GRKs. GRKs in this group contain an N-terminal RGS
homology (RH) domain and a catalytic domain, but lack a
G protein betagamma-subunit binding domain. They are
localized to the plasma membrane through
post-translational lipid modification or direct binding
to PIP2.
Length = 285
Score = 38.3 bits (89), Expect = 2e-04
Identities = 12/31 (38%), Positives = 22/31 (70%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ +I GL+ +H +++RDLKP N+LL+
Sbjct: 106 FYAAEITCGLEDLHRERIVYRDLKPENILLD 136
>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine
Kinase, Thousand-and-one amino acids proteins.
Serine/threonine kinases (STKs), thousand-and-one amino
acids (TAO) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The TAO subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. TAO proteins possess mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
activity. They activate the MAPKs, p38 and c-Jun
N-terminal kinase (JNK), by phosphorylating and
activating the respective MAP/ERK kinases (MEKs, also
known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK
signaling cascades are important in mediating cellular
responses to extracellular signals. Vertebrates contain
three TAO subfamily members, named TAO1, TAO2, and TAO3.
Length = 307
Score = 38.2 bits (89), Expect = 2e-04
Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 3/46 (6%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+ H+ Q + IC+ L+GL Y+HS +HRD+K N+LL
Sbjct: 106 EVHKKPLQEVEIAAICH---GALQGLAYLHSHERIHRDIKAGNILL 148
>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein
Serine/Threonine Kinase, Microtubule-associated
serine/threonine kinase. Serine/Threonine Kinases
(STKs), Microtubule-associated serine/threonine (MAST)
kinase subfamily, MAST, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MAST kinase subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. MAST kinases contain an
N-terminal domain of unknown function, a central
catalytic domain, and a C-terminal PDZ domain that
mediates protein-protein interactions. There are four
mammalian MAST kinases, named MAST1-MAST4. MAST1 is also
referred to as syntrophin-associated STK (SAST), while
MAST2 is also called MAST205. MAST kinases are
cytoskeletal associated kinases of unknown function that
are also expressed at neuromuscular junctions and
postsynaptic densities. MAST1, MAST2, and MAST3 bind and
phosphorylate the tumor suppressor PTEN, and may
contribute to the regulation and stabilization of PTEN.
MAST2 is involved in the regulation of the Fc-gamma
receptor of the innate immune response in macrophages,
and may also be involved in the regulation of the Na+/H+
exchanger NHE3.
Length = 305
Score = 37.8 bits (88), Expect = 2e-04
Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 1/37 (2%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
YF +L L+Y+H+ ++HRDLKP NLL+ + +K
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIK 141
>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen-activated protein
kinase kinase kinase kinase 3. Serine/threonine kinases
(STKs), mitogen-activated protein kinase (MAPK) kinase
kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAP4K3 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Members of this
subfamily contain an N-terminal catalytic domain and a
C-terminal citron homology (CNH) regulatory domain,
similar to MAP4K4/6. MAP4Ks are involved in some MAPK
signaling pathways that are important in mediating
cellular responses to extracellular signals by
activating a MAPK kinase kinase (MAPKKK or MAP3K or
MKKK). Each MAPK cascade is activated either by a small
GTP-binding protein or by an adaptor protein, which
transmits the signal either directly to a MAP3K to start
the triple kinase core cascade or indirectly through a
mediator kinase, a MAP4K. MAP4K3 plays a role in the
nutrient-responsive pathway of mTOR (mammalian target of
rapamycin) signaling. MAP4K3 is required in the
activation of S6 kinase by amino acids and for the
phosphorylation of the mTOR-regulated inhibitor of
eukaryotic initiation factor 4E. mTOR regulates ribosome
biogenesis and protein translation, and is frequently
deregulated in cancer.
Length = 267
Score = 37.7 bits (87), Expect = 3e-04
Identities = 17/37 (45%), Positives = 24/37 (64%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
LS I Y + L+GL Y+HS +HRD+K +N+LL
Sbjct: 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL 139
>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine
Kinases, Lymphocyte-specific kinase and Blk. Protein
Tyrosine Kinase (PTK) family; Lck and Blk kinases;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lck (lymphocyte-specific
kinase) and Blk are members of the Src subfamily of
proteins, which are cytoplasmic (or non-receptor) tyr
kinases. Src kinases contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Lck is expressed in T-cells and natural
killer (NK) cells. It plays a critical role in T-cell
maturation, activation, and T-cell receptor (TCR)
signaling. Lck phosphorylates ITAM (immunoreceptor tyr
activation motif) sequences on several subunits of TCRs,
leading to the activation of different second messenger
cascades. Phosphorylated ITAMs serve as binding sites
for other signaling factor such as Syk and ZAP-70,
leading to their activation and propagation of
downstream events. In addition, Lck regulates
drug-induced apoptosis by interfering with the
mitochondrial death pathway. The apototic role of Lck is
independent of its primary function in T-cell signaling.
Blk is expressed specifically in B-cells. It is involved
in pre-BCR (B-cell receptor) signaling.
Length = 260
Score = 37.5 bits (87), Expect = 3e-04
Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 5/72 (6%)
Query: 5 QDQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHR 64
Q+ I I + SLV F + + + +L + QI G+ +I N +HR
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID-----MAAQIAEGMAFIERKNYIHR 126
Query: 65 DLKPSNLLLNTT 76
DL+ +N+L++ T
Sbjct: 127 DLRAANILVSET 138
>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine
Kinase, Ste20-like kinase. Serine/threonine kinases
(STKs), Ste20-like kinase (SLK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The SLK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. SLK promotes
apoptosis through apoptosis signal-regulating kinase 1
(ASK1) and the mitogen-activated protein kinase (MAPK)
p38. It acts as a MAPK kinase kinase (MAPKKK) by
phosphorylating ASK1, resulting in the phosphorylation
of p38. SLK also plays a role in mediating actin
reorganization. It is part of a microtubule-associated
complex that is targeted at adhesion sites, and is
required in focal adhesion turnover and in regulating
cell migration.
Length = 282
Score = 37.7 bits (87), Expect = 3e-04
Identities = 14/34 (41%), Positives = 19/34 (55%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
Q L L Y+H ++HRDLK N+L D+K
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKL 144
>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase,
Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Yes (or c-Yes) is a
member of the Src subfamily of proteins, which are
cytoplasmic (or non-receptor) tyr kinases. Src kinases
contain an N-terminal SH4 domain with a myristoylation
site, followed by SH3 and SH2 domains, a tyr kinase
domain, and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. c-Yes
kinase is the cellular homolog of the oncogenic protein
(v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma
viruses. It displays functional overlap with other Src
subfamily members, particularly Src. It also shows some
unique functions such as binding to occludins,
transmembrane proteins that regulate extracellular
interactions in tight junctions. Yes also associates
with a number of proteins in different cell types that
Src does not interact with, like JAK2 and gp130 in
pre-adipocytes, and Pyk2 in treated pulmonary vein
endothelial cells. Although the biological function of
Yes remains unclear, it appears to have a role in
regulating cell-cell interactions and vesicle
trafficking in polarized cells.
Length = 260
Score = 37.3 bits (86), Expect = 4e-04
Identities = 24/80 (30%), Positives = 37/80 (46%), Gaps = 7/80 (8%)
Query: 5 QDQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHR 64
++ I I K SL+ F + D K +L + QI G+ YI N +HR
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD-----MAAQIADGMAYIERMNYIHR 126
Query: 65 DLKPSNLLL--NTTCDLKFF 82
DL+ +N+L+ N C + F
Sbjct: 127 DLRAANILVGDNLVCKIADF 146
>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine
Kinase, Colony-Stimulating Factor-1 Receptor. Protein
Tyrosine Kinase (PTK) family; Colony-Stimulating
Factor-1 Receptor (CSF-1R); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CSF-1R,
also called c-Fms, is a member of the Platelet Derived
Growth Factor Receptor (PDGFR) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
CSF-1R to its ligand, CSF-1, leads to receptor
dimerization, trans phosphorylation and activation, and
intracellular signaling. CSF-1R signaling is critical in
the regulation of macrophages and osteoclasts. It leads
to increases in gene transcription and protein
translation, and induces cytoskeletal remodeling. CSF-1R
signaling leads to a variety of cellular responses
including survival, proliferation, and differentiation
of target cells. It plays an important role in innate
immunity, tissue development and function, and the
pathogenesis of some diseases including atherosclerosis
and cancer. CSF-1R signaling is also implicated in
mammary gland development during pregnancy and
lactation. Aberrant CSF-1/CSF-1R expression correlates
with tumor cell invasiveness, poor clinical prognosis,
and bone metastasis in breast cancer. Although the
structure of the human CSF-1R catalytic domain is known,
it is excluded from this specific alignment model
because it contains a deletion in its sequence.
Length = 374
Score = 37.5 bits (87), Expect = 4e-04
Identities = 17/64 (26%), Positives = 30/64 (46%)
Query: 10 IEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 69
+E+R + S S + L D + F Q+ +G+ ++ S N +HRD+
Sbjct: 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241
Query: 70 NLLL 73
N+LL
Sbjct: 242 NVLL 245
>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinases, Janus kinases. Protein Tyrosine
Kinase (PTK) family; Janus kinase (Jak) subfamily;
catalytic (c) domain (repeat 2). The Jak subfamily is
composed of Jak1, Jak2, Jak3, TYK2, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Jak subfamily proteins are cytoplasmic (or nonreceptor)
tyr kinases containing an N-terminal FERM domain,
followed by a Src homology 2 (SH2) domain, a
pseudokinase domain, and a C-terminal tyr kinase
catalytic domain. Most Jaks are expressed in a wide
variety of tissues, except for Jak3, which is expressed
only in hematopoietic cells. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jaks are also involved in regulating the surface
expression of some cytokine receptors. The Jak-STAT
pathway is involved in many biological processes
including hematopoiesis, immunoregulation, host defense,
fertility, lactation, growth, and embryogenesis.
Length = 284
Score = 37.4 bits (87), Expect = 4e-04
Identities = 17/52 (32%), Positives = 28/52 (53%), Gaps = 3/52 (5%)
Query: 22 SFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
S R+Y HR +++ + F QI +G+ Y+ S +HRDL N+L+
Sbjct: 94 SLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142
>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 5. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK5
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK5 is widely expressed in many tissues.
It associates with the membrane though an N-terminal
PIP2 binding domain and also binds phospholipids via its
C-terminus. GRK5 deficiency is associated with early
Alzheimer's disease in humans and mouse models. GRK5
also plays a crucial role in the pathogenesis of
sporadic Parkinson's disease. It participates in the
regulation and desensitization of PDGFRbeta, a receptor
tyrosine kinase involved in a variety of downstream
cellular effects including cell growth, chemotaxis,
apoptosis, and angiogenesis. GRK5 also regulates
Toll-like receptor 4, which is involved in innate and
adaptive immunity.
Length = 285
Score = 37.3 bits (86), Expect = 4e-04
Identities = 14/35 (40%), Positives = 24/35 (68%)
Query: 40 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+ ++ +IL GL+ +H N ++RDLKP N+LL+
Sbjct: 102 ERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136
>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine
Kinases, Platelet Derived Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) subfamily; catalytic (c)
domain. The PDGFR subfamily consists of PDGFR alpha,
PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
PDGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. PDGFR
kinase domains are autoinhibited by their juxtamembrane
regions containing tyr residues. The binding to their
ligands leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. PDGFR subfamily receptors are important in
the development of a variety of cells. PDGFRs are
expressed in a many cells including fibroblasts,
neurons, endometrial cells, mammary epithelial cells,
and vascular smooth muscle cells. PDGFR signaling is
critical in normal embryonic development, angiogenesis,
and wound healing. PDGFRs transduce mitogenic signals
for connective tissue cells and are important for cell
shape and motility. Kit is important in the development
of melanocytes, germ cells, mast cells, hematopoietic
stem cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. CSF-1R signaling is
critical in the regulation of macrophages and
osteoclasts. Mammalian FLT3 plays an important role in
the survival, proliferation, and differentiation of stem
cells.
Length = 302
Score = 37.5 bits (87), Expect = 4e-04
Identities = 15/44 (34%), Positives = 26/44 (59%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
R + L+ + + F YQ+ +G+ ++ S N +HRDL N+LL
Sbjct: 131 RRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL 174
>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein
Serine/Threonine Kinase, Protein Kinase B beta.
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
or Akt subfamily, beta (or Akt2) isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. There are three
PKB isoforms from different genes, PKB-alpha (or Akt1),
PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
contains an N-terminal pleckstrin homology (PH) domain
and a C-terminal catalytic domain. PKB-beta is the
predominant PKB isoform expressed in insulin-responsive
tissues. It plays a critical role in the regulation of
glucose homeostasis. It is also implicated in muscle
cell differentiation. Mice deficient in PKB-beta display
normal growth weights but exhibit severe insulin
resistance and diabetes, accompanied by lipoatrophy and
B-cell failure.
Length = 323
Score = 37.3 bits (86), Expect = 4e-04
Identities = 18/77 (23%), Positives = 41/77 (53%), Gaps = 5/77 (6%)
Query: 9 TIEIRHSTKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLH 63
++ T + L EY++ H ++ + + + ++ +I+ L+Y+HS +V++
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 64 RDLKPSNLLLNTTCDLK 80
RD+K NL+L+ +K
Sbjct: 119 RDIKLENLMLDKDGHIK 135
>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of
cAMP-dependent protein kinase-like Protein
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), Fission yeast Suppressor of loss of
cAMP-dependent protein kinase (Sck1)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Sck1-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of fungal proteins
with similarity to the Schizosaccharomyces pombe STK
Sck1. Sck1 plays a role in trehalase activation
triggered by glucose and a nitrogen source. Trehalase
catalyzes the cleavage of the disaccharide trehalose to
glucose. Trehalose, as a carbohydrate reserve and stress
metabolite, plays an important role in the response of
yeast to environmental changes.
Length = 330
Score = 37.2 bits (86), Expect = 5e-04
Identities = 16/47 (34%), Positives = 31/47 (65%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
H K R S D +++ +++ L+++H ++++RDLKP N+LL+ T
Sbjct: 86 HLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132
>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 6.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 6, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK6 belongs to group II. Group II PAKs contain a PBD
(p21-binding domain) and a C-terminal catalytic domain,
but do not harbor an AID (autoinhibitory domain) or SH3
binding sites. PAK6 may play a role in stress responses
through its activation by the mitogen-activated protein
kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6
is highly expressed in the brain. It is not required for
viability, but together with PAK5, it is required for
normal levels of locomotion and activity, and for
learning and memory. Increased expression of PAK6 is
found in primary and metastatic prostate cancer. PAK6
may play a role in the regulation of motility.
Length = 297
Score = 37.3 bits (86), Expect = 5e-04
Identities = 15/38 (39%), Positives = 24/38 (63%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
RL+ + I +L+ L Y+HS V+HRD+K ++LL
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150
>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein
Serine/Threonine Kinase, Protein Kinase B gamma.
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
or Akt subfamily, gamma (or Akt3) isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. There are three
PKB isoforms from different genes, PKB-alpha (or Akt1),
PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
contains an N-terminal pleckstrin homology (PH) domain
and a C-terminal catalytic domain. PKB-gamma is
predominantly expressed in neuronal tissues. Mice
deficient in PKB-gamma show a reduction in brain weight
due to the decreases in cell size and cell number.
PKB-gamma has also been shown to be upregulated in
estrogen-deficient breast cancer cells,
androgen-independent prostate cancer cells, and primary
ovarian tumors. It acts as a key mediator in the genesis
of ovarian cancer.
Length = 328
Score = 37.0 bits (85), Expect = 5e-04
Identities = 21/77 (27%), Positives = 40/77 (51%), Gaps = 5/77 (6%)
Query: 9 TIEIRHSTKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLH 63
+++ TK+ L EY + H ++ + S D ++ +I+ L Y+HS +++
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 64 RDLKPSNLLLNTTCDLK 80
RDLK NL+L+ +K
Sbjct: 119 RDLKLENLMLDKDGHIK 135
>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein
Kinase, MAP/ERK Kinase 1. Protein kinases (PKs),
MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The MEK subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising the MAP kinase
(MAPK), which is phosphorylated and activated by a MAPK
kinase (MAPKK or MKK), which itself is phosphorylated
and activated by a MAPK kinase kinase (MAPKKK or MKKK).
MEK1 is a dual-specificity PK that phosphorylates and
activates the downstream targets, extracellular
signal-regulated kinase (ERK) 1 and ERK2, on specific
threonine and tyrosine residues. The ERK cascade starts
with extracellular signals including growth factors,
hormones, and neurotransmitters, which act through
receptors and ion channels to initiate intracellular
signaling that leads to the activation at the MAPKKK
(Raf-1 or MOS) level, which leads to the transmission of
signals to MEK1, and finally to ERK1/2. The ERK cascade
plays an important role in cell proliferation,
differentiation, oncogenic transformation, and cell
cycle control, as well as in apoptosis and cell survival
under certain conditions. Gain-of-function mutations in
genes encoding ERK cascade proteins, including MEK1,
cause cardiofaciocutaneous (CFC) syndrome, a condition
leading to multiple congenital anomalies and mental
retardation in patients. MEK1 also plays a role in cell
cycle control.
Length = 333
Score = 37.3 bits (86), Expect = 5e-04
Identities = 13/34 (38%), Positives = 26/34 (76%), Gaps = 1/34 (2%)
Query: 49 ILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLKF 81
+++GL Y+ + ++HRD+KPSN+L+N+ ++K
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKL 145
>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein
Serine/Threonine Kinase, Novel Protein Kinase C eta.
Serine/Threonine Kinases (STKs), Novel Protein Kinase C
(nPKC), eta isoform, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
nPKC subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PKCs are classified into three groups
(classical, atypical, and novel) depending on their mode
of activation and the structural characteristics of
their regulatory domain. nPKCs are calcium-independent,
but require DAG (1,2-diacylglycerol) and
phosphatidylserine (PS) for activity. There are four
nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta
is predominantly expressed in squamous epithelia, where
it plays a crucial role in the signaling of cell-type
specific differentiation. It is also expressed in pro-B
cells and early-stage thymocytes, and acts as a key
regulator in early B-cell development. PKC-eta increases
glioblastoma multiforme (GBM) proliferation and
resistance to radiation, and is being developed as a
therapeutic target for the management of GBM.
Length = 320
Score = 37.2 bits (86), Expect = 5e-04
Identities = 13/45 (28%), Positives = 24/45 (53%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
H K +R ++ +I L ++H +++RDLK N+LL+
Sbjct: 86 HIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130
>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like
dual-specificity MAP kinase kinases. Protein kinases
(PKs), MAP kinase kinase (MAPKK) subfamily, fungal
PBS2-like proteins, catalytic (c) domain. PKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The MAPKK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases, protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
mitogen-activated protein (MAP) kinase signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising of the MAP kinase (MAPK),
which is phosphorylated and activated by a MAPK kinase
(MAPKK or MKK), which itself is phosphorylated and
activated by a MAPK kinase kinase (MAPKKK or MKKK).
Members of this group include the MAPKKs Polymyxin B
resistance protein 2 (PBS2) from Saccharomyces
cerevisiae, Wis1 from Schizosaccharomyces pombe, and
related proteins. PBS2 and Wis1 are components of
stress-activated MAPK cascades in budding and fission
yeast, respectively. PBS2 is the specific activator of
the MAPK Hog1, which plays a central role in the
response of budding yeast to stress including exposure
to arsenite and hyperosmotic environments. Wis1
phosphorylates and activates the MAPK Sty1 (also called
Spc1 or Phh1), which stimulates a transcriptional
response to a wide range of cellular insults through the
bZip transcription factors Atf1, Pcr1, and Pap1.
Length = 286
Score = 37.1 bits (86), Expect = 5e-04
Identities = 14/35 (40%), Positives = 26/35 (74%), Gaps = 1/35 (2%)
Query: 47 YQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLK 80
Y +++GLK++ N++HRD+KP+N+L+N +K
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVK 143
>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 2. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek2 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. The Nek2
subfamily includes Aspergillus nidulans NIMA kinase, the
founding member of the Nek family, which was identified
in a screen for cell cycle mutants prevented from
entering mitosis. NIMA is essential for mitotic entry
and progression through mitosis, and its degradation is
essential for mitotic exit. NIMA is involved in nuclear
membrane fission. Vertebrate Nek2 is a cell
cycle-regulated STK, localized in centrosomes and
kinetochores, that regulates centrosome splitting at the
G2/M phase. It also interacts with other mitotic kinases
such as Polo-like kinase 1 and may play a role in
spindle checkpoint. An increase in the expression of the
human NEK2 gene is strongly associated with the
progression of non-Hodgkin lymphoma.
Length = 265
Score = 36.8 bits (86), Expect = 6e-04
Identities = 17/51 (33%), Positives = 26/51 (50%), Gaps = 5/51 (9%)
Query: 35 QRLSNDHICYFLYQILRGLKYIH-----SANVLHRDLKPSNLLLNTTCDLK 80
+ + + I L Q+L L H VLHRDLKP+N+ L+ ++K
Sbjct: 100 KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150
>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein
Serine/Threonine Kinase, Serum- and
Glucocorticoid-induced Kinase 1. Serine/Threonine
Kinases (STKs), Serum- and Glucocorticoid-induced Kinase
(SGK) subfamily, SGK1 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The SGK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. There are three isoforms of
SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously
expressed and is under transcriptional control of
numerous stimuli including cell stress (cell shrinkage),
serum, hormones (gluco- and mineralocorticoids),
gonadotropins, growth factors, interleukin-6, and other
cytokines. It plays roles in sodium retention and
potassium elimination in the kidney, nutrient transport,
salt sensitivity, memory consolidation, and cardiac
repolarization. A common SGK1 variant is associated with
increased blood pressure and body weight. SGK1 may also
contribute to tumor growth, neurodegeneration, fibrosing
disease, and ischemia.
Length = 325
Score = 36.9 bits (85), Expect = 6e-04
Identities = 14/32 (43%), Positives = 24/32 (75%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
++ +I L Y+HS N+++RDLKP N+LL++
Sbjct: 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDS 131
>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase,
Hematopoietic cell kinase. Protein Tyrosine Kinase
(PTK) family; Hematopoietic cell kinase (Hck); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Hck is a member of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Hck is present in myeloid and lymphoid
cells that play a role in the development of cancer. It
may be important in the oncogenic signaling of the
protein Tel-Abl, which induces a chronic myelogenous
leukemia (CML)-like disease. Hck also acts as a negative
regulator of granulocyte colony-stimulating factor
(G-CSF)-induced proliferation of granulocytic
precursors, suggesting a possible role in the
development of acute myeloid leukemia (AML). In
addition, Hck is essential in regulating the
degranulation of polymorphonuclear leukocytes (PMNs).
Genetic polymorphisms affect the expression level of
Hck, which affects PMN mediator release and influences
the development of chronic obstructive pulmonary disease
(COPD).
Length = 260
Score = 36.9 bits (85), Expect = 6e-04
Identities = 17/58 (29%), Positives = 31/58 (53%), Gaps = 5/58 (8%)
Query: 17 KESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
K SL+ F + + + +L + F QI G+ +I N +HRDL+ +N+L++
Sbjct: 84 KGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAFIEQRNYIHRDLRAANILVS 136
>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine
Kinase, Activated Cdc42-associated kinase. Protein
Tyrosine Kinase (PTK) family; Activated Cdc42-associated
kinase (Ack) subfamily; catalytic (c) domain. Ack
subfamily members include Ack1, thirty-eight-negative
kinase 1 (Tnk1), and similar proteins. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ack
subfamily members are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal catalytic domain, an
SH3 domain, a Cdc42-binding CRIB domain, and a
proline-rich region. They are mainly expressed in brain
and skeletal tissues and are involved in the regulation
of cell adhesion and growth, receptor degradation, and
axonal guidance. Ack1 is also associated with
androgen-independent prostate cancer progression. Tnk1
regulates TNFalpha signaling and may play an important
role in cell death.
Length = 257
Score = 36.6 bits (85), Expect = 6e-04
Identities = 13/32 (40%), Positives = 20/32 (62%)
Query: 42 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+C + QI G++Y+ S +HRDL N+LL
Sbjct: 99 LCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein
Serine/Threonine Kinase, Serum- and
Glucocorticoid-induced Kinase 3. Serine/Threonine
Kinases (STKs), Serum- and Glucocorticoid-induced Kinase
(SGK) subfamily, SGK3 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The SGK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. There are three isoforms of
SGK, named SGK1, SGK2, and SGK3 (also called
cytokine-independent survival kinase CISK). SGK3 is
expressed in most tissues and is most abundant in the
embryo and adult heart and spleen. It was originally
discovered in a screen for antiapoptotic genes. It
phosphorylates and inhibits the proapoptotic proteins,
Bad and FKHRL1. SGK3 also regulates many transporters,
ion channels, and receptors. It plays a critical role in
hair follicle morphogenesis and hair cycling.
Length = 325
Score = 36.9 bits (85), Expect = 7e-04
Identities = 14/32 (43%), Positives = 24/32 (75%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
++ +I L Y+HS N+++RDLKP N+LL++
Sbjct: 100 FYAAEIASALGYLHSINIVYRDLKPENILLDS 131
>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine
Kinase, Platelet Derived Growth Factor Receptor alpha.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) alpha; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. PDGFR
alpha is a receptor tyr kinase (RTK) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding to
its ligands, the PDGFs, leads to receptor dimerization,
trans phosphorylation and activation, and intracellular
signaling. PDGFR alpha forms homodimers or heterodimers
with PDGFR beta, depending on the nature of the PDGF
ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha
homodimerization. PDGFR signaling plays many roles in
normal embryonic development and adult physiology. PDGFR
alpha signaling is important in the formation of lung
alveoli, intestinal villi, mesenchymal dermis, and hair
follicles, as well as in the development of
oligodendrocytes, retinal astrocytes, neural crest
cells, and testicular cells. Aberrant PDGFR alpha
expression is associated with some human cancers.
Mutations in PDGFR alpha have been found within a subset
of gastrointestinal stromal tumors (GISTs). An active
fusion protein FIP1L1-PDGFR alpha, derived from
interstitial deletion, is associated with idiopathic
hypereosinophilic syndrome (HES) and chronic
eosinophilic leukemia (CEL).
Length = 400
Score = 36.9 bits (85), Expect = 7e-04
Identities = 15/37 (40%), Positives = 24/37 (64%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
L+ + F YQ+ RG++++ S N +HRDL N+LL
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270
>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase,
Src. Protein Tyrosine Kinase (PTK) family; Src kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Src (or c-Src) is a
cytoplasmic (or non-receptor) tyr kinase, containing an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region with a conserved tyr.
It is activated by autophosphorylation at the tyr kinase
domain, and is negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
c-Src is the vertebrate homolog of the oncogenic protein
(v-Src) from Rous sarcoma virus. Together with other Src
subfamily proteins, it is involved in signaling pathways
that regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Src also play a role in regulating cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Elevated levels of Src kinase activity
have been reported in a variety of human cancers.
Several inhibitors of Src have been developed as
anti-cancer drugs. Src is also implicated in acute
inflammatory responses and osteoclast function.
Length = 262
Score = 36.6 bits (84), Expect = 7e-04
Identities = 24/80 (30%), Positives = 39/80 (48%), Gaps = 7/80 (8%)
Query: 5 QDQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHR 64
++ I I + +K SL+ F + KY RL + QI G+ Y+ N +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK---GEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVHR 126
Query: 65 DLKPSNLLL--NTTCDLKFF 82
DL+ +N+L+ N C + F
Sbjct: 127 DLRAANILVGENLVCKVADF 146
>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine
Kinase, G protein-coupled Receptor Kinase.
Serine/Threonine Kinases (STKs), G protein-coupled
Receptor Kinase (GRK) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The GRK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. GRKs phosphorylate and
regulate G protein-coupled receptors (GPCRs), the
largest superfamily of cell surface receptors, which
regulate some part of nearly all physiological
functions. Phosphorylated GPCRs bind to arrestins, which
prevents further G protein signaling despite the
presence of activating ligand. GRKs contain a central
catalytic domain, flanked by N- and C-terminal
extensions. The N-terminus contains an RGS (regulator of
G protein signaling) homology (RH) domain and several
motifs. The C-terminus diverges among different groups
of GRKs. There are seven types of GRKs, named GRK1 to
GRK7. They are subdivided into three main groups: visual
(GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and
GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is
widespread while GRK1/4/7 show a limited tissue
distribution. The substrate spectrum of the widely
expressed GRKs partially overlaps. GRKs play important
roles in the cardiovascular, immune, respiratory,
skeletal, and nervous systems.
Length = 277
Score = 36.3 bits (84), Expect = 8e-04
Identities = 13/31 (41%), Positives = 24/31 (77%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ QI+ GL+++H +++RDLKP N+LL+
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLD 129
>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 2. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 2 (FGFR2); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR2 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. There are many splice
variants of FGFR2 which show differential expression and
binding to FGF ligands. Disruption of either FGFR2 or
FGFR2b is lethal in mice, due to defects in the placenta
or severe impairment of tissue development including
lung, limb, and thyroid, respectively. Disruption of
FGFR2c in mice results in defective bone and skull
development. Genetic alterations of FGFR2 are associated
with many human skeletal disorders including Apert
syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and
Pfeiffer syndrome.
Length = 304
Score = 36.5 bits (84), Expect = 8e-04
Identities = 18/57 (31%), Positives = 31/57 (54%), Gaps = 1/57 (1%)
Query: 25 EYS-DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
EYS D R ++++ + YQ+ RG++Y+ S +HRDL N+L+ +K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177
>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein
Serine/Threonine Kinase, beta-adrenergic receptor
kinase. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily,
beta-adrenergic receptor kinase (beta-ARK) group,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The GRK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. GRKs
phosphorylate and regulate G protein-coupled receptors
(GPCRs), the largest superfamily of cell surface
receptors which regulate some part of nearly all
physiological functions. Phosphorylated GPCRs bind to
arrestins, which prevents further G protein signaling
despite the presence of activating ligand. There are
seven types of GRKs, named GRK1 to GRK7. The beta-ARK
group is composed of GRK2, GRK3, and similar proteins.
GRK2 and GRK3 are both widely expressed in many tissues,
although GRK2 is present at higher levels. They contain
an N-terminal RGS homology (RH) domain, a central
catalytic domain, and C-terminal pleckstrin homology
(PH) domain that mediates PIP2 and G protein
betagamma-subunit translocation to the membrane. GRK2
(also called beta-ARK or beta-ARK1) is important in
regulating several cardiac receptor responses. It plays
a role in cardiac development and in hypertension.
Deletion of GRK2 in mice results in embryonic lethality,
caused by hypoplasia of the ventricular myocardium. GRK2
also plays important roles in the liver (as a regulator
of portal blood pressure), in immune cells, and in the
nervous system. Altered GRK2 expression has been
reported in several disorders including major
depression, schizophrenia, bipolar disorder, and
Parkinsonism.
Length = 278
Score = 36.5 bits (84), Expect = 9e-04
Identities = 15/45 (33%), Positives = 32/45 (71%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
H +++ S + ++ +I+ GL+++H+ V++RDLKP+N+LL+
Sbjct: 87 HLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 131
>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 3. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK3
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK3 (also known as beta-adrenergic
receptor kinase 2) is widely expressed in many tissues.
GRK3-deficient mice show a lack of olfactory receptor
desensitization and altered regulation of the M2
muscarinic airway. GRK3 is involved in modulating the
cholinergic response of airway smooth muscles. It also
plays a role in dopamine receptor regulation. GRK3
promoter polymorphisms may be associated with bipolar
disorder.
Length = 279
Score = 36.1 bits (83), Expect = 0.001
Identities = 15/45 (33%), Positives = 32/45 (71%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
H +++ S + ++ +I+ GL+++H+ V++RDLKP+N+LL+
Sbjct: 87 HLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131
>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine
Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyk2 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase catalytic domain. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Tyk2 is widely expressed in many tissues. It is involved
in signaling via the cytokine receptors IFN-alphabeta,
IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell
surface urokinase receptor (uPAR) signaling and plays a
role in modulating vascular smooth muscle cell (VSMC)
functional behavior in response to injury. Tyk2 is also
important in dendritic cell function and T helper (Th)1
cell differentiation. A homozygous mutation of Tyk2 was
found in a patient with hyper-IgE syndrome (HIES), a
primary immunodeficiency characterized by recurrent skin
abscesses, pneumonia, and elevated serum IgE. This
suggests that Tyk2 may play important roles in multiple
cytokine signaling involved in innate and adaptive
immunity.
Length = 283
Score = 36.0 bits (83), Expect = 0.001
Identities = 20/55 (36%), Positives = 30/55 (54%), Gaps = 5/55 (9%)
Query: 20 LVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L S R+Y H+ L+ + F QI G+ Y+HS + +HRDL N+LL+
Sbjct: 92 LGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD 141
>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional.
Length = 496
Score = 36.4 bits (84), Expect = 0.001
Identities = 23/68 (33%), Positives = 38/68 (55%), Gaps = 2/68 (2%)
Query: 31 RTKYQRLSNDHICYFLY-QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFYFFFSF 89
R K R +H L+ Q+L + ++HS +++HRD+K +N+LL + +K F FS
Sbjct: 133 RAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK-LGDFGFSK 191
Query: 90 FFHFTVHD 97
+ TV D
Sbjct: 192 MYAATVSD 199
>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 3.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR3 (or Flt4) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. VEGFR3
preferentially binds the ligands VEGFC and VEGFD. VEGFR3
is essential for lymphatic endothelial cell (EC)
development and function. It has been shown to regulate
adaptive immunity during corneal transplantation. VEGFR3
is upregulated on blood vascular ECs in pathological
conditions such as vascular tumors and the periphery of
solid tumors. It plays a role in cancer progression and
lymph node metastasis. Missense mutations in the VEGFR3
gene are associated with primary human lymphedema.
Length = 338
Score = 36.1 bits (83), Expect = 0.001
Identities = 15/35 (42%), Positives = 24/35 (68%), Gaps = 1/35 (2%)
Query: 40 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
D ICY +Q+ RG++++ S +HRDL N+LL+
Sbjct: 175 DLICYS-FQVARGMEFLASRKCIHRDLAARNILLS 208
>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein
Serine/Threonine Kinase, Thousand-and-one amino acids 1.
Serine/threonine kinases (STKs), thousand-and-one amino
acids 1 (TAO1) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The TAO subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. TAO proteins possess mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
activity. MAPK signaling cascades are important in
mediating cellular responses to extracellular signals.
TAO1 is sometimes referred to as prostate-derived
sterile 20-like kinase 2 (PSK2). TAO1 activates the p38
MAPK through direct interaction with and activation of
MEK3. TAO1 is highly expressed in the brain and may play
a role in neuronal apoptosis. TAO1 interacts with the
checkpoint proteins BubR1 and Mad2, and plays an
important role in regulating mitotic progression, which
is required for both chromosome congression and
checkpoint-induced anaphase delay. TAO1 may play a role
in protecting genomic stability.
Length = 317
Score = 36.2 bits (83), Expect = 0.001
Identities = 15/32 (46%), Positives = 22/32 (68%)
Query: 50 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
L+GL Y+HS N++HRD+K N+LL +K
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL 166
>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein
Serine/Threonine Kinase, Group I p21-activated kinase.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) subfamily, Group I, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PAK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs are
implicated in the regulation of many cellular processes
including growth factor receptor-mediated proliferation,
cell polarity, cell motility, cell death and survival,
and actin cytoskeleton organization. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
Group I PAKs, also called conventional PAKs, include
PAK1, PAK2, and PAK3. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). They interact
with the SH3 domain containing proteins Nck, Grb2 and
PIX. Binding of group I PAKs to activated GTPases leads
to conformational changes that destabilize the AID,
allowing autophosphorylation and full activation of the
kinase domain. Known group I PAK substrates include
MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc,
Stat5a, and Aurora A, among others.
Length = 293
Score = 36.0 bits (83), Expect = 0.001
Identities = 12/26 (46%), Positives = 20/26 (76%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLL 73
+ L+ L+++HS V+HRD+K N+LL
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILL 148
>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine
Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK)
family; Src-related kinase lacking C-terminal regulatory
tyrosine and N-terminal myristylation sites (Srm) and
breast tumor kinase (Brk, also called protein tyrosine
kinase 6); catalytic (c) domains. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Srm and
Brk are a member of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases in general contain an N-terminal SH4 domain with
a myristoylation site, followed by SH3 and SH2 domains,
a tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr; they are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Srm and
Brk however, lack the N-terminal myristylation sites.
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Brk has been found to be overexpressed
in a majority of breast tumors.
Length = 261
Score = 35.9 bits (83), Expect = 0.001
Identities = 18/69 (26%), Positives = 30/69 (43%), Gaps = 7/69 (10%)
Query: 16 TKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 73
K SL++F + Q L + Q+ G+ Y+ N +HRDL N+L+
Sbjct: 85 EKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139
Query: 74 NTTCDLKFF 82
+ C + F
Sbjct: 140 DLVCKVADF 148
>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase
1-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Yeast protein kinase 1
(YPK1)-like subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The YPK1-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
fungal proteins with similarity to the AGC STKs,
Saccharomyces cerevisiae YPK1 and Schizosaccharomyces
pombe Gad8p. YPK1 is required for cell growth and acts
as a downstream kinase in the sphingolipid-mediated
signaling pathway of yeast. It also plays a role in
efficient endocytosis and in the maintenance of cell
wall integrity. Gad8p is a downstream target of Tor1p,
the fission yeast homolog of mTOR. It plays a role in
cell growth and sexual development.
Length = 312
Score = 36.1 bits (83), Expect = 0.001
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
++ ++L L+ +H NV++RDLKP N+LL+
Sbjct: 97 FYTAELLCALENLHKFNVIYRDLKPENILLDYQ 129
>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein
Serine/Threonine Kinase, Atypical Protein Kinase C iota.
Serine/Threonine Kinases (STKs), Atypical Protein
Kinase C (aPKC) subfamily, iota isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The aPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
aPKCs only require phosphatidylserine (PS) for
activation. There are two aPKC isoforms, zeta and iota.
PKC-iota is directly implicated in carcinogenesis. It is
critical to oncogenic signaling mediated by Ras and
Bcr-Abl. The PKC-iota gene is the target of
tumor-specific gene amplification in many human cancers,
and has been identified as a human oncogene. In addition
to its role in transformed growth, PKC-iota also
promotes invasion, chemoresistance, and tumor cell
survival. Expression profiling of PKC-iota is a
prognostic marker of poor clinical outcome in several
human cancers. PKC-iota also plays a role in
establishing cell polarity, and has critical embryonic
functions.
Length = 329
Score = 35.8 bits (82), Expect = 0.001
Identities = 16/55 (29%), Positives = 31/55 (56%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFY 84
H + ++L +H ++ +I L Y+H +++RDLK N+LL++ +K Y
Sbjct: 86 HMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDY 140
>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein
Serine/Threonine Kinase, Thousand-and-one amino acids 2.
Serine/threonine kinases (STKs), thousand-and-one amino
acids 2 (TAO2) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The TAO subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. TAO proteins possess mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
activity. MAPK signaling cascades are important in
mediating cellular responses to extracellular signals.
Human TAO2 is also known as prostate-derived Ste20-like
kinase (PSK) and was identified in a screen for
overexpressed RNAs in prostate cancer. TAO2 activates
both p38 and c-Jun N-terminal kinase (JNK), by
phosphorylating and activating the respective MAP/ERK
kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6
and MKK4/MKK7. TAO2 contains a long C-terminal extension
with autoinhibitory segments. It is activated by the
release of this inhibition and the phosphorylation of
its activation loop serine. TAO2 functions as a
regulator of actin cytoskeletal and microtubule
organization. In addition, it regulates the transforming
growth factor-activated kinase 1 (TAK1), which is a
MAPKKK that plays an essential role in the signaling
pathways of tumor necrosis factor (TNF), interleukin 1
(IL-1), and Toll-like receptor (TLR).
Length = 308
Score = 35.8 bits (82), Expect = 0.001
Identities = 14/24 (58%), Positives = 20/24 (83%)
Query: 50 LRGLKYIHSANVLHRDLKPSNLLL 73
L+GL Y+HS N++HRD+K N+LL
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL 148
>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 7. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK7
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors, which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs
to the visual group of GRKs. It is primarily found in
the retina and plays a role in the regulation of opsin
light receptors. GRK7 is located in retinal cone outer
segments and plays an important role in regulating
photoresponse of the cones.
Length = 277
Score = 35.7 bits (82), Expect = 0.002
Identities = 13/38 (34%), Positives = 27/38 (71%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L + + ++ QI G+ ++HS ++++RD+KP N+LL+
Sbjct: 92 LEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD 129
>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 1. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek1 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek1 is
associated with centrosomes throughout the cell cycle.
It is involved in the formation of primary cilium and in
the maintenance of centrosomes. It cycles through the
nucleus and may be capable of relaying signals between
the cilium and the nucleus. Nek1 is implicated in the
development of polycystic kidney disease, which is
characterized by benign polycystic tumors formed by
abnormal overgrowth of renal epithelial cells. It
appears also to be involved in DNA damage response, and
may be important for both correct DNA damage checkpoint
activation and DNA repair.
Length = 256
Score = 35.6 bits (82), Expect = 0.002
Identities = 14/37 (37%), Positives = 20/37 (54%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
D I + QI LK++H +LHRD+K N+ L
Sbjct: 98 FPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 134
>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein
Serine/Threonine Kinase, Serum- and
Glucocorticoid-induced Kinase 2. Serine/Threonine
Kinases (STKs), Serum- and Glucocorticoid-induced Kinase
(SGK) subfamily, SGK2 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The SGK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. There are three isoforms of
SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more
restricted distribution that SGK1 and is most abundantly
expressed in epithelial tissues including kidney, liver,
pancreas, and the choroid plexus of the brain. In vitro
cellular assays show that SGK2 can stimulate the
activity of ion channels, the glutamate transporter
EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Length = 321
Score = 35.7 bits (82), Expect = 0.002
Identities = 13/46 (28%), Positives = 27/46 (58%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
H + + ++ ++ + Y+HS N+++RDLKP N+LL++
Sbjct: 86 HLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS 131
>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein
Serine/Threonine Kinase, Rho-associated coiled-coil
containing protein kinase 1. Serine/Threonine Kinases
(STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ROCK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. ROCK contains an
N-terminal extension, a catalytic kinase domain, and a
C-terminal extension, which contains a coiled-coil
region encompassing a Rho-binding domain (RBD) and a
pleckstrin homology (PH) domain. ROCK is auto-inhibited
by the RBD and PH domain interacting with the catalytic
domain, and is activated via interaction with Rho
GTPases. ROCK1 is preferentially expressed in the liver,
lung, spleen, testes, and kidney. It mediates signaling
from Rho to the actin cytoskeleton. It is implicated in
the development of cardiac fibrosis, cardiomyocyte
apoptosis, and hyperglycemia. Mice deficient with ROCK1
display eyelids open at birth (EOB) and omphalocele
phenotypes due to the disorganization of actin filaments
in the eyelids and the umbilical ring.
Length = 371
Score = 35.8 bits (82), Expect = 0.002
Identities = 14/38 (36%), Positives = 24/38 (63%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
++ +++ L IHS +HRD+KP N+LL+ + LK
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine
Kinase, Protein Kinase C. Serine/Threonine Kinases
(STKs), Protein Kinase C (PKC) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
PKCs undergo three phosphorylations in order to take
mature forms. In addition, classical PKCs depend on
calcium, DAG (1,2-diacylglycerol), and in most cases,
phosphatidylserine (PS) for activation. Novel PKCs are
calcium-independent, but require DAG and PS for
activity, while atypical PKCs only require PS. PKCs
phosphorylate and modify the activities of a wide
variety of cellular proteins including receptors,
enzymes, cytoskeletal proteins, transcription factors,
and other kinases. They play a central role in signal
transduction pathways that regulate cell migration and
polarity, proliferation, differentiation, and apoptosis.
Also included in this subfamily are the PKC-like
proteins, called PKNs.
Length = 318
Score = 35.4 bits (82), Expect = 0.002
Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 5/65 (7%)
Query: 16 TKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
TK+ L EY + H + R ++ +I+ GL+++H +++RDLK N
Sbjct: 67 TKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDN 126
Query: 71 LLLNT 75
+LL++
Sbjct: 127 VLLDS 131
>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine
Kinase, Protein Kinase N. Serine/Threonine Kinases
(STKs), Protein Kinase N (PKN) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKN subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKN has a
C-terminal catalytic domain that is highly homologous to
PKCs. Its unique N-terminal regulatory region contains
antiparallel coiled-coil (ACC) domains. In mammals,
there are three PKN isoforms from different genes
(designated PKN-alpha, beta, and gamma), which show
different enzymatic properties, tissue distribution, and
varied functions. PKN can be activated by the small
GTPase Rho, and by fatty acids such as arachidonic and
linoleic acids. It is involved in many biological
processes including cytokeletal regulation, cell
adhesion, vesicle transport, glucose transport,
regulation of meiotic maturation and embryonic cell
cycles, signaling to the nucleus, and tumorigenesis.
Length = 324
Score = 35.4 bits (82), Expect = 0.002
Identities = 13/33 (39%), Positives = 23/33 (69%)
Query: 43 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
++ ++ GL+Y+H +++RDLK NLLL+T
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136
>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase,
Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lyn is a member of the
Src subfamily of proteins, which are cytoplasmic (or
non-receptor) tyr kinases. Src kinases contain an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. Lyn is
expressed in B lymphocytes and myeloid cells. It
exhibits both positive and negative regulatory roles in
B cell receptor (BCR) signaling. Lyn, as well as Fyn and
Blk, promotes B cell activation by phosphorylating ITAMs
(immunoreceptor tyr activation motifs) in CD19 and in Ig
components of BCR. It negatively regulates signaling by
its unique ability to phosphorylate ITIMs
(immunoreceptor tyr inhibition motifs) in cell surface
receptors like CD22 and CD5. Lyn also plays an important
role in G-CSF receptor signaling by phosphorylating a
variety of adaptor molecules.
Length = 261
Score = 35.4 bits (81), Expect = 0.002
Identities = 20/70 (28%), Positives = 36/70 (51%), Gaps = 5/70 (7%)
Query: 5 QDQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHR 64
++ I I + K SL+ F + + + +L + F QI G+ YI N +HR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID-----FSAQIAEGMAYIERKNYIHR 127
Query: 65 DLKPSNLLLN 74
DL+ +N+L++
Sbjct: 128 DLRAANVLVS 137
>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein
Serine/Threonine Kinase, Thousand-and-one amino acids 3.
Serine/threonine kinases (STKs), thousand-and-one amino
acids 3 (TAO3) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The TAO subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. TAO proteins possess mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
activity. MAPK signaling cascades are important in
mediating cellular responses to extracellular signals.
TAO3 is also known as JIK (JNK inhibitory kinase) or KFC
(kinase from chicken). It specifically activates c-Jun
N-terminal kinase (JNK), presumably by phosphorylating
and activating MKK4/MKK7. In Saccharomyces cerevisiae,
TAO3 is a component of the RAM (regulation of Ace2p
activity and cellular morphogenesis) signaling pathway.
TAO3 is upregulated in retinal ganglion cells after
axotomy, and may play a role in apoptosis.
Length = 313
Score = 35.4 bits (81), Expect = 0.002
Identities = 15/32 (46%), Positives = 22/32 (68%)
Query: 50 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
L+GL Y+HS N++HRD+K N+LL +K
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKL 162
>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine
Kinase, Serum- and Glucocorticoid-induced Kinase.
Serine/Threonine Kinases (STKs), Serum- and
Glucocorticoid-induced Kinase (SGK) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The SGK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. There are three
isoforms of SGK, named SGK1, SGK2, and SGK3 (also called
cytokine-independent survival kinase CISK). SGKs are
activated by insulin and growth factors via
phosphoinositide 3-kinase and PDK1. They activate ion
channels, ion carriers, and the Na-K-ATPase, as well as
regulate the activity of enzymes and transcription
factors. SGKs play important roles in transport, hormone
release, neuroexcitability, cell proliferation, and
apoptosis.
Length = 323
Score = 35.5 bits (82), Expect = 0.002
Identities = 14/31 (45%), Positives = 23/31 (74%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ +I L Y+HS N+++RDLKP N+LL+
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLD 130
>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase,
Kit. Protein Tyrosine Kinase (PTK) family; Kit (or
c-Kit); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Kit is a member of the
Platelet Derived Growth Factor Receptor (PDGFR)
subfamily of proteins, which are receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of Kit to its ligand, the stem-cell factor
(SCF), leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. Kit is important in the development of
melanocytes, germ cells, mast cells, hematopoietic stem
cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. Kit signaling is
involved in major cellular functions including cell
survival, proliferation, differentiation, adhesion, and
chemotaxis. Mutations in Kit, which result in
constitutive ligand-independent activation, are found in
human cancers such as gastrointestinal stromal tumor
(GIST) and testicular germ cell tumor (TGCT). The
aberrant expression of Kit and/or SCF is associated with
other tumor types such as systemic mastocytosis and
cancers of the breast, neurons, lung, prostate, colon,
and rectum. Although the structure of the human Kit
catalytic domain is known, it is excluded from this
specific alignment model because it contains a deletion
in its sequence.
Length = 375
Score = 35.3 bits (81), Expect = 0.002
Identities = 13/29 (44%), Positives = 20/29 (68%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLL 73
F YQ+ +G+ ++ S N +HRDL N+LL
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL 247
>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine
Kinase, Protein Kinase B. Serine/Threonine Kinases
(STKs), Protein Kinase B (PKB) or Akt subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase (PI3K). There are
three PKB isoforms from different genes, PKB-alpha (or
Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
contains an N-terminal pleckstrin homology (PH) domain
and a C-terminal catalytic domain. It is activated
downstream of PI3K and plays important roles in diverse
cellular functions including cell survival, growth,
proliferation, angiogenesis, motility, and migration.
PKB also has a central role in a variety of human
cancers, having been implicated in tumor initiation,
progression, and metastasis.
Length = 323
Score = 35.2 bits (81), Expect = 0.002
Identities = 16/45 (35%), Positives = 29/45 (64%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
H ++ + S D ++ +I+ L Y+HS +V++RDLK NL+L+
Sbjct: 85 HLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD 129
>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 7. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek7 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek7 is required
for mitotic spindle formation and cytokinesis. It is
enriched in the centrosome and is critical for
microtubule nucleation. Nek7 is activated by Nek9 during
mitosis, and may regulate the p70 ribosomal S6 kinase.
Length = 267
Score = 35.4 bits (81), Expect = 0.002
Identities = 16/48 (33%), Positives = 29/48 (60%), Gaps = 1/48 (2%)
Query: 30 HRTKYQRLSNDHICY-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTT 76
H K +RL + + + Q+ L+++HS V+HRD+KP+N+ + T
Sbjct: 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT 142
>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 1.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 1, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK1 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK1 is
important in the regulation of many cellular processes
including cytoskeletal dynamics, cell motility, growth,
and proliferation. Although PAK1 has been regarded
mainly as a cytosolic protein, recent reports indicate
that PAK1 also exists in significant amounts in the
nucleus, where it is involved in transcription
modulation and in cell cycle regulatory events. PAK1 is
also involved in transformation and tumorigenesis. Its
overexpression, hyperactivation and increased nuclear
accumulation is correlated to breast cancer invasiveness
and progression. Nuclear accumulation is also linked to
tamoxifen resistance in breast cancer cells.
Length = 296
Score = 35.5 bits (81), Expect = 0.002
Identities = 14/39 (35%), Positives = 24/39 (61%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFYFF 86
+ L+ L+++HS V+HRD+K N+LL +K + F
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine
Kinases, Tyrosine kinase expressed in hepatocellular
carcinoma and Resting lymphocyte kinase. Protein
Tyrosine Kinase (PTK) family; Tyrosine kinase expressed
in hepatocellular carcinoma (Tec) and Resting lymphocyte
kinase (Rlk); catalytic (c) domain. The PTKc family is
part of a larger superfamily, that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Tec and
Rlk (also named Txk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. Instead of PH, Rlk
contains an N-terminal cysteine-rich region. In addition
to PH, Tec also contains the Tec homology (TH) domain
with proline-rich and zinc-binding regions. Tec kinases
are expressed mainly by haematopoietic cells. Tec is
more widely-expressed than other Tec subfamily kinases.
It is found in endothelial cells, both B- and T-cells,
and a variety of myeloid cells including mast cells,
erythroid cells, platelets, macrophages and neutrophils.
Rlk is expressed in T-cells and mast cell lines. Tec and
Rlk are both key components of T-cell receptor (TCR)
signaling. They are important in TCR-stimulated
proliferation, IL-2 production and phopholipase C-gamma1
activation.
Length = 256
Score = 35.2 bits (81), Expect = 0.002
Identities = 14/50 (28%), Positives = 27/50 (54%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
R + +LS D + + G++Y+ + +HRDL N L+++T +K
Sbjct: 91 RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVK 140
>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional.
Length = 391
Score = 35.4 bits (81), Expect = 0.002
Identities = 11/31 (35%), Positives = 21/31 (67%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDL 79
+LR ++Y+H ++HRD+K N+ +N D+
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine
Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family;
Tyro3; catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyro3 (or Sky) is a
member of the Axl subfamily, which is composed of
receptor tyr kinases (RTKs) containing an extracellular
ligand-binding region with two immunoglobulin-like
domains followed by two fibronectin type III repeats, a
transmembrane segment, and an intracellular catalytic
domain. Binding to their ligands, Gas6 and protein S,
leads to receptor dimerization, autophosphorylation,
activation, and intracellular signaling. Tyro3 is
predominantly expressed in the central nervous system
and the brain, and functions as a neurotrophic factor.
It is also expressed in osteoclasts and has a role in
bone resorption.
Length = 273
Score = 34.9 bits (80), Expect = 0.003
Identities = 13/30 (43%), Positives = 19/30 (63%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
F+ I G++Y+ S N +HRDL N +LN
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine
Kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; Spleen Tyrosine Kinase (Syk)
subfamily; catalytic (c) domain. The Syk subfamily is
composed of Syk, ZAP-70, Shark, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing two Src homology 2 (SH2) domains
N-terminal to the catalytic tyr kinase domain. They are
involved in the signaling downstream of activated
receptors (including B-cell, T-cell, and Fc receptors)
that contain ITAMs (immunoreceptor tyr activation
motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. Syk is important in B-cell
receptor (BCR) signaling, while Zap-70 is primarily
expressed in T-cells and NK cells, and is a crucial
component in T-cell receptor (TCR) signaling. Syk also
plays a central role in Fc receptor-mediated
phagocytosis in the adaptive immune system. Shark is
exclusively expressed in ectodermally derived epithelia,
and is localized preferentially to the apical surface of
the epithelial cells, it may play a role in a signaling
pathway for epithelial cell polarity.
Length = 257
Score = 35.0 bits (81), Expect = 0.003
Identities = 12/41 (29%), Positives = 22/41 (53%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
K + + + +Q+ G+ Y+ S + +HRDL N+LL
Sbjct: 88 KRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL 128
>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 2.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR2 (or Flk1) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of VEGFRs to their ligands, the VEGFs, leads to
receptor dimerization, activation, and intracellular
signaling. The carboxyl terminus of VEGFR2 plays an
important role in its autophosphorylation and
activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD
and VEGFE. VEGFR2 signaling is implicated in all aspects
of normal and pathological vascular endothelial cell
biology. It induces a variety of cellular effects
including migration, survival, and proliferation. It is
critical in regulating embryonic vascular development
and angiogenesis. VEGFR2 is the major signal transducer
in pathological angiogenesis including cancer and
diabetic retinopathy, and is a target for inhibition in
cancer therapy.
Length = 343
Score = 35.0 bits (80), Expect = 0.003
Identities = 15/67 (22%), Positives = 33/67 (49%), Gaps = 7/67 (10%)
Query: 15 STKESLVSFREYSDSHRTKYQR-------LSNDHICYFLYQILRGLKYIHSANVLHRDLK 67
S V + SD + ++ L+ + + + +Q+ +G++++ S +HRDL
Sbjct: 147 SASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLA 206
Query: 68 PSNLLLN 74
N+LL+
Sbjct: 207 ARNILLS 213
>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like
dual-specificity MAP kinase kinases. Protein kinases
(PKs), MAP kinase kinase (MAPKK) subfamily, fungal
Byr1-like proteins, catalytic (c) domain. PKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The MAPKK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases, protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
mitogen-activated protein (MAP) kinase signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising of the MAP kinase (MAPK),
which is phosphorylated and activated by a MAPK kinase
(MAPKK or MKK), which itself is phosphorylated and
activated by a MAPK kinase kinase (MAPKKK or MKKK).
Members of this group include the MAPKKs Byr1 from
Schizosaccharomyces pombe, FUZ7 from Ustilago maydis,
and related proteins. Byr1 phosphorylates its downstream
target, the MAPK Spk1, and is regulated by the MAPKKK
Byr2. The Spk1 cascade is pheromone-responsive and is
essential for sporulation and sexual differentiation in
fission yeast. FUZ7 phosphorylates and activates its
target, the MAPK Crk1, which is required in mating and
virulence in U. maydis.
Length = 284
Score = 35.2 bits (81), Expect = 0.003
Identities = 13/33 (39%), Positives = 26/33 (78%), Gaps = 1/33 (3%)
Query: 49 ILRGLKYIHSAN-VLHRDLKPSNLLLNTTCDLK 80
++ GL Y+++ + ++HRD+KPSN+L+N+ +K
Sbjct: 112 VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIK 144
>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to
tyrosine kinase). Protein Tyrosine Kinase (PTK) family;
Receptor related to tyrosine kinase (Ryk); pseudokinase
domain. The PTKc (catalytic domain) family to which this
subfamily belongs, is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ryk is a
receptor tyr kinase (RTK) containing an extracellular
region with two leucine-rich motifs, a transmembrane
segment, and an intracellular inactive pseudokinase
domain. The extracellular region of Ryk shows homology
to the N-terminal domain of Wnt inhibitory factor-1
(WIF) and serves as the ligand (Wnt) binding domain of
Ryk. Ryk is expressed in many different tissues both
during development and in adults, suggesting a
widespread function. It acts as a chemorepulsive axon
guidance receptor of Wnt glycoproteins and is
responsible for the establishment of axon tracts during
the development of the central nervous system. In
addition, studies in mice reveal that Ryk is essential
in skeletal, craniofacial, and cardiac development.
Thus, it appears Ryk is involved in signal transduction
despite its lack of kinase activity. Ryk may function as
an accessory protein that modulates the signals coming
from catalytically active partner RTKs such as the Eph
receptors.
Length = 280
Score = 35.1 bits (81), Expect = 0.003
Identities = 15/69 (21%), Positives = 30/69 (43%), Gaps = 1/69 (1%)
Query: 13 RHSTKESLVSF-REYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 71
+ +L F ++ Q LS + + QI G+ Y+H V+H+D+ N
Sbjct: 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNC 148
Query: 72 LLNTTCDLK 80
+++ +K
Sbjct: 149 VIDEELQVK 157
>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine
Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK)
family; Fyn and Yrk kinases; catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fyn and
Yrk are members of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Fyn, together with Lck, plays a
critical role in T-cell signal transduction by
phosphorylating ITAM (immunoreceptor tyr activation
motif) sequences on T-cell receptors, ultimately leading
to the proliferation and differentiation of T-cells. In
addition, Fyn is involved in the myelination of neurons,
and is implicated in Alzheimer's and Parkinson's
diseases. Yrk has been detected only in chickens. It is
primarily found in neuronal and epithelial cells and in
macrophages. It may play a role in inflammation and in
response to injury.
Length = 260
Score = 34.6 bits (79), Expect = 0.003
Identities = 21/80 (26%), Positives = 37/80 (46%), Gaps = 7/80 (8%)
Query: 5 QDQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHR 64
++ I I + +K SL+ F + + K L + Q+ G+ YI N +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVD-----MAAQVAAGMAYIERMNYIHR 126
Query: 65 DLKPSNLLL--NTTCDLKFF 82
DL+ +N+L+ C + F
Sbjct: 127 DLRSANILVGDGLVCKIADF 146
>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7;
Provisional.
Length = 566
Score = 34.8 bits (80), Expect = 0.003
Identities = 12/25 (48%), Positives = 18/25 (72%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLL 72
QIL L +HS ++HRD+KP N++
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNII 287
>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine
Kinase, Zeta-chain-associated protein of 70kDa. Protein
Tyrosine Kinase (PTK) family; Zeta-chain-associated
protein of 70kDa (Zap-70); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Zap-70 is
a member of the Syk subfamily of kinases, which are
cytoplasmic (or nonreceptor) tyr kinases containing two
Src homology 2 (SH2) domains N-terminal to the catalytic
tyr kinase domain. Zap-70 is primarily expressed in
T-cells and NK cells, and is a crucial component in
T-cell receptor (TCR) signaling. Zap-70 binds the
phosphorylated ITAM (immunoreceptor tyr activation
motif) sequences of the activated TCR zeta-chain through
its SH2 domains, leading to its phosphorylation and
activation. It then phosphorylates target proteins,
which propagate the signals to downstream pathways.
Zap-70 is hardly detected in normal peripheral B-cells,
but is present in some B-cell malignancies. It is used
as a diagnostic marker for chronic lymphocytic leukemia
(CLL) as it is associated with the more aggressive
subtype of the disease.
Length = 257
Score = 34.5 bits (79), Expect = 0.003
Identities = 13/41 (31%), Positives = 24/41 (58%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
K ++ ++ ++Q+ G+KY+ N +HRDL N+LL
Sbjct: 88 KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL 128
>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein
Serine/Threonine Kinase, Novel Protein Kinase C theta.
Serine/Threonine Kinases (STKs), Novel Protein Kinase C
(nPKC), theta isoform, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The nPKC subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PKCs are classified into three groups
(classical, atypical, and novel) depending on their mode
of activation and the structural characteristics of
their regulatory domain. nPKCs are calcium-independent,
but require DAG (1,2-diacylglycerol) and
phosphatidylserine (PS) for activity. There are four
nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta
is selectively expressed in T-cells and plays an
important and non-redundant role in several aspects of
T-cell biology. Although T-cells also express other PKC
isoforms, PKC-theta is unique in that upon antigen
stimulation, it is translocated to the plasma membrane
at the immunological synapse, where it mediates signals
essential for T-cell activation. It is essential for
TCR-induced proliferation, cytokine production, T-cell
survival, and the differentiation and effector function
of T-helper (Th) cells, particularly Th2 and Th17.
PKC-theta is being developed as a therapeutic target for
Th2-mediated allergic inflammation and Th17-mediated
autoimmune diseases.
Length = 316
Score = 34.9 bits (80), Expect = 0.003
Identities = 21/70 (30%), Positives = 37/70 (52%), Gaps = 5/70 (7%)
Query: 16 TKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
TKE+L EY + H + ++ +I+ GL+++HS +++RDLK N
Sbjct: 67 TKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDN 126
Query: 71 LLLNTTCDLK 80
+LL+T +K
Sbjct: 127 ILLDTDGHIK 136
>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear
Dbf2-Related kinase-like Protein Serine/Threonine
Kinases. Serine/Threonine Kinases (STKs), NDR kinase
subfamily, fungal NDR-like proteins, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The NDR subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This group is
composed of fungal NDR-like proteins including
Saccharomyces cerevisiae CBK1 (or CBK1p),
Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago
maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like
NDR kinase, group members contain an N-terminal
regulatory (NTR) domain and an insert within the
catalytic domain that contains an auto-inhibitory
sequence. CBK1 is an essential component in the RAM
(regulation of Ace2p activity and cellular
morphogenesis) network. CBK1 and Orb6 play similar roles
in coordinating cell morphology with cell cycle
progression. Ukc1 is involved in morphogenesis,
pathogenicity, and pigment formation. Cot1 plays a role
in polar tip extension.
Length = 377
Score = 34.8 bits (80), Expect = 0.003
Identities = 19/65 (29%), Positives = 33/65 (50%), Gaps = 2/65 (3%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFYFFFSFFFH 92
KY S D +++ + + ++ +H +HRD+KP N+L++ +K F S FH
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIK-LSDFGLSTGFH 152
Query: 93 FTVHD 97
HD
Sbjct: 153 KQ-HD 156
>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine
Kinase, Epidermal Growth Factor Receptor. Protein
Tyrosine Kinase (PTK) family; Epidermal Growth Factor
Receptor (EGFR); catalytic (c) domain. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EGFR
(HER1, ErbB1) is a member of the EGFR (HER, ErbB)
subfamily of proteins, which are receptor tyr kinases
(RTKs) containing an extracellular EGF-related
ligand-binding region, a transmembrane helix, and a
cytoplasmic region with a tyr kinase domain and a
regulatory C-terminal tail. Unlike other tyr kinases,
phosphorylation of the activation loop of EGFR proteins
is not critical to their activation. Instead, they are
activated by ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Ligands for EGFR include EGF, heparin binding
EGF-like growth factor (HBEGF), epiregulin,
amphiregulin, TGFalpha, and betacellulin. Upon ligand
binding, EGFR can form homo- or heterodimers with other
EGFR subfamily members. The EGFR signaling pathway is
one of the most important pathways regulating cell
proliferation, differentiation, survival, and growth.
Overexpression and mutation in the kinase domain of EGFR
have been implicated in the development and progression
of a variety of cancers. A number of monoclonal
antibodies and small molecule inhibitors have been
developed that target EGFR, including the antibodies
Cetuximab and Panitumumab, which are used in combination
with other therapies for the treatment of colorectal
cancer and non-small cell lung carcinoma (NSCLC). The
small molecule inhibitors Gefitinib (Iressa) and
Erlotinib (Tarceva), already used for NSCLC, are
undergoing clinical trials for other types of cancer
including gastrointestinal, breast, head and neck, and
bladder.
Length = 316
Score = 34.6 bits (79), Expect = 0.003
Identities = 13/48 (27%), Positives = 25/48 (52%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
D R + + ++ + QI +G+ Y+ ++HRDL N+L+ T
Sbjct: 97 DYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT 144
>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related
kinase-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related
(NDR) kinase subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The NDR subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. NDR kinase contains an N-terminal regulatory
(NTR) domain and an insert within the catalytic domain
that contains an auto-inhibitory sequence. Like many
other AGC kinases, NDR kinase requires phosphorylation
at two sites, the activation loop (A-loop) and the
hydrophobic motif (HM), for activity. NDR kinases
regulate mitosis, cell growth, embryonic development,
and neurological processes. They are also required for
proper centrosome duplication. Higher eukaryotes contain
two NDR isoforms, NDR1 and NDR2. This subfamily also
contains fungal NDR-like kinases.
Length = 364
Score = 34.6 bits (80), Expect = 0.003
Identities = 13/48 (27%), Positives = 25/48 (52%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
K + + +++ + + + IH +HRD+KP NLLL+ +K
Sbjct: 94 KKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIK 141
>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional.
Length = 467
Score = 34.9 bits (80), Expect = 0.003
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTT 76
K+ S+ H+ ++Q L Y H+ +++H DLKP N+L+ T+
Sbjct: 224 KHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETS 268
>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 1. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 1 (FGFR1); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR1 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Alternative splicing of
FGFR1 transcripts produces a variety of isoforms, which
are differentially expressed in cells. FGFR1 binds the
ligands, FGF1 and FGF2, with high affinity and has also
been reported to bind FGF4, FGF6, and FGF9. FGFR1
signaling is critical in the control of cell migration
during embryo development. It promotes cell
proliferation in fibroblasts. Nuclear FGFR1 plays a role
in the regulation of transcription. Mutations,
insertions or deletions of FGFR1 have been identified in
patients with Kallman's syndrome (KS), an inherited
disorder characterized by hypogonadotropic hypogonadism
and loss of olfaction. Aberrant FGFR1 expression has
been found in some human cancers including 8P11
myeloproliferative syndrome (EMS), breast cancer, and
pancreatic adenocarcinoma.
Length = 307
Score = 34.6 bits (79), Expect = 0.004
Identities = 14/39 (35%), Positives = 24/39 (61%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
++LS + YQ+ RG++Y+ S +HRDL N+L+
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein
Serine/Threonine Kinase, Rho-associated coiled-coil
containing protein kinase 2. Serine/Threonine Kinases
(STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ROCK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. ROCK contains an
N-terminal extension, a catalytic kinase domain, and a
C-terminal extension, which contains a coiled-coil
region encompassing a Rho-binding domain (RBD) and a
pleckstrin homology (PH) domain. ROCK is auto-inhibited
by the RBD and PH domain interacting with the catalytic
domain, and is activated via interaction with Rho
GTPases. ROCK2 was the first identified target of
activated RhoA, and was found to play a role in stress
fiber and focal adhesion formation. It is prominently
expressed in the brain, heart, and skeletal muscles. It
is implicated in vascular and neurological disorders,
such as hypertension and vasospasm of the coronary and
cerebral arteries. ROCK2 is also activated by caspase-2
cleavage, resulting in thrombin-induced microparticle
generation in response to cell activation. Mice
deficient in ROCK2 show intrauterine growth retardation
and embryonic lethality because of placental
dysfunction.
Length = 370
Score = 34.6 bits (79), Expect = 0.004
Identities = 14/38 (36%), Positives = 24/38 (63%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
++ +++ L IHS ++HRD+KP N+LL+ LK
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKL 183
>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 3.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 3, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK3 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK3 is
highly expressed in the brain. It is implicated in
neuronal plasticity, synapse formation, dendritic spine
morphogenesis, cell cycle progression, neuronal
migration, and apoptosis. Inactivating mutations in the
PAK3 gene cause X-linked non-syndromic mental
retardation, the severity of which depends on the site
of the mutation.
Length = 297
Score = 34.7 bits (79), Expect = 0.004
Identities = 14/39 (35%), Positives = 23/39 (58%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFYFF 86
+ L+ L ++HS V+HRD+K N+LL +K + F
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 161
>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase,
Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK)
family; Spleen tyrosine kinase (Syk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk,
together with Zap-70, form the Syk subfamily of kinases
which are cytoplasmic (or nonreceptor) tyr kinases
containing two Src homology 2 (SH2) domains N-terminal
to the catalytic tyr kinase domain. Syk was first cloned
from the spleen, and its function in hematopoietic cells
is well-established. Syk is involved in the signaling
downstream of activated receptors (including B-cell and
Fc receptors) that contain ITAMs (immunoreceptor tyr
activation motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. More recently, Syk
expression has been detected in other cell types
(including epithelial cells, vascular endothelial cells,
neurons, hepatocytes, and melanocytes), suggesting a
variety of biological functions in non-immune cells. Syk
plays a critical role in maintaining vascular integrity
and in wound healing during embryogenesis. It also
regulates Vav3, which is important in osteoclast
function including bone development. In breast
epithelial cells, where Syk acts as a negative regulator
for epidermal growth factor receptor (EGFR) signaling,
loss of Syk expression is associated with abnormal
proliferation during cancer development suggesting a
potential role as a tumor suppressor. In mice, Syk has
been shown to inhibit malignant transformation of
mammary epithelial cells induced with murine mammary
tumor virus (MMTV).
Length = 257
Score = 34.6 bits (79), Expect = 0.004
Identities = 15/43 (34%), Positives = 26/43 (60%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
K + ++ +I ++Q+ G+KY+ N +HRDL N+LL T
Sbjct: 88 KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT 130
>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein
Serine/Threonine Kinase, Atypical Protein Kinase C.
Serine/Threonine Kinases (STKs), Atypical Protein Kinase
C (aPKC) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
aPKC subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PKCs are classified into three groups
(classical, atypical, and novel) depending on their mode
of activation and the structural characteristics of
their regulatory domain. aPKCs only require
phosphatidylserine (PS) for activation. They contain a
C2-like region, instead of a calcium-binding (C2) region
found in classical PKCs, in their regulatory domain.
There are two aPKC isoforms, zeta and iota. aPKCs are
involved in many cellular functions including
proliferation, migration, apoptosis, polarity
maintenance and cytoskeletal regulation. They also play
a critical role in the regulation of glucose metabolism
and in the pathogenesis of type 2 diabetes.
Length = 329
Score = 34.4 bits (79), Expect = 0.004
Identities = 15/55 (27%), Positives = 30/55 (54%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFY 84
H + ++L +H ++ +I L ++H +++RDLK N+LL+ +K Y
Sbjct: 86 HMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDY 140
>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase
adapter protein. Protein Kinase family, STE20-related
kinase adapter protein (STRAD) subfamily, pseudokinase
domain. The STRAD subfamily is part of a larger
superfamily that includes the catalytic domains of
serine/threonine kinases (STKs), protein tyrosine
kinases, RIO kinases, aminoglycoside phosphotransferase,
choline kinase, and phosphoinositide 3-kinase. The
pseudokinase domain shows similarity to protein kinases
but lacks crucial residues for catalytic activity. STRAD
forms a complex with the scaffolding protein MO25, and
the STK, LKB1, resulting in the activation of the
kinase. In the complex, LKB1 phosphorylates and
activates adenosine monophosphate-activated protein
kinases (AMPKs), which regulate cell energy metabolism
and cell polarity. LKB1 is a tumor suppressor linked to
the rare inherited disease, Peutz-Jeghers syndrome,
which is characterized by a predisposition to benign
polyps and hyperpigmentation of the buccal mucosa. There
are two forms of STRAD, alpha and beta, that complex
with LKB1 and MO25. The structure of STRAD-alpha is
available and shows that this protein binds ATP, has an
ordered activation loop, and adopts a closed
conformation typical of fully active protein kinases. It
does not possess activity due to nonconservative
substitutions of essential catalytic residues. ATP
binding enhances the affinity of STRAD for MO25. The
conformation of STRAD-alpha stabilized through ATP and
MO25 may be needed to activate LKB1.
Length = 314
Score = 34.6 bits (80), Expect = 0.004
Identities = 14/32 (43%), Positives = 20/32 (62%)
Query: 42 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
I + L +L L YIHS +HR +K S++LL
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILL 134
>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional.
Length = 501
Score = 34.7 bits (79), Expect = 0.004
Identities = 14/31 (45%), Positives = 21/31 (67%), Gaps = 2/31 (6%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCD 78
Q+L ++YIH ++HRD+K N+ LN CD
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLN--CD 303
>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine
Kinase, Platelet Derived Growth Factor Receptor beta.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) beta; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. PDGFR
beta is a receptor tyr kinase (RTK) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding to
its ligands, the PDGFs, leads to receptor dimerization,
trans phosphorylation and activation, and intracellular
signaling. PDGFR beta forms homodimers or heterodimers
with PDGFR alpha, depending on the nature of the PDGF
ligand. PDGF-BB and PDGF-DD induce PDGFR beta
homodimerization. PDGFR signaling plays many roles in
normal embryonic development and adult physiology. PDGFR
beta signaling leads to a variety of cellular effects
including the stimulation of cell growth and chemotaxis,
as well as the inhibition of apoptosis and GAP
junctional communication. It is critical in normal
angiogenesis as it is involved in the recruitment of
pericytes and smooth muscle cells essential for vessel
stability. Aberrant PDGFR beta expression is associated
with some human cancers. The continuously-active fusion
proteins of PDGFR beta with COL1A1 and TEL are
associated with dermatofibrosarcoma protuberans (DFSP)
and a subset of chronic myelomonocytic leukemia (CMML),
respectively.
Length = 401
Score = 34.6 bits (79), Expect = 0.004
Identities = 14/37 (37%), Positives = 23/37 (62%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
LS + F YQ+ G++++ S N +HRDL N+L+
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272
>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein
Serine/Threonine Kinase, Microtubule-associated
serine/threonine-like kinase. Serine/Threonine Kinases
(STKs), Microtubule-associated serine/threonine (MAST)
kinase subfamily, MAST-like (MASTL) kinases, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAST kinase
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAST kinases contain an N-terminal domain of
unknown function, a central catalytic domain, and a
C-terminal PDZ domain that mediates protein-protein
interactions. The MASTL kinases in this group carry only
a catalytic domain, which contains a long insertion
relative to MAST kinases. The human MASTL gene has also
been labelled FLJ14813. A missense mutation in FLJ14813
is associated with autosomal dominant thrombocytopenia.
To date, the function of MASTL is unknown.
Length = 669
Score = 34.5 bits (79), Expect = 0.004
Identities = 12/28 (42%), Positives = 19/28 (67%)
Query: 53 LKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L Y+H ++HRDLKP N+L++ +K
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIK 144
>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 6. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek6 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek6 is required
for the transition from metaphase to anaphase. It also
plays important roles in mitotic spindle formation and
cytokinesis. Activated by Nek9 during mitosis, Nek6
phosphorylates Eg5, a kinesin that is important for
spindle bipolarity. Nek6 localizes to spindle
microtubules during metaphase and anaphase, and to the
midbody during cytokinesis.
Length = 267
Score = 34.2 bits (78), Expect = 0.005
Identities = 15/53 (28%), Positives = 31/53 (58%), Gaps = 1/53 (1%)
Query: 30 HRTKYQRLSNDHICY-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+ K +RL + + + Q+ ++++HS V+HRD+KP+N+ + T +K
Sbjct: 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKL 147
>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 3. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 3 (FGFR3); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR3 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Many FGFR3 splice
variants have been reported with the IIIb and IIIc
isoforms being the predominant forms. FGFR3 IIIc is the
isoform expressed in chondrocytes, the cells affected in
dwarfism, while IIIb is expressed in epithelial cells.
FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and
FGF23. It is a negative regulator of long bone growth.
In the cochlear duct and in the lens, FGFR3 is involved
in differentiation while it appears to have a role in
cell proliferation in epithelial cells. Germline
mutations in FGFR3 are associated with skeletal
disorders including several forms of dwarfism. Some
missense mutations are associated with multiple myeloma
and carcinomas of the bladder and cervix. Overexpression
of FGFR3 is found in thyroid carcinoma.
Length = 334
Score = 34.2 bits (78), Expect = 0.005
Identities = 16/50 (32%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 25 EYS-DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+YS D+ + ++L+ + YQ+ RG++Y+ S +HRDL N+L+
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine
Kinases, Vascular Endothelial Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor (VEGFR) subfamily;
catalytic (c) domain. The VEGFR subfamily consists of
VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. There are five
VEGF ligands in mammals, which bind, in an overlapping
pattern to the three VEGFRs, which can form homo or
heterodimers. VEGFRs regulate the cardiovascular system.
They are critical for vascular development during
embryogenesis and blood vessel formation in adults. They
induce cellular functions common to other growth factor
receptors such as cell migration, survival, and
proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta
growth factor (PLGF). It regulates monocyte and
macrophage migration, vascular permeability,
haematopoiesis, and the recruitment of haematopietic
progenitor cells from the bone marrow.
Length = 337
Score = 34.4 bits (79), Expect = 0.005
Identities = 15/47 (31%), Positives = 24/47 (51%), Gaps = 1/47 (2%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
K D I Y +Q+ RG++++ S +HRDL N+LL+
Sbjct: 162 GDELYKEPLTLEDLISYS-FQVARGMEFLASRKCIHRDLAARNILLS 207
>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein
Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP
kinase kinase 4 (MKK4) subfamily, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The MKK4 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising of the MAP
kinase (MAPK), which is phosphorylated and activated by
a MAPK kinase (MAPKK or MKK), which itself is
phosphorylated and activated by a MAPK kinase kinase
(MAPKKK or MKKK). MKK4 is a dual-specificity PK that
phosphorylates and activates the downstream targets,
c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific
threonine and tyrosine residues. JNK and p38 are
collectively known as stress-activated MAPKs, as they
are activated in response to a variety of environmental
stresses and pro-inflammatory cytokines. Their
activation is associated with the induction of cell
death. Mice deficient in MKK4 die during embryogenesis
and display anemia, severe liver hemorrhage, and
abnormal hepatogenesis. MKK4 may also play roles in the
immune system and in cardiac hypertrophy. It plays a
major role in cancer as a tumor and metastasis
suppressor. Under certain conditions, MKK4 is
pro-oncogenic.
Length = 288
Score = 34.3 bits (79), Expect = 0.005
Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 26 YSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLK 80
Y + + + + ++ L Y+ ++HRD+KPSN+LL+ ++K
Sbjct: 93 YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIK 148
>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Tyrosine kinase expressed in hepatocellular carcinoma
(Tec) subfamily; catalytic (c) domain. The Tec subfamily
is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk
(Txk), and similar proteins. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tec kinases are
cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with
similarity to Src kinases in that they contain Src
homology protein interaction domains (SH3, SH2)
N-terminal to the catalytic tyr kinase domain. Unlike
Src kinases, most Tec subfamily members (except Rlk)
also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, some
members contain the Tec homology (TH) domain, which
contains proline-rich and zinc-binding regions. Tec
kinases form the second largest subfamily of nRTKs and
are expressed mainly by haematopoietic cells, although
Tec and Bmx are also found in endothelial cells. B-cells
express Btk and Tec, while T-cells express Itk, Txk, and
Tec. Collectively, Tec kinases are expressed in a
variety of myeloid cells such as mast cells, platelets,
macrophages, and dendritic cells. Each Tec kinase shows
a distinct cell-type pattern of expression. The function
of Tec kinases in lymphoid cells have been studied
extensively. They play important roles in the
development, differentiation, maturation, regulation,
survival, and function of B-cells and T-cells. Mutations
in Btk cause the severe B-cell immunodeficiency,
X-linked agammaglobulinaemia (XLA).
Length = 256
Score = 34.0 bits (78), Expect = 0.005
Identities = 9/33 (27%), Positives = 16/33 (48%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ ++Y+ S +HRDL N L+ +K
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVK 140
>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 4. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 4 (FGFR4); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR4 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Unlike other FGFRs,
there is only one splice form of FGFR4. It binds FGF1,
FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective
ligand for FGFR4. Although disruption of FGFR4 in mice
causes no obvious phenotype, in vivo inhibition of FGFR4
in cultured skeletal muscle cells resulted in an arrest
of muscle progenitor differentiation. FGF6 and FGFR4 are
uniquely expressed in myofibers and satellite cells.
FGF6/FGFR4 signaling appears to play a key role in the
regulation of muscle regeneration. A polymorphism in
FGFR4 is found in head and neck squamous cell carcinoma.
Length = 314
Score = 34.2 bits (78), Expect = 0.005
Identities = 12/27 (44%), Positives = 19/27 (70%)
Query: 47 YQILRGLKYIHSANVLHRDLKPSNLLL 73
YQ+ RG++Y+ S +HRDL N+L+
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLV 167
>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein
Serine/Threonine Kinases, RPK118 and similar proteins.
Serine/Threonine Kinases (STKs), RPK118-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The RPK118-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this subfamily show similarity to
human RPK118, which contains an N-terminal Phox homology
(PX) domain, a Microtubule Interacting and Trafficking
(MIT) domain, and a kinase domain containing a long
insert. Also included in the family is human RPK60 (or
ribosomal protein S6 kinase-like 1), which also contains
MIT and kinase domains but lacks a PX domain. RPK118
binds sphingosine kinase, a key enzyme in the synthesis
of sphingosine 1-phosphate (SPP), a lipid messenger
involved in many cellular events. RPK118 may be involved
in transmitting SPP-mediated signaling. RPK118 also
binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118
may be involved in the transport of PRDX3 from the
cytoplasm to its site of function in the mitochondria.
Length = 237
Score = 34.1 bits (78), Expect = 0.005
Identities = 12/46 (26%), Positives = 27/46 (58%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
SH +K+ + + + + +++ L +H ++ RDL P+N+LL+
Sbjct: 74 SHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119
>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional.
Length = 478
Score = 34.2 bits (78), Expect = 0.006
Identities = 15/37 (40%), Positives = 22/37 (59%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
YQI+ L +HS ++HRDLK +N+ L T +K
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase,
Axl. Protein Tyrosine Kinase (PTK) family; Axl;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl is a member of the
Axl subfamily, which is composed of receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with two immunoglobulin-like domains followed by two
fibronectin type III repeats, a transmembrane segment,
and an intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl is widely expressed in a
variety of organs and cells including epithelial,
mesenchymal, hematopoietic, as well as non-transformed
cells. Axl signaling is important in many cellular
functions such as survival, anti-apoptosis,
proliferation, migration, and adhesion. Axl was
originally isolated from patients with chronic
myelogenous leukemia and a chronic myeloproliferative
disorder. Axl is overexpressed in many human cancers
including colon, squamous cell, thyroid, breast, and
lung carcinomas.
Length = 272
Score = 33.9 bits (77), Expect = 0.006
Identities = 14/40 (35%), Positives = 22/40 (55%)
Query: 35 QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
Q L + F+ I G++Y+ S + +HRDL N +LN
Sbjct: 107 QYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN 146
>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src
kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; C-terminal Src kinase (Csk)
subfamily; catalytic (c) domain. The Csk subfamily is
composed of Csk, Chk, and similar proteins. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk and Chk are translocated to the membrane via binding
to specific transmembrane proteins, G-proteins, or
adaptor proteins near the membrane. Csk catalyzes the
tyr phosphorylation of the regulatory C-terminal tail of
Src kinases, resulting in their inactivation. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As negative regulators of Src
kinases, Csk and Chk play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression.
Length = 256
Score = 33.9 bits (78), Expect = 0.006
Identities = 19/72 (26%), Positives = 32/72 (44%), Gaps = 7/72 (9%)
Query: 3 FHQDQITIEIRHSTKESLVSF-REYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANV 61
+ + I + K SLV + R + T Q+L F + G++Y+ N
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG------FALDVCEGMEYLEEKNF 123
Query: 62 LHRDLKPSNLLL 73
+HRDL N+L+
Sbjct: 124 VHRDLAARNVLV 135
>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein
Serine/Threonine Kinase, Atypical Protein Kinase C zeta.
Serine/Threonine Kinases (STKs), Atypical Protein
Kinase C (aPKC) subfamily, zeta isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The aPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
aPKCs only require phosphatidylserine (PS) for
activation. There are two aPKC isoforms, zeta and iota.
PKC-zeta plays a critical role in activating the glucose
transport response. It is activated by glucose, insulin,
and exercise through diverse pathways. PKC-zeta also
plays a central role in maintaining cell polarity in
yeast and mammalian cells. In addition, it affects actin
remodeling in muscle cells.
Length = 327
Score = 33.9 bits (77), Expect = 0.006
Identities = 15/55 (27%), Positives = 30/55 (54%)
Query: 30 HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFY 84
H + ++L +H ++ +I L ++H +++RDLK N+LL+ +K Y
Sbjct: 86 HMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDY 140
>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 4.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 4, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK4 belongs to group II. Group II PAKs contain a PBD
(p21-binding domain) and a C-terminal catalytic domain,
but do not harbor an AID (autoinhibitory domain) or SH3
binding sites. PAK4 regulates cell morphology and
cytoskeletal organization. It is essential for embryonic
viability and proper neural development. Mice lacking
PAK4 die due to defects in the fetal heart. In addition,
their spinal cord motor neurons showed failure to
differentiate and migrate. PAK4 also plays a role in
cell survival and tumorigenesis. It is overexpressed in
many primary tumors including colon, esophageal, and
mammary tumors. PAK4 has also been implicated in viral
and bacterial infection pathways.
Length = 292
Score = 33.8 bits (77), Expect = 0.007
Identities = 12/40 (30%), Positives = 24/40 (60%)
Query: 34 YQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+ R++ + I +L+ L +H+ V+HRD+K ++LL
Sbjct: 110 HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL 149
>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR
kinase-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Rho-associated
coiled-coil containing protein kinase (ROCK) and Nuclear
Dbf2-Related (NDR)-like kinase subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ROCK- and NDR-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this subfamily include ROCK and
ROCK-like proteins such as DMPK, MRCK, and CRIK, as well
as NDR and NDR-like proteins such as LATS, CBK1 and
Sid2p. ROCK and CRIK are effectors of the small GTPase
Rho, while MRCK is an effector of the small GTPase
Cdc42. NDR and NDR-like kinases contain an N-terminal
regulatory (NTR) domain and an insert within the
catalytic domain that contains an auto-inhibitory
sequence. Proteins in this subfamily are involved in
regulating many cellular functions including
contraction, motility, division, proliferation,
apoptosis, morphogenesis, and cytokinesis.
Length = 350
Score = 33.8 bits (78), Expect = 0.007
Identities = 9/41 (21%), Positives = 22/41 (53%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+ + +++ +++ L +H +HRD+KP N+L+
Sbjct: 94 RKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134
>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain
Receptor-like Protein Tyrosine Kinases. Protein
Tyrosine Kinase (PTK) family; Discoidin Domain Receptor
(DDR)-like proteins; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR-like
proteins are members of the DDR subfamily, which are
receptor tyr kinases (RTKs) containing an extracellular
discoidin homology domain, a transmembrane segment, an
extended juxtamembrane region, and an intracellular
catalytic domain. The binding of the ligand, collagen,
to DDRs results in a slow but sustained receptor
activation. DDRs regulate cell adhesion, proliferation,
and extracellular matrix remodeling. They have been
linked to a variety of human cancers including breast,
colon, ovarian, brain, and lung. There is no evidence
showing that DDRs act as transforming oncogenes. They
are more likely to play a role in the regulation of
tumor growth and metastasis.
Length = 295
Score = 33.8 bits (77), Expect = 0.007
Identities = 16/44 (36%), Positives = 24/44 (54%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+S ++ Y QI G+KY+ S N +HRDL N L+ +K
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIK 169
>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein
Serine/Threonine Kinase, p21-activated kinase 2.
Serine/threonine kinases (STKs), p21-activated kinase
(PAK) 2, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PAKs are Rho family GTPase-regulated kinases
that serve as important mediators in the function of
Cdc42 (cell division cycle 42) and Rac. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
PAK2 belongs to group I. Group I PAKs contain a PBD
(p21-binding domain) overlapping with an AID
(autoinhibitory domain), a C-terminal catalytic domain,
SH3 binding sites and a non-classical SH3 binding site
for PIX (PAK-interacting exchange factor). PAK2 plays a
role in pro-apoptotic signaling. It is cleaved and
activated by caspases leading to morphological changes
during apoptosis. PAK2 is also activated in response to
a variety of stresses including DNA damage,
hyperosmolarity, serum starvation, and contact
inhibition, and may play a role in coordinating the
stress response. PAK2 also contributes to cancer cell
invasion through a mechanism distinct from that of PAK1.
Length = 296
Score = 33.5 bits (76), Expect = 0.008
Identities = 13/39 (33%), Positives = 24/39 (61%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKFFFYFF 86
+ L+ L+++H+ V+HRD+K N+LL +K + F
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGF 161
>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the
Protein Tyrosine Kinases, Janus kinases 2 and 3.
Protein Tyrosine Kinase (PTK) family; Janus kinase 2
(Jak2) and Jak3; catalytic (c) domain (repeat 2). The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Jak2 and
Jak3 are members of the Janus kinase (Jak) subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal FERM domain, followed
by a Src homology 2 (SH2) domain, a pseudokinase domain,
and a C-terminal catalytic tyr kinase domain. Jaks are
crucial for cytokine receptor signaling. They are
activated by autophosphorylation upon cytokine-induced
receptor aggregation, and subsequently trigger
downstream signaling events such as the phosphorylation
of signal transducers and activators of transcription
(STATs). Jak2 is widely expressed in many tissues while
Jak3 is expressed only in hematopoietic cells. Jak2 is
essential for the signaling of hormone-like cytokines
such as growth hormone, erythropoietin, thrombopoietin,
and prolactin, as well as some IFNs and cytokines that
signal through the IL-3 and gp130 receptors. Jak3 binds
the shared receptor subunit common gamma chain and thus,
is essential in the signaling of cytokines that use it
such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
Disruption of Jak2 in mice results in an embryonic
lethal phenotype with multiple defects including
erythropoietic and cardiac abnormalities. It is the only
Jak gene that results in a lethal phenotype when
disrupted in mice. A mutation in the pseudokinase domain
of Jak2, V617F, is present in many myeloproliferative
diseases, including almost all patients with
polycythemia vera, and 50% of patients with essential
thrombocytosis and myelofibrosis. Jak3 is important in
lymphoid development and myeloid cell differentiation.
Inactivating mutations in Jak3 have been reported in
humans with severe combined immunodeficiency (SCID).
Length = 284
Score = 33.6 bits (77), Expect = 0.009
Identities = 20/54 (37%), Positives = 29/54 (53%), Gaps = 7/54 (12%)
Query: 22 SFREYSDSHRTKYQRLSNDHICYFLY--QILRGLKYIHSANVLHRDLKPSNLLL 73
S R+Y HR + DH LY QI +G++Y+ S +HRDL N+L+
Sbjct: 93 SLRDYLQKHRERL-----DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141
>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine
Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase
(PTK) family; Ephrin Receptor (EphR) subfamily; EphA2
receptor; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). In general, class EphA receptors bind
GPI-anchored ephrin-A ligands. There are ten vertebrate
EphA receptors (EphA1-10), which display promiscuous
interactions with six ephrin-A ligands. EphRs contain an
ephrin binding domain and two fibronectin repeats
extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion, making it important in neural development and
plasticity, cell morphogenesis, cell-fate determination,
embryonic development, tissue patterning, and
angiogenesis. The EphA2 receptor is overexpressed in
tumor cells and tumor blood vessels in a variety of
cancers including breast, prostate, lung, and colon. As
a result, it is an attractive target for drug design
since its inhibition could affect several aspects of
tumor progression.
Length = 268
Score = 33.4 bits (76), Expect = 0.009
Identities = 14/35 (40%), Positives = 21/35 (60%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
L I G+KY+ N +HRDL N+L+N+ + K
Sbjct: 113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECK 147
>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein
Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP
kinase kinase 7 (MKK7) subfamily, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The MKK7 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein serine/threonine kinases, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The mitogen-activated protein (MAP) kinase
signaling pathways are important mediators of cellular
responses to extracellular signals. The pathways involve
a triple kinase core cascade comprising the MAP kinase
(MAPK), which is phosphorylated and activated by a MAPK
kinase (MAPKK or MKK), which itself is phosphorylated
and activated by a MAPK kinase kinase (MAPKKK or MKKK).
MKK7 is a dual-specificity PK that phosphorylates and
activates its downstream target, c-Jun N-terminal kinase
(JNK), on specific threonine and tyrosine residues.
Although MKK7 is capable of dual phosphorylation, it
prefers to phosphorylate the threonine residue of JNK.
Thus, optimal activation of JNK requires both MKK4 (not
included in this subfamily) and MKK7. MKK7 is primarily
activated by cytokines. MKK7 is essential for liver
formation during embryogenesis. It plays roles in G2/M
cell cycle arrest and cell growth. In addition, it is
involved in the control of programmed cell death, which
is crucial in oncogenesis, cancer chemoresistance, and
antagonism to TNFalpha-induced killing, through its
inhibition by Gadd45beta and the subsequent suppression
of the JNK cascade.
Length = 296
Score = 33.5 bits (77), Expect = 0.010
Identities = 14/35 (40%), Positives = 24/35 (68%), Gaps = 1/35 (2%)
Query: 47 YQILRGLKYIHSA-NVLHRDLKPSNLLLNTTCDLK 80
I++ L Y+ V+HRD+KPSN+LL+ + ++K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVK 155
>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase,
Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK)
family; Focal Adhesion Kinase (FAK); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FAK is a
cytoplasmic (or nonreceptor) tyr kinase that contains an
autophosphorylation site and a FERM domain at the
N-terminus, a central tyr kinase domain, proline-rich
regions, and a C-terminal FAT (focal adhesion targeting)
domain. FAK activity is dependent on integrin-mediated
cell adhesion, which facilitates N-terminal
autophosphorylation. Full activation is achieved by the
phosphorylation of its two adjacent A-loop tyrosines.
FAK is important in mediating signaling initiated at
sites of cell adhesions and at growth factor receptors.
Through diverse molecular interactions, FAK functions as
a biosensor or integrator to control cell motility. It
is a key regulator of cell survival, proliferation,
migration and invasion, and thus plays an important role
in the development and progression of cancer. Src binds
to autophosphorylated FAK forming the FAK-Src dual
kinase complex, which is activated in a wide variety of
tumor cells and generates signals promoting growth and
metastasis. FAK is being developed as a target for
cancer therapy.
Length = 270
Score = 33.2 bits (76), Expect = 0.010
Identities = 13/49 (26%), Positives = 22/49 (44%), Gaps = 3/49 (6%)
Query: 24 REYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 72
R Y ++ L + + YQ+ L Y+ S +HRD+ N+L
Sbjct: 94 RSYLQVNK---YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139
>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase,
REarranged during Transfection protein. Protein
Tyrosine Kinase (PTK) family; RET (REarranged during
Transfection) protein; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. RET is a
receptor tyr kinase (RTK) containing an extracellular
region with four cadherin-like repeats, a
calcium-binding site, and a cysteine-rich domain, a
transmembrane segment, and an intracellular catalytic
domain. It is part of a multisubunit complex that binds
glial-derived neurotropic factor (GDNF) family ligands
(GFLs) including GDNF, neurturin, artemin, and
persephin. GFLs bind RET along with four GPI-anchored
coreceptors, bringing two RET molecules together,
leading to autophosphorylation, activation, and
intracellular signaling. RET is essential for the
development of the sympathetic, parasympathetic and
enteric nervous systems, and the kidney. RET disruption
by germline mutations causes diseases in humans
including congenital aganglionosis of the
gastrointestinal tract (Hirschsprung's disease) and
three related inherited cancers: multiple endocrine
neoplasia type 2A (MEN2A), MEN2B, and familial medullary
thyroid carcinoma (FMTC).
Length = 290
Score = 33.4 bits (76), Expect = 0.011
Identities = 12/29 (41%), Positives = 20/29 (68%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLL 73
F +QI RG++Y+ ++HRDL N+L+
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLV 160
>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 6. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK6
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK6 is widely expressed in many tissues.
t is expressed as multiple splice variants with
different domain architectures. It is
post-translationally palmitoylated and localized in the
membrane. GRK6 plays important roles in the regulation
of dopamine, M3 muscarinic, opioid, and chemokine
receptor signaling. It also plays maladaptive roles in
addiction and Parkinson's disease. GRK6-deficient mice
exhibit altered dopamine receptor regulation, decreased
lymphocyte chemotaxis, and increased acute inflammation
and neutrophil chemotaxis.
Length = 285
Score = 33.5 bits (76), Expect = 0.011
Identities = 12/31 (38%), Positives = 22/31 (70%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ +I GL+ +H +++RDLKP N+LL+
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD 136
>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional.
Length = 1021
Score = 33.6 bits (76), Expect = 0.011
Identities = 16/35 (45%), Positives = 20/35 (57%), Gaps = 7/35 (20%)
Query: 48 QILRGLKYIHS-------ANVLHRDLKPSNLLLNT 75
Q+L L Y H+ VLHRDLKP N+ L+T
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160
>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein
Serine/Threonine Kinase, 90 kDa ribosomal protein S6
kinase. Serine/Threonine Kinases (STKs), 90 kDa
ribosomal protein S6 kinase (RSK) subfamily, N-terminal
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The RSK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. RSKs contain an
N-terminal kinase domain (NTD) from the AGC family and a
C-terminal kinase domain (CTD) from the CAMK family.
They are activated by signaling inputs from
extracellular regulated kinase (ERK) and
phosphoinositide dependent kinase 1 (PDK1). ERK
phosphorylates and activates the CTD of RSK, serving as
a docking site for PDK1, which phosphorylates and
activates the NTD, which in turn phosphorylates all
known RSK substrates. RSKs act as downstream effectors
of mitogen-activated protein kinase (MAPK) and play key
roles in mitogen-activated cell growth, differentiation,
and survival. Mammals possess four RSK isoforms (RSK1-4)
from distinct genes. RSK proteins are also referred to
as MAP kinase-activated protein kinases (MAPKAPKs),
p90-RSKs, or p90S6Ks.
Length = 318
Score = 33.2 bits (76), Expect = 0.011
Identities = 12/31 (38%), Positives = 23/31 (74%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++L ++ L ++HS +++RDLKP N+LL+
Sbjct: 102 FYLAELALALDHLHSLGIIYRDLKPENILLD 132
>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein
Serine/Threonine Kinase, Rho-associated coiled-coil
containing protein kinase. Serine/Threonine Kinases
(STKs), Rho-associated coiled-coil containing protein
kinase (ROCK) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The ROCK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. ROCK is also referred to as Rho-associated
kinase or simply as Rho kinase. It contains an
N-terminal extension, a catalytic kinase domain, and a
long C-terminal extension, which contains a coiled-coil
region encompassing a Rho-binding domain (RBD) and a
pleckstrin homology (PH) domain. ROCK is auto-inhibited
by the RBD and PH domain interacting with the catalytic
domain. It is activated via interaction with Rho GTPases
and is involved in many cellular functions including
contraction, adhesion, migration, motility,
proliferation, and apoptosis. The ROCK subfamily
consists of two isoforms, ROCK1 and ROCK2, which may be
functionally redundant in some systems, but exhibit
different tissue distributions. Both isoforms are
ubiquitously expressed in most tissues, but ROCK2 is
more prominent in brain and skeletal muscle while ROCK1
is more pronounced in the liver, testes, and kidney.
Studies in knockout mice result in different phenotypes,
suggesting that the two isoforms do not compensate for
each other during embryonic development.
Length = 370
Score = 33.2 bits (76), Expect = 0.012
Identities = 14/37 (37%), Positives = 24/37 (64%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
++ +++ L IHS +HRD+KP N+LL+ + LK
Sbjct: 146 FYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 182
>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein
Serine/Threonine Kinase, Classical Protein Kinase C
beta. Serine/Threonine Kinases (STKs), Classical
Protein Kinase C (cPKC) subfamily, beta isoforms,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The cPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
PKCs undergo three phosphorylations in order to take
mature forms. In addition, cPKCs depend on calcium, DAG
(1,2-diacylglycerol), and in most cases,
phosphatidylserine (PS) for activation. There are four
cPKC isoforms, named alpha, betaI, betaII, and gamma.
The PKC beta isoforms (I and II), generated by
alternative splicing of a single gene, are
preferentially activated by hyperglycemia-induced DAG in
retinal tissues. This is implicated in diabetic
microangiopathy such as ischemia, neovascularization,
and abnormal vasodilator function. PKC-beta also plays
an important role in VEGF signaling. In addition,
glucose regulates proliferation in retinal endothelial
cells via PKC-betaI. PKC-beta is also being explored as
a therapeutic target in cancer. It contributes to tumor
formation and is involved in the tumor host mechanisms
of inflammation and angiogenesis.
Length = 323
Score = 33.1 bits (75), Expect = 0.012
Identities = 20/70 (28%), Positives = 35/70 (50%), Gaps = 5/70 (7%)
Query: 16 TKESLVSFREYSDSHRTKYQ-----RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
T + L EY + YQ R H ++ +I GL ++HS +++RDLK N
Sbjct: 72 TMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDN 131
Query: 71 LLLNTTCDLK 80
++L++ +K
Sbjct: 132 VMLDSEGHIK 141
>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein
Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2.
Serine/Threonine Kinases (STKs), NDR kinase subfamily,
NDR2 isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The NDR
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. NDR kinase contains an N-terminal regulatory
(NTR) domain and an insert within the catalytic domain
that contains an auto-inhibitory sequence. Like many
other AGC kinases, NDR kinase requires phosphorylation
at two sites, the activation loop (A-loop) and the
hydrophobic motif (HM), for activity. Higher eukaryotes
contain two NDR isoforms, NDR1 and NDR2. Both isoforms
play a role in proper centrosome duplication. In
addition, NDR2 plays a role in regulating neuronal
growth and differentiation, as well as in facilitating
neurite outgrowth. It is also implicated in fear
conditioning as it contributes to the coupling of
neuronal morphological changes with fear-memory
consolidation. NDR2 is also referred to as STK38-like.
Length = 360
Score = 33.1 bits (75), Expect = 0.012
Identities = 15/49 (30%), Positives = 26/49 (53%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
K LS + +++ + + + IH +HRD+KP NLLL+ +K
Sbjct: 94 KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKL 142
>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine
Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine
Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4);
pseudokinase domain. The PTKc (catalytic domain) family,
to which this subfamily belongs, includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CCK4,
also called protein tyrosine kinase 7 (PTK7), is an
orphan receptor tyr kinase (RTK) containing an
extracellular region with seven immunoglobulin domains,
a transmembrane segment, and an intracellular inactive
pseudokinase domain. Studies in mice reveal that CCK4 is
essential for neural development. Mouse embryos
containing a truncated CCK4 die perinatally and display
craniorachischisis, a severe form of neural tube defect.
The mechanism of action of the CCK4 pseudokinase is
still unknown. Other pseudokinases such as HER3 rely on
the activity of partner RTKs.
Length = 275
Score = 32.8 bits (75), Expect = 0.013
Identities = 15/54 (27%), Positives = 26/54 (48%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
S + K LS QI G+ ++ +A +HRDL N L+++ ++K
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157
>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein
Serine/Threonine Kinase, DMPK-related cell division
control protein 42 binding kinase beta.
Serine/Threonine Kinases (STKs), DMPK-like subfamily,
DMPK-related cell division control protein 42 (Cdc42)
binding kinase (MRCK) beta isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The DMPK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MRCK is activated via interaction with the
small GTPase Cdc42. MRCK/Cdc42 signaling mediates
myosin-dependent cell motility. MRCKbeta is expressed
ubiquitously in many tissues.
Length = 331
Score = 33.1 bits (75), Expect = 0.014
Identities = 13/39 (33%), Positives = 25/39 (64%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
RL D +++ +++ + IH + +HRD+KP N+LL+
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136
>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and
Dbf2p-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), ROCK- and NDR-like
subfamily, fungal Sid2p- and Dbf2p-like proteins,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Sid2p- and
Dbf2p-like group is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This group contains fungal kinases including
Schizosaccharomyces pombe Sid2p and Saccharomyces
cerevisiae Dbf2p. Group members show similarity to NDR
kinases in that they contain an N-terminal regulatory
(NTR) domain and an insert within the catalytic domain
that contains an auto-inhibitory sequence. Sid2p plays a
crucial role in the septum initiation network (SIN) and
in the initiation of cytokinesis. Dbf2p is important in
regulating the mitotic exit network (MEN) and in
cytokinesis.
Length = 333
Score = 32.8 bits (75), Expect = 0.015
Identities = 14/44 (31%), Positives = 26/44 (59%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
LS DH +++ ++ + +H +HRDLKP N L++ + +K
Sbjct: 98 LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIK 141
>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine
Kinase, HER2. Protein Tyrosine Kinase (PTK) family;
HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER2 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. HER2 does not bind to any known EGFR
subfamily ligands, but contributes to the kinase
activity of all possible heterodimers. It acts as the
preferred partner with other ligand-bound EGFR proteins
and functions as a signal amplifier, with the HER2-HER3
heterodimer being the most potent pair in mitogenic
signaling. HER2 plays an important role in cell
development, proliferation, survival and motility.
Overexpression of HER2 results in its activation and
downstream signaling, even in the absence of ligand.
HER2 overexpression, mainly due to gene amplification,
has been shown in a variety of human cancers. Its role
in breast cancer is especially well-documented. HER2 is
up-regulated in about 25% of breast tumors and is
associated with increases in tumor aggressiveness,
recurrence and mortality. HER2 is a target for
monoclonal antibodies and small molecule inhibitors,
which are being developed as treatments for cancer. The
first humanized antibody approved for clinical use is
Trastuzumab (Herceptin), which is being used in
combination with other therapies to improve the survival
rates of patients with HER2-overexpressing breast
cancer.
Length = 279
Score = 32.7 bits (74), Expect = 0.015
Identities = 14/53 (26%), Positives = 27/53 (50%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
D R R+ + + + QI +G+ Y+ ++HRDL N+L+ + +K
Sbjct: 97 DYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK 149
>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein
Serine/Threonine Kinase, DMPK-related cell division
control protein 42 binding kinase alpha.
Serine/Threonine Kinases (STKs), DMPK-like subfamily,
DMPK-related cell division control protein 42 (Cdc42)
binding kinase (MRCK) alpha isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The DMPK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MRCK is activated via interaction with the
small GTPase Cdc42. MRCK/Cdc42 signaling mediates
myosin-dependent cell motility. MRCKalpha is expressed
ubiquitously in many tissues. It plays a role in the
regulation of peripheral actin reorganization and
neurite outgrowth. It may also play a role in the
transferrin iron uptake pathway.
Length = 332
Score = 32.7 bits (74), Expect = 0.016
Identities = 12/39 (30%), Positives = 25/39 (64%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
RL D ++L +++ + +H + +HRD+KP N+L++
Sbjct: 98 RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136
>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein
Serine/Threonine Kinases, Novel Protein Kinase C theta
and delta. Serine/Threonine Kinases (STKs), Novel
Protein Kinase C (nPKC), theta and delta-like isoforms,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The nPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
nPKCs are calcium-independent, but require DAG
(1,2-diacylglycerol) and phosphatidylserine (PS) for
activity. There are four nPKC isoforms, delta, epsilon,
eta, and theta. PKC-theta is selectively expressed in
T-cells and plays an important and non-redundant role in
several aspects of T-cell biology. PKC-delta plays a
role in cell cycle regulation and programmed cell death
in many cell types.
Length = 316
Score = 32.8 bits (75), Expect = 0.017
Identities = 19/64 (29%), Positives = 32/64 (50%), Gaps = 5/64 (7%)
Query: 16 TKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 70
TKE L EY + H R ++ +I+ GL+++H +++RDLK N
Sbjct: 67 TKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDN 126
Query: 71 LLLN 74
+LL+
Sbjct: 127 VLLD 130
>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth
Factor Receptor-like Protein Tyrosine Kinases. Protein
Tyrosine Kinase (PTK) family; Epidermal Growth Factor
Receptor (EGFR) subfamily; catalytic (c) domain. EGFR
(HER, ErbB) subfamily members include EGFR (HER1,
ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
The EGFR proteins are receptor tyr kinases (RTKs)
containing an extracellular EGF-related ligand-binding
region, a transmembrane helix, and a cytoplasmic region
with a tyr kinase domain and a regulatory C-terminal
tail. Unlike other tyr kinases, phosphorylation of the
activation loop of EGFR proteins is not critical to
their activation. Instead, they are activated by
ligand-induced dimerization, resulting in the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Collectively, they can recognize a variety of
ligands including EGF, TGFalpha, and neuregulins, among
others. All four subfamily members can form homo- or
heterodimers. HER3 contains an impaired kinase domain
and depends on its heterodimerization partner for
activation. EGFR subfamily members are involved in
signaling pathways leading to a broad range of cellular
responses including cell proliferation, differentiation,
migration, growth inhibition, and apoptosis. Gain of
function alterations, through their overexpression,
deletions, or point mutations in their kinase domains,
have been implicated in various cancers. These receptors
are targets of many small molecule inhibitors and
monoclonal antibodies used in cancer therapy.
Length = 279
Score = 32.8 bits (75), Expect = 0.017
Identities = 13/51 (25%), Positives = 28/51 (54%), Gaps = 3/51 (5%)
Query: 25 EYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
+Y +H+ + + ++ + QI +G+ Y+ ++HRDL N+L+ T
Sbjct: 97 DYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT 144
>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen and stress-activated
kinase 1. Serine/Threonine Kinases (STKs), Mitogen and
stress-activated kinase (MSK) subfamily, MSK1,
N-terminal catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The MSK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MSKs contain an N-terminal kinase domain (NTD)
from the AGC family and a C-terminal kinase domain (CTD)
from the CAMK family, similar to 90 kDa ribosomal
protein S6 kinases (RSKs). MSKs are activated by two
major signaling cascades, the Ras-MAPK and p38 stress
kinase pathways, which trigger phosphorylation in the
activation loop (A-loop) of the CTD of MSK. The active
CTD phosphorylates the hydrophobic motif (HM) of NTD,
which facilitates the phosphorylation of the A-loop and
activates the NTD, which in turn phosphorylates
downstream targets. MSK1 plays a role in the regulation
of translational control and transcriptional activation.
It phosphorylates the transcription factors, CREB and
NFkappaB. It also phosphorylates the nucleosomal
proteins H3 and HMG-14. Increased phosphorylation of
MEK1 is associated with the development of cerebral
ischemic/hypoxic preconditioning.
Length = 290
Score = 32.7 bits (74), Expect = 0.019
Identities = 11/47 (23%), Positives = 29/47 (61%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
+H ++ +R + + +I+ L+++H +++RD+K N+LL++
Sbjct: 94 THLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS 140
>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein
Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1.
Serine/Threonine Kinases (STKs), NDR kinase subfamily,
NDR1 isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The NDR
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. NDR kinase contains an N-terminal regulatory
(NTR) domain and an insert within the catalytic domain
that contains an auto-inhibitory sequence. Like many
other AGC kinases, NDR kinase requires phosphorylation
at two sites, the activation loop (A-loop) and the
hydrophobic motif (HM), for activity. Higher eukaryotes
contain two NDR isoforms, NDR1 and NDR2. Both isoforms
play a role in proper centrosome duplication. NDR1 is
highly expressed in thymus, muscle, lung and spleen. It
is not an essential protein because mice deficient of
NDR1 remain viable and fertile. However, these mice
develop T-cell lymphomas and appear to be hypersenstive
to carcinogenic treatment. NDR1 appears to act as a
tumor suppressor. NDR1 is also called STK38.
Length = 363
Score = 32.7 bits (74), Expect = 0.020
Identities = 14/49 (28%), Positives = 27/49 (55%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
K L+ + +++ + + + IH +HRD+KP NLLL++ +K
Sbjct: 94 KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKL 142
>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Src kinase subfamily; catalytic (c) domain. Src
subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr,
Fyn, Yrk, and Yes. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Src (or c-Src) proteins are cytoplasmic (or
non-receptor) tyr kinases which are anchored to the
plasma membrane. They contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. They were identified as the first
proto-oncogene products, and they regulate cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Src kinases are overexpressed in a
variety of human cancers, making them attractive targets
for therapy. They are also implicated in acute
inflammatory responses and osteoclast function. Src,
Fyn, Yes, and Yrk are widely expressed, while Blk, Lck,
Hck, Fgr, and Lyn show a limited expression pattern.
Length = 261
Score = 32.3 bits (74), Expect = 0.021
Identities = 15/40 (37%), Positives = 20/40 (50%), Gaps = 2/40 (5%)
Query: 33 KYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 72
K RL + QI G+ Y+ S N +HRDL N+L
Sbjct: 98 KKLRL-PQLV-DMAAQIAEGMAYLESRNYIHRDLAARNIL 135
>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional.
Length = 392
Score = 32.5 bits (74), Expect = 0.023
Identities = 10/26 (38%), Positives = 17/26 (65%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLN 74
+L L Y+H ++HRD+K N+ L+
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLD 219
>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine
Kinases, Receptor tyrosine kinase-like Orphan Receptors.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor (Ror) subfamily; catalytic
(c) domain. The Ror subfamily consists of Ror1, Ror2,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Ror proteins are orphan
receptor tyr kinases (RTKs) containing an extracellular
region with immunoglobulin-like, cysteine-rich, and
kringle domains, a transmembrane segment, and an
intracellular catalytic domain. Ror RTKs are unrelated
to the nuclear receptor subfamily called
retinoid-related orphan receptors (RORs). RTKs are
usually activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. Ror kinases
are expressed in many tissues during development. They
play important roles in bone and heart formation.
Mutations in human Ror2 result in two different bone
development genetic disorders, recessive Robinow
syndrome and brachydactyly type B. Drosophila Ror is
expressed only in the developing nervous system during
neurite outgrowth and neuronal differentiation,
suggesting a role for Drosophila Ror in neural
development. More recently, mouse Ror1 and Ror2 have
also been found to play an important role in regulating
neurite growth in central neurons. Ror1 and Ror2 are
believed to have some overlapping and redundant
functions.
Length = 283
Score = 32.0 bits (73), Expect = 0.025
Identities = 15/63 (23%), Positives = 25/63 (39%), Gaps = 4/63 (6%)
Query: 12 IRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 71
+R+S + T L + QI G++Y+ S + +HRDL N
Sbjct: 100 VRNSPHSDV----GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNC 155
Query: 72 LLN 74
L+
Sbjct: 156 LVG 158
>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein
Serine/Threonine Kinase, Protein Kinase B alpha.
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB)
or Akt subfamily, alpha (or Akt1) isoform, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. There are three
PKB isoforms from different genes, PKB-alpha (or Akt1),
PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB
contains an N-terminal pleckstrin homology (PH) domain
and a C-terminal catalytic domain. PKB-alpha is
predominantly expressed in endothelial cells. It is
critical for the regulation of angiogenesis and the
maintenance of vascular integrity. It also plays a role
in adipocyte differentiation. Mice deficient in
PKB-alpha exhibit perinatal morbidity, growth
retardation, reduction in body weight accompanied by
reduced sizes of multiple organs, and enhanced apoptosis
in some cell types. PKB-alpha activity has been reported
to be frequently elevated in breast and prostate
cancers. In some cancer cells, PKB-alpha may act as a
suppressor of metastasis.
Length = 325
Score = 32.3 bits (73), Expect = 0.027
Identities = 22/71 (30%), Positives = 38/71 (53%), Gaps = 6/71 (8%)
Query: 16 TKESLVSFREYSDS-----HRTKYQRLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPS 69
T + L EY++ H ++ + S D ++ +I+ L Y+HS NV++RDLK
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 125
Query: 70 NLLLNTTCDLK 80
NL+L+ +K
Sbjct: 126 NLMLDKDGHIK 136
>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related
kinase adapter protein alpha. Protein Kinase family,
STE20-related kinase adapter protein (STRAD) alpha
subfamily, pseudokinase domain. The STRAD alpha
subfamily is part of a larger superfamily that includes
the catalytic domains of serine/threonine kinases
(STKs), protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The pseudokinase domain shows
similarity to protein kinases but lacks crucial residues
for catalytic activity. STRAD forms a complex with the
scaffolding protein MO25, and the STK, LKB1, resulting
in the activation of the kinase. In the complex, LKB1
phosphorylates and activates adenosine
monophosphate-activated protein kinases (AMPKs), which
regulate cell energy metabolism and cell polarity. LKB1
is a tumor suppressor linked to the rare inherited
disease, Peutz-Jeghers syndrome, which is characterized
by a predisposition to benign polyps and
hyperpigmentation of the buccal mucosa. There are two
forms of STRAD, alpha and beta, that complex with LKB1
and MO25. The structure of STRAD-alpha is available and
shows that this protein binds ATP, has an ordered
activation loop, and adopts a closed conformation
typical of fully active protein kinases. It does not
possess activity due to nonconservative substitutions of
essential catalytic residues. ATP binding enhances the
affinity of STRAD for MO25. The conformation of
STRAD-alpha, stabilized through ATP and MO25, may be
needed to activate LKB1. A mutation which results in a
truncation of a C-terminal part of the human STRAD-alpha
pseudokinase domain and disrupts its association with
LKB1, leads to PMSE (polyhydramnios, megalencephaly,
symptomatic epilepsy) syndrome. Several splice variants
of STRAD-alpha exist which exhibit different effects on
the localization and activation of LKB1.
Length = 327
Score = 31.8 bits (72), Expect = 0.034
Identities = 14/38 (36%), Positives = 23/38 (60%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+S I Y L +L+ L YIH +HR +K S++L++
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS 135
>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase,
Csk homologous kinase. Protein Tyrosine Kinase (PTK)
family; Csk homologous kinase (Chk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. Chk is also referred to
as megakaryocyte-associated tyrosine kinase (Matk). To
inhibit Src kinases, Chk is translocated to the membrane
via binding to specific transmembrane proteins,
G-proteins, or adaptor proteins near the membrane. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As a negative regulator of Src
kinases, Chk may play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. Chk
is expressed in brain and hematopoietic cells. Studies
in mice reveal that Chk is not functionally redundant
with Csk and that it plays an important role as a
regulator of immune responses. Chk also plays a role in
neural differentiation in a manner independent of Src by
enhancing Mapk activation via Ras-mediated signaling.
Length = 254
Score = 31.9 bits (72), Expect = 0.035
Identities = 18/66 (27%), Positives = 35/66 (53%), Gaps = 7/66 (10%)
Query: 10 IEIRHSTKESLVSFREYSDSHRTKYQRLSN-DHICYFLYQILRGLKYIHSANVLHRDLKP 68
I + +K +LV+F RT+ + L + + F + G++Y+ S ++HRDL
Sbjct: 75 IVMELMSKGNLVNFL------RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128
Query: 69 SNLLLN 74
N+L++
Sbjct: 129 RNILVS 134
>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine
Kinases, Discoidin Domain Receptors. Protein Tyrosine
Kinase (PTK) family; Discoidin Domain Receptor (DDR)
subfamily; catalytic (c) domain. The DDR subfamily
consists of homologs of mammalian DDR1, DDR2, and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
DDR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular discoidin homology domain, a
transmembrane segment, an extended juxtamembrane region,
and an intracellular catalytic domain. The binding of
the ligand, collagen, to DDRs results in a slow but
sustained receptor activation. DDRs regulate cell
adhesion, proliferation, and extracellular matrix
remodeling. They have been linked to a variety of human
cancers including breast, colon, ovarian, brain, and
lung. There is no evidence showing that DDRs act as
transforming oncogenes. They are more likely to play a
role in the regulation of tumor growth and metastasis.
Length = 296
Score = 31.5 bits (72), Expect = 0.038
Identities = 15/38 (39%), Positives = 21/38 (55%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
LS + Y QI G++Y+ S N +HRDL N L+
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164
>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine
Kinases, Class EphB Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
class EphB receptors; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). Class EphB receptors bind to transmembrane
ephrin-B ligands. There are six vertebrate EhpB
receptors (EphB1-6), which display promiscuous
interactions with three ephrin-B ligands. One exception
is EphB2, which also interacts with ephrin A5. EphRs
contain an ephrin-binding domain and two fibronectin
repeats extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion. EphBRs play important roles in synapse
formation and plasticity, spine morphogenesis, axon
guidance, and angiogenesis. In the intestinal
epithelium, EphBRs are Wnt signaling target genes that
control cell compartmentalization. They function as
suppressors of color cancer progression.
Length = 269
Score = 31.8 bits (72), Expect = 0.041
Identities = 19/57 (33%), Positives = 28/57 (49%), Gaps = 6/57 (10%)
Query: 19 SLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
+L SF +D T Q + L I G+KY+ N +HRDL N+L+N+
Sbjct: 91 ALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYLSEMNYVHRDLAARNILVNS 141
>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine
Kinases, Class EphA Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
most class EphA receptors including EphA3, EphA4, EphA5,
and EphA7, but excluding EphA1, EphA2 and EphA10;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. EphRs comprise the
largest subfamily of receptor tyr kinases (RTKs). In
general, class EphA receptors bind GPI-anchored ephrin-A
ligands. There are ten vertebrate EphA receptors
(EphA1-10), which display promiscuous interactions with
six ephrin-A ligands. One exception is EphA4, which also
binds ephrins-B2/B3. EphRs contain an ephrin-binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). Ephrin/EphR interaction mainly results in
cell-cell repulsion or adhesion, making it important in
neural development and plasticity, cell morphogenesis,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis. EphARs and ephrin-A
ligands are expressed in multiple areas of the
developing brain, especially in the retina and tectum.
They are part of a system controlling retinotectal
mapping.
Length = 267
Score = 31.4 bits (71), Expect = 0.042
Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 6/57 (10%)
Query: 19 SLVSFREYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
SL +F D T Q + L I G+KY+ +HRDL N+L+N+
Sbjct: 91 SLDAFLRKHDGQFTVIQLVG------MLRGIASGMKYLSDMGYVHRDLAARNILVNS 141
>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase,
Interleukin-2-inducible T-cell Kinase. Protein Tyrosine
Kinase (PTK) family; Interleukin-2 (IL-2)-inducible
T-cell kinase (Itk); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Itk (also
known as Tsk or Emt) is a member of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Itk
contains the Tec homology (TH) domain containing one
proline-rich region and a zinc-binding region. Tec
kinases are expressed mainly by haematopoietic cells.
Itk is expressed in T-cells and mast cells, and is
important in their development and differentiation. Of
the three Tec kinases expressed in T-cells, Itk plays
the predominant role in T-cell receptor (TCR) signaling.
It is activated by phosphorylation upon TCR crosslinking
and is involved in the pathway resulting in
phospholipase C-gamma1 activation and actin
polymerization. It also plays a role in the downstream
signaling of the T-cell costimulatory receptor CD28, the
T-cell surface receptor CD2, and the chemokine receptor
CXCR4. In addition, Itk is crucial for the development
of T-helper(Th)2 effector responses.
Length = 256
Score = 31.5 bits (71), Expect = 0.044
Identities = 15/47 (31%), Positives = 25/47 (53%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
SD R + + S + + + G+ Y+ S+NV+HRDL N L+
Sbjct: 87 SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133
>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen and stress-activated
kinase 2. Serine/Threonine Kinases (STKs), Mitogen and
stress-activated kinase (MSK) subfamily, MSK2,
N-terminal catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The MSK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MSKs contain an N-terminal kinase domain (NTD)
from the AGC family and a C-terminal kinase domain (CTD)
from the CAMK family, similar to 90 kDa ribosomal
protein S6 kinases (RSKs). MSKs are activated by two
major signaling cascades, the Ras-MAPK and p38 stress
kinase pathways, which trigger phosphorylation in the
activation loop (A-loop) of the CTD of MSK. The active
CTD phosphorylates the hydrophobic motif (HM) of NTD,
which facilitates the phosphorylation of the A-loop and
activates the NTD, which in turn phosphorylates
downstream targets. MSK2 and MSK1 play nonredundant
roles in activating histone H3 kinases, which play
pivotal roles in compaction of the chromatin fiber. MSK2
is the required H3 kinase in response to stress stimuli
and activation of the p38 MAPK pathway. MSK2 also plays
a role in the pathogenesis of psoriasis.
Length = 332
Score = 31.5 bits (71), Expect = 0.046
Identities = 14/44 (31%), Positives = 29/44 (65%), Gaps = 2/44 (4%)
Query: 34 YQR--LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
YQR S D + ++ +I+ L+++H +++RD+K N+LL++
Sbjct: 97 YQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS 140
>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine
Kinase, Tie2. Protein Tyrosine Kinase (PTK) family;
Tie2; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie2 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie2 is expressed
mainly in endothelial cells and hematopoietic stem
cells. It is also found in a subset of tumor-associated
monocytes and eosinophils. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2. The binding of Ang-1
to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. Tie2 signaling plays key regulatory roles in
vascular integrity and quiescence, and in inflammation.
Length = 303
Score = 31.5 bits (71), Expect = 0.046
Identities = 13/48 (27%), Positives = 26/48 (54%), Gaps = 1/48 (2%)
Query: 26 YSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
++ ++ T LS+ + +F + RG+ Y+ +HRDL N+L+
Sbjct: 111 FAIANSTA-STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157
>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein
Serine/Threonine Kinase, Classical Protein Kinase C.
Serine/Threonine Kinases (STKs), Classical (or
Conventional) Protein Kinase C (cPKC) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The cPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase (PI3K). PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
PKCs undergo three phosphorylations in order to take
mature forms. In addition, cPKCs depend on calcium, DAG
(1,2-diacylglycerol), and in most cases,
phosphatidylserine (PS) for activation. cPKCs contain a
calcium-binding C2 region in their regulatory domain.
There are four cPKC isoforms, named alpha, betaI,
betaII, and gamma. cPKCs are potent kinases for
histones, myelin basic protein, and protamine. PKC-gamma
is mainly expressed in neuronal tissues. It plays a role
in protection from ischemia.
Length = 324
Score = 31.3 bits (71), Expect = 0.051
Identities = 13/40 (32%), Positives = 25/40 (62%)
Query: 41 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
H ++ +I GL ++HS +++RDLK N++L+ +K
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIK 141
>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Axl subfamily; catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). The Axl subfamily
consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and
similar proteins. PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with two
immunoglobulin-like domains followed by two fibronectin
type III repeats, a transmembrane segment, and an
intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl subfamily members are
implicated in a variety of cellular effects including
survival, proliferation, migration, and phagocytosis.
They are also associated with several types of cancer as
well as inflammatory, autoimmune, vascular, and kidney
diseases. Mer is named after its original reported
expression pattern (monocytes, epithelial, and
reproductive tissues). It is required for the ingestion
of apoptotic cells by phagocytes such as macrophages,
retinal pigment epithelial cells, and dendritic cells.
Mer is also important in maintaining immune homeostasis.
Length = 273
Score = 30.9 bits (70), Expect = 0.061
Identities = 11/30 (36%), Positives = 18/30 (60%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
F+ I G++Y+ + N +HRDL N +L
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLR 147
>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 1. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
1 (DDR1) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR1 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR1 binds to all collagens tested to date (types I-IV).
It is widely expressed in many tissues. It is abundant
in the brain and is also found in keratinocytes, colonic
mucosa epithelium, lung epithelium, thyroid follicles,
and the islets of Langerhans. During embryonic
development, it is found in the developing
neuroectoderm. DDR1 is a key regulator of cell
morphogenesis, differentiation and proliferation. It is
important in the development of the mammary gland, the
vasculator and the kidney. DDR1 is also found in human
leukocytes, where it facilitates cell adhesion,
migration, maturation, and cytokine production.
Length = 304
Score = 31.1 bits (70), Expect = 0.064
Identities = 13/26 (50%), Positives = 17/26 (65%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLL 73
QI G+KY+ S N +HRDL N L+
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLV 171
>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase
adapter protein beta. Protein Kinase family,
STE20-related kinase adapter protein (STRAD) beta
subfamily, pseudokinase domain. The STRAD-beta subfamily
is part of a larger superfamily that includes the
catalytic domains of serine/threonine kinases (STKs),
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The pseudokinase domain shows similarity to
protein kinases but lacks crucial residues for catalytic
activity. STRAD forms a complex with the scaffolding
protein MO25, and the STK, LKB1, resulting in the
activation of the kinase. In the complex, LKB1
phosphorylates and activates adenosine
monophosphate-activated protein kinases (AMPKs), which
regulate cell energy metabolism and cell polarity. LKB1
is a tumor suppressor linked to the rare inherited
disease, Peutz-Jeghers syndrome, which is characterized
by a predisposition to benign polyps and
hyperpigmentation of the buccal mucosa. There are two
forms of STRAD, alpha and beta, that complex with LKB1
and MO25. STRAD-beta is also referred to as ALS2CR2
(Amyotrophic lateral sclerosis 2 chromosomal region
candidate gene 2 protein), since the human gene encoding
it is located within the juvenile ALS2 critical region
on chromosome 2q33-q34. It is not linked to the
development of ALS2.
Length = 328
Score = 30.7 bits (69), Expect = 0.085
Identities = 12/29 (41%), Positives = 21/29 (72%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L+ LRGL Y+H +HR++K S++L++
Sbjct: 107 LFGALRGLNYLHQNGYIHRNIKASHILIS 135
>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase,
Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Fer kinase is a member
of the Fes subfamily of proteins which are cytoplasmic
(or nonreceptor) tyr kinases containing an N-terminal
region with FCH (Fes/Fer/CIP4 homology) and coiled-coil
domains, followed by a SH2 domain, and a C-terminal
catalytic domain. Fer kinase is expressed in a wide
variety of tissues, and is found to reside in both the
cytoplasm and the nucleus. It plays important roles in
neuronal polarization and neurite development,
cytoskeletal reorganization, cell migration, growth
factor signaling, and the regulation of cell-cell
interactions mediated by adherens junctions and focal
adhesions. Fer kinase also regulates cell cycle
progression in malignant cells.
Length = 250
Score = 30.7 bits (69), Expect = 0.094
Identities = 16/50 (32%), Positives = 21/50 (42%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
R K L + F G+ Y+ S N +HRDL N L+ LK
Sbjct: 84 RKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLK 133
>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein
Serine/Threonine Kinase, Citron Rho-interacting kinase.
Serine/Threonine Kinases (STKs), Citron Rho-interacting
kinase (CRIK) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The CRIK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CRIK is also called citron kinase. It contains
a catalytic domain, a central coiled-coil domain, and a
C-terminal region containing a Rho-binding domain (RBD),
a zinc finger, and a pleckstrin homology (PH) domain, in
addition to other motifs. CRIK, an effector of the small
GTPase Rho, plays an important function during
cytokinesis and affects its contractile process.
CRIK-deficient mice show severe ataxia and epilepsy as a
result of abnormal cytokinesis and massive apoptosis in
neuronal precursors. A Down syndrome critical region
protein TTC3 interacts with CRIK and inhibits
CRIK-dependent neuronal differentiation and neurite
extension.
Length = 330
Score = 30.6 bits (69), Expect = 0.10
Identities = 12/44 (27%), Positives = 25/44 (56%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
D ++L +++ + +H +HRD+KP N+L++ T +K
Sbjct: 99 FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIK 142
>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Ephrin Receptor (EphR) subfamily; catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). They can be classified into two classes (EphA
and EphB), according to their extracellular sequences,
which largely correspond to binding preferences for
either GPI-anchored ephrin-A ligands or transmembrane
ephrin-B ligands. Vertebrates have ten EphA and six EhpB
receptors, which display promiscuous ligand interactions
within each class. EphRs contain an ephrin binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. This allows ephrin/EphR dimers to form,
leading to the activation of the intracellular tyr
kinase domain. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). The main effect of ephrin/EphR interaction
is cell-cell repulsion or adhesion. Ephrin/EphR
signaling is important in neural development and
plasticity, cell morphogenesis and proliferation,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis.
Length = 266
Score = 30.0 bits (68), Expect = 0.13
Identities = 13/29 (44%), Positives = 18/29 (62%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L I G+KY+ N +HRDL N+L+N
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVN 140
>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein
Serine/Threonine Kinase, Novel Protein Kinase C delta.
Serine/Threonine Kinases (STKs), Novel Protein Kinase C
(nPKC), delta isoform, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The nPKC subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PKCs are classified into three groups
(classical, atypical, and novel) depending on their mode
of activation and the structural characteristics of
their regulatory domain. nPKCs are calcium-independent,
but require DAG (1,2-diacylglycerol) and
phosphatidylserine (PS) for activity. There are four
nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta
plays a role in cell cycle regulation and programmed
cell death in many cell types. It slows down cell
proliferation, inducing cell cycle arrest and enhancing
cell differentiation. PKC-delta is also involved in the
regulation of transcription as well as immune and
inflammatory responses. It plays a central role in the
genotoxic stress response that leads to DNA
damaged-induced apoptosis.
Length = 316
Score = 30.3 bits (68), Expect = 0.13
Identities = 11/31 (35%), Positives = 24/31 (77%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ +I+ GL+++HS +++RDLK N++L+
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD 130
>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine
Kinases, Met and Ron. Protein Tyrosine Kinase (PTK)
family; Met and Ron; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Met and
Ron are receptor tyr kinases (RTKs) composed of an
alpha-beta heterodimer. The extracellular alpha chain is
disulfide linked to the beta chain, which contains an
extracellular ligand-binding region with a sema domain,
a PSI domain and four IPT repeats, a transmembrane
segment, and an intracellular catalytic domain. Binding
to their ligands leads to receptor dimerization,
autophosphorylation, activation, and intracellular
signaling. Met binds to the ligand, hepatocyte growth
factor/scatter factor (HGF/SF), and is also called the
HGF receptor. HGF/Met signaling plays a role in growth,
transformation, cell motility, invasion, metastasis,
angiogenesis, wound healing, and tissue regeneration.
Aberrant expression of Met through mutations or gene
amplification is associated with many human cancers
including hereditary papillary renal and gastric
carcinomas. The ligand for Ron is macrophage stimulating
protein (MSP). Ron signaling is important in regulating
cell motility, adhesion, proliferation, and apoptosis.
Aberrant Ron expression is implicated in tumorigenesis
and metastasis.
Length = 262
Score = 30.1 bits (68), Expect = 0.13
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
F Q+ +G++Y+ S +HRDL N +L+ + +K
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK 138
>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Human Fyn-related kinase (Frk) and similar
proteins; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Frk and
Srk are members of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Frk, also known as Rak, is specifically
expressed in liver, lung, kidney, intestine, mammary
glands, and the islets of Langerhans. Rodent homologs
were previously referred to as GTK (gastrointestinal tyr
kinase), BSK (beta-cell Src-like kinase), or IYK
(intestinal tyr kinase). Studies in mice reveal that Frk
is not essential for viability. It plays a role in the
signaling that leads to cytokine-induced beta-cell death
in Type I diabetes. It also regulates beta-cell number
during embryogenesis and early in life.
Length = 261
Score = 30.1 bits (68), Expect = 0.13
Identities = 10/27 (37%), Positives = 17/27 (62%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLN 74
Q+ G+ Y+ + N +HRDL N+L+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG 137
>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy
protein kinase-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Myotonic Dystrophy
protein kinase (DMPK)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The DMPK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The DMPK-like subfamily is composed of DMPK
and DMPK-related cell division control protein 42
(Cdc42) binding kinase (MRCK). Three isoforms of MRCK
are known, named alpha, beta and gamma. The DMPK gene is
implicated in myotonic dystrophy 1 (DM1), an inherited
multisystemic disorder with symptoms that include muscle
hyperexcitability, progressive muscle weakness and
wasting, cataract development, testicular atrophy, and
cardiac conduction defects. The genetic basis for DM1 is
the mutational expansion of a CTG repeat in the 3'-UTR
of DMPK. DMPK is expressed in skeletal and cardiac
muscles, and in central nervous tissues. The functional
role of DMPK is not fully understood. It may play a role
in the signal transduction and homeostasis of calcium.
MRCK is activated via interaction with the small GTPase
Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent
cell motility. MRCKgamma is expressed in heart and
skeletal muscles, unlike MRCKalpha and MRCKbeta, which
are expressed ubiquitously.
Length = 331
Score = 30.1 bits (68), Expect = 0.13
Identities = 13/39 (33%), Positives = 24/39 (61%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
RL D ++L +++ + +H +HRD+KP N+LL+
Sbjct: 98 RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136
>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein
Serine/Threonine Kinase, G protein-coupled Receptor
Kinase 4. Serine/Threonine Kinases (STKs), G
protein-coupled Receptor Kinase (GRK) subfamily, GRK4
isoform, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The GRK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. GRKs phosphorylate and regulate G
protein-coupled receptors (GPCRs), the largest
superfamily of cell surface receptors which regulate
some part of nearly all physiological functions.
Phosphorylated GPCRs bind to arrestins, which prevents
further G protein signaling despite the presence of
activating ligand. There are seven types of GRKs, named
GRK1 to GRK7. GRK4 has a limited tissue distribution. It
is mainly found in the testis, but is also present in
the cerebellum and kidney. It is expressed as multiple
splice variants with different domain architectures. It
is post-translationally palmitoylated and localized in
the membrane. GRK4 polymorphisms are associated with
hypertension and salt sensitivity, as they cause
hyperphosphorylation, desensitization, and
internalization of the dopamine 1 (D1) receptor while
increasing the expression of the angiotensin II type 1
receptor. GRK4 plays a crucial role in the D1 receptor
regulation of sodium excretion and blood pressure.
Length = 285
Score = 30.0 bits (67), Expect = 0.14
Identities = 10/31 (32%), Positives = 21/31 (67%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ ++ GL+ + +++RDLKP N+LL+
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD 136
>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase,
C-terminal Src kinase. Protein Tyrosine Kinase (PTK)
family; C-terminal Src kinase (Csk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. The Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk is translocated to the membrane via binding to
specific transmembrane proteins, G-proteins, or adaptor
proteins near the membrane. Csk catalyzes the tyr
phosphorylation of the regulatory C-terminal tail of Src
kinases, resulting in their inactivation. Csk is
expressed in a wide variety of tissues. As a negative
regulator of Src, Csk plays a role in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. In
addition, Csk also shows Src-independent functions. It
is a critical component in G-protein signaling, and
plays a role in cytoskeletal reorganization and cell
migration.
Length = 256
Score = 29.9 bits (67), Expect = 0.15
Identities = 11/38 (28%), Positives = 21/38 (55%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L D + F + ++Y+ + N +HRDL N+L++
Sbjct: 99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136
>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase,
Abelson kinase. Protein Tyrosine Kinase (PTK) family;
Abelson (Abl) kinase; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Abl (or
c-Abl) is a ubiquitously-expressed cytoplasmic (or
nonreceptor) tyr kinase that contains SH3, SH2, and tyr
kinase domains in its N-terminal region, as well as
nuclear localization motifs, a putative DNA-binding
domain, and F- and G-actin binding domains in its
C-terminal tail. It also contains a short autoinhibitory
cap region in its N-terminus. Abl is normally inactive
and requires phosphorylation and myristoylation for
activation. Abl function depends on its subcellular
localization. In the cytoplasm, Abl plays a role in cell
proliferation and survival. In response to DNA damage or
oxidative stress, Abl is transported to the nucleus
where it induces apoptosis. In chronic myelogenous
leukemia (CML) patients, an aberrant translocation
results in the replacement of the first exon of Abl with
the BCR (breakpoint cluster region) gene. The resulting
BCR-Abl fusion protein is constitutively active and
associates into tetramers, resulting in a hyperactive
kinase sending a continuous signal. This leads to
uncontrolled proliferation, morphological transformation
and anti-apoptotic effects. BCR-Abl is the target of
selective inhibitors, such as imatinib (Gleevec), used
in the treatment of CML. Abl2, also known as ARG
(Abelson-related gene), is thought to play a cooperative
role with Abl in the proper development of the nervous
system. The Tel-ARG fusion protein, resulting from
reciprocal translocation between chromosomes 1 and 12,
is associated with acute myeloid leukemia (AML). The TEL
gene is a frequent fusion partner of other tyr kinase
oncogenes, including Tel/Abl, Tel/PDGFRbeta, and
Tel/Jak2, found in patients with leukemia and
myeloproliferative disorders.
Length = 263
Score = 29.4 bits (66), Expect = 0.24
Identities = 11/30 (36%), Positives = 16/30 (53%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
Y QI ++Y+ N +HRDL N L+
Sbjct: 108 YMATQISSAMEYLEKKNFIHRDLAARNCLV 137
>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional.
Length = 294
Score = 29.1 bits (65), Expect = 0.26
Identities = 10/27 (37%), Positives = 18/27 (66%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLNT 75
+L L+YIH + H D+KP N++++
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDG 161
>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Janus kinase 1. Protein Tyrosine
Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Jak1 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase domain. Jaks are crucial for cytokine
receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jak1 is widely expressed in many tissues. Many cytokines
are dependent on Jak1 for signaling, including those
that use the shared receptor subunits common gamma chain
(IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6,
IL-11, oncostatin M, G-CSF, and IFNs, among others). The
many varied interactions of Jak1 and its ubiquitous
expression suggest many biological roles. Jak1 is
important in neurological development, as well as in
lymphoid development and function. It also plays a role
in the pathophysiology of cardiac hypertrophy and heart
failure. A mutation in the ATP-binding site of Jak1 was
identified in a human uterine leiomyosarcoma cell line,
resulting in defective cytokine induction and antigen
presentation, thus allowing the tumor to evade the
immune system.
Length = 284
Score = 29.1 bits (65), Expect = 0.27
Identities = 11/26 (42%), Positives = 17/26 (65%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLL 73
QI +G+ Y+ S +HRDL N+L+
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLV 142
>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine
Kinases, Tropomyosin Related Kinases. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase (Trk)
subfamily; catalytic (c) domain. The Trk subfamily
consists of TrkA, TrkB, TrkC, and similar proteins. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Trk
subfamily members are receptor tyr kinases (RTKs)
containing an extracellular region with arrays of
leucine-rich motifs flanked by two cysteine-rich
clusters followed by two immunoglobulin-like domains, a
transmembrane segment, and an intracellular catalytic
domain. Binding to their ligands, the nerve growth
factor (NGF) family of neutrotrophins, leads to Trk
receptor oligomerization and activation of the catalytic
domain. Trk receptors are mainly expressed in the
peripheral and central nervous systems. They play
important roles in cell fate determination, neuronal
survival and differentiation, as well as in the
regulation of synaptic plasticity. Altered expression of
Trk receptors is associated with many human diseases.
Length = 280
Score = 29.3 bits (66), Expect = 0.29
Identities = 13/49 (26%), Positives = 21/49 (42%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
S + L+ + QI G+ Y+ S + +HRDL N L+
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY 157
>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 2.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 2 (Ror2); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror2 plays important roles in skeletal
and heart formation. Ror2-deficient mice show widespread
bone abnormalities, ventricular defects in the heart,
and respiratory dysfunction. Mutations in human Ror2
result in two different bone development genetic
disorders, recessive Robinow syndrome and brachydactyly
type B. Ror2 is also implicated in neural development.
Length = 283
Score = 28.8 bits (64), Expect = 0.37
Identities = 13/47 (27%), Positives = 26/47 (55%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+D +T L + + QI G++++ S +V+H+DL N+L+
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157
>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine
Kinase, HER4. Protein Tyrosine Kinase (PTK) family;
HER4 (ErbB4); catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER4 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Ligands that bind HER4 fall into two groups,
the neuregulins (or heregulins) and some EGFR (HER1)
ligands including betacellulin, HBEGF, and epiregulin.
All four neuregulins (NRG1-4) interact with HER4. Upon
ligand binding, HER4 forms homo- or heterodimers with
other HER proteins. HER4 is essential in embryonic
development. It is implicated in mammary gland, cardiac,
and neural development. As a postsynaptic receptor of
NRG1, HER4 plays an important role in synaptic
plasticity and maturation. The impairment of NRG1/HER4
signaling may contribute to schizophrenia.
Length = 303
Score = 28.9 bits (64), Expect = 0.37
Identities = 13/56 (23%), Positives = 28/56 (50%), Gaps = 3/56 (5%)
Query: 25 EYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+Y H+ + + + + QI +G+ Y+ ++HRDL N+L+ + +K
Sbjct: 97 DYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVK 149
>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein
Serine/Threonine Kinase, Classical Protein Kinase C
alpha. Serine/Threonine Kinases (STKs), Classical
Protein Kinase C (cPKC) subfamily, alpha isoform,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The cPKC subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKCs are
classified into three groups (classical, atypical, and
novel) depending on their mode of activation and the
structural characteristics of their regulatory domain.
PKCs undergo three phosphorylations in order to take
mature forms. In addition, cPKCs depend on calcium, DAG
(1,2-diacylglycerol), and in most cases,
phosphatidylserine (PS) for activation. There are four
cPKC isoforms, named alpha, betaI, betaII, and gamma.
PKC-alpha is expressed in many tissues and is associated
with cell proliferation, apoptosis, and cell motility.
It plays a role in the signaling of the growth factors
PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha
have been detected in many transformed cell lines and
several human tumors. In addition, PKC-alpha is required
for HER2 dependent breast cancer invasion.
Length = 323
Score = 28.8 bits (64), Expect = 0.47
Identities = 11/37 (29%), Positives = 24/37 (64%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
++ +I GL ++H +++RDLK N++L++ +K
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIK 141
>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor 2.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, LATS2 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The LATS subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. LATS functions as a tumor
suppressor and is implicated in cell cycle regulation.
LATS2 is an essential mitotic regulator responsible for
coordinating accurate cytokinesis completion and
governing the stabilization of other mitotic regulators.
It is also critical in the maintenance of proper
chromosome number, genomic stability, mitotic fidelity,
and the integrity of centrosome duplication.
Downregulation of LATS2 is associated with poor
prognosis in acute lymphoblastic leukemia and breast
cancer.
Length = 381
Score = 28.4 bits (63), Expect = 0.49
Identities = 9/38 (23%), Positives = 23/38 (60%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+++ ++ ++ +H +HRD+KP N+L++ +K
Sbjct: 105 FYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKL 142
>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor 1.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, LATS1 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The LATS subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. LATS functions as a tumor
suppressor and is implicated in cell cycle regulation.
Inactivation of LATS1 in mice results in the development
of various tumors, including sarcomas and ovarian
cancer. Promoter methylation, loss of heterozygosity,
and missense mutations targeting the LATS1 gene have
also been found in human sarcomas and ovarian cancers.
In addition, decreased expression of LATS1 is associated
with an aggressive phenotype and poor prognosis. LATS1
induces G2 arrest and promotes cytokinesis. It may be a
component of the mitotic exit network in higher
eukaryotes.
Length = 382
Score = 28.4 bits (63), Expect = 0.49
Identities = 9/38 (23%), Positives = 23/38 (60%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKF 81
+++ ++ ++ +H +HRD+KP N+L++ +K
Sbjct: 105 FYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKL 142
>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional.
Length = 267
Score = 28.3 bits (64), Expect = 0.56
Identities = 11/39 (28%), Positives = 22/39 (56%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+LS + + Q++ L +H N++H D+K N+L +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional.
Length = 211
Score = 27.9 bits (63), Expect = 0.63
Identities = 9/19 (47%), Positives = 14/19 (73%)
Query: 57 HSANVLHRDLKPSNLLLNT 75
HSA ++H DL SN++L+
Sbjct: 112 HSAGIIHGDLTTSNMILSG 130
>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
LATS subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. LATS was originally identified in Drosophila
using a screen for genes whose inactivation led to
overproliferation of cells. In tetrapods, there are two
LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in
mice results in the development of various tumors,
including sarcomas and ovarian cancer. LATS functions as
a tumor suppressor and is implicated in cell cycle
regulation.
Length = 376
Score = 28.2 bits (63), Expect = 0.69
Identities = 8/31 (25%), Positives = 21/31 (67%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+++ ++ ++ +H +HRD+KP N+L++
Sbjct: 105 FYIAELTCAIESVHKMGFIHRDIKPDNILID 135
>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Fes subfamily; catalytic (c) domain. Fes subfamily
members include Fes (or Fps), Fer, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes and Fer kinases play roles in haematopoiesis,
inflammation and immunity, growth factor signaling,
cytoskeletal regulation, cell migration and adhesion,
and the regulation of cell-cell interactions. Fes and
Fer show redundancy in their biological functions.
Length = 251
Score = 27.4 bits (61), Expect = 1.1
Identities = 12/29 (41%), Positives = 17/29 (58%)
Query: 52 GLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
G++Y+ S N +HRDL N L+ LK
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLK 133
>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Insulin Receptor (InsR) subfamily; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). The InsR subfamily
is composed of InsR, Insulin-like Growth Factor-1
Receptor (IGF-1R), and similar proteins. PTKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. InsR and
IGF-1R are receptor tyr kinases (RTKs) composed of two
alphabeta heterodimers. Binding of the ligand (insulin,
IGF-1, or IGF-2) to the extracellular alpha subunit
activates the intracellular tyr kinase domain of the
transmembrane beta subunit. Receptor activation leads to
autophosphorylation, stimulating downstream kinase
activities, which initiate signaling cascades and
biological function. InsR and IGF-1R, which share 84%
sequence identity in their kinase domains, display
physiologically distinct yet overlapping functions in
cell growth, differentiation, and metabolism. InsR
activation leads primarily to metabolic effects while
IGF-1R activation stimulates mitogenic pathways. In
cells expressing both receptors, InsR/IGF-1R hybrids are
found together with classical receptors. Both receptors
can interact with common adaptor molecules such as IRS-1
and IRS-2.
Length = 277
Score = 27.3 bits (61), Expect = 1.1
Identities = 8/27 (29%), Positives = 15/27 (55%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLLN 74
+I G+ Y+ + +HRDL N ++
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVA 153
>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32. Members of
this protein family are the Bud32 protein associated
with Kae1 (kinase-associated endopeptidase 1) in the
Archaea. In many Archaeal genomes, Kae1 and Bud32 are
fused. The complex is homologous to the Kae1 and Bud32
subunits of the eukaryotic KEOPS complex, an apparently
ancient protein kinase-containing molecular machine
[Unknown function, General].
Length = 199
Score = 27.2 bits (61), Expect = 1.4
Identities = 7/19 (36%), Positives = 13/19 (68%)
Query: 56 IHSANVLHRDLKPSNLLLN 74
+H A ++H DL SN+++
Sbjct: 106 LHKAGIVHGDLTTSNIIVR 124
>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine
Kinase, HER3. Protein Tyrosine Kinase (PTK) family;
HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic
domain) family to which this subfamily belongs, is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER3 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. HER3 binds the neuregulin ligands, NRG1 and
NRG2. HER3 contains an impaired tyr kinase domain and
relies on its heterodimerization partners for activity
following ligand binding. The HER2-HER3 heterodimer
constitutes a high affinity co-receptor capable of
potent mitogenic signaling. HER3 participates in a
signaling pathway involved in the proliferation,
survival, adhesion, and motility of tumor cells.
Length = 279
Score = 27.2 bits (60), Expect = 1.4
Identities = 17/56 (30%), Positives = 28/56 (50%), Gaps = 7/56 (12%)
Query: 22 SFREYSDSHRTKY--QRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
S ++ HR QRL N + QI +G+ Y+ ++HR+L N+LL +
Sbjct: 94 SLLDHVRQHRDSLDPQRLLN-----WCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein
Serine/Threonine Kinase, Novel Protein Kinase C epsilon.
Serine/Threonine Kinases (STKs), Novel Protein Kinase C
(nPKC), epsilon isoform, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The nPKC subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. PKCs are classified into three groups
(classical, atypical, and novel) depending on their mode
of activation and the structural characteristics of
their regulatory domain. nPKCs are calcium-independent,
but require DAG (1,2-diacylglycerol) and
phosphatidylserine (PS) for activity. There are four
nPKC isoforms, delta, epsilon, eta, and theta.
PKC-epsilon has been shown to behave as an oncoprotein.
Its overexpression contributes to neoplastic
transformation depending on the cell type. It
contributes to oncogenesis by inducing disordered cell
growth and inhibiting cell death. It also plays a role
in tumor invasion and metastasis. PKC-epsilon has also
been found to confer cardioprotection against ischemia
and reperfusion-mediated damage. Other cellular
functions include the regulation of gene expression,
cell adhesion, and cell motility.
Length = 321
Score = 27.1 bits (60), Expect = 1.7
Identities = 10/31 (32%), Positives = 20/31 (64%)
Query: 44 YFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
++ ++ L ++H V++RDLK N+LL+
Sbjct: 100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130
>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine
Kinases, Bruton's tyrosine kinase and Bone marrow kinase
on the X chromosome. Protein Tyrosine Kinase (PTK)
family; Bruton's tyrosine kinase (Btk) and Bone marrow
kinase on the X chromosome (Bmx); catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Btk and
Bmx (also named Etk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Btk
contains the Tec homology (TH) domain with proline-rich
and zinc-binding regions. Tec kinases are expressed
mainly by haematopoietic cells. Btk is expressed in
B-cells, and a variety of myeloid cells including mast
cells, platelets, neutrophils, and dendrictic cells. It
interacts with a variety of partners, from cytosolic
proteins to nuclear transcription factors, suggesting a
diversity of functions. Stimulation of a diverse array
of cell surface receptors, including antigen engagement
of the B-cell receptor (BCR), leads to PH-mediated
membrane translocation of Btk and subsequent
phosphorylation by Src kinase and activation. Btk plays
an important role in the life cycle of B-cells including
their development, differentiation, proliferation,
survival, and apoptosis. Mutations in Btk cause the
primary immunodeficiency disease, X-linked
agammaglobulinaemia (XLA) in humans. Bmx is primarily
expressed in bone marrow and the arterial endothelium,
and plays an important role in ischemia-induced
angiogenesis. It facilitates arterial growth, capillary
formation, vessel maturation, and bone marrow-derived
endothelial progenitor cell mobilization.
Length = 256
Score = 26.8 bits (59), Expect = 1.9
Identities = 11/44 (25%), Positives = 19/44 (43%)
Query: 31 RTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
R +R + + G+ Y+ S +HRDL N L++
Sbjct: 91 REHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD 134
>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase,
Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps)
kinase subfamily; catalytic (c) domain. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes kinase is expressed in myeloid, vascular
endothelial, epithelial, and neuronal cells. It plays
important roles in cell growth and differentiation,
angiogenesis, inflammation and immunity, and
cytoskeletal regulation. A recent study implicates Fes
kinase as a tumor suppressor in colorectal cancer.
Length = 252
Score = 26.9 bits (59), Expect = 2.0
Identities = 11/29 (37%), Positives = 17/29 (58%)
Query: 52 GLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
G++Y+ S + +HRDL N L+ LK
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLK 134
>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine
Kinases, Anaplastic Lymphoma Kinase and Leukocyte
Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family;
Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine
(tyr) Kinase (LTK); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to tyr
residues in protein substrates. ALK and LTK are orphan
receptor tyr kinases (RTKs) whose ligands are not yet
well-defined. RTKs contain an extracellular
ligand-binding domain, a transmembrane region, and an
intracellular tyr kinase domain. They are usually
activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. ALK appears
to play an important role in mammalian neural
development as well as visceral muscle differentiation
in Drosophila. ALK is aberrantly expressed as fusion
proteins, due to chromosomal translocations, in about
60% of anaplastic large cell lymphomas (ALCLs). ALK
fusion proteins are also found in rare cases of diffuse
large B cell lymphomas (DLBCLs). LTK is mainly expressed
in B lymphocytes and neuronal tissues. It is important
in cell proliferation and survival. Transgenic mice
expressing TLK display retarded growth and high
mortality rate. In addition, a polymorphism in mouse and
human LTK is implicated in the pathogenesis of systemic
lupus erythematosus.
Length = 277
Score = 26.6 bits (59), Expect = 2.1
Identities = 9/28 (32%), Positives = 15/28 (53%)
Query: 49 ILRGLKYIHSANVLHRDLKPSNLLLNTT 76
+ +G KY+ + +HRD+ N LL
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCK 152
>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family
protein/serine/threonine protein kinase; Validated.
Length = 535
Score = 26.8 bits (60), Expect = 2.3
Identities = 7/18 (38%), Positives = 12/18 (66%)
Query: 56 IHSANVLHRDLKPSNLLL 73
+H A ++H DL SN ++
Sbjct: 444 LHKAGIVHGDLTTSNFIV 461
>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine
Kinase, Tie1. Protein Tyrosine Kinase (PTK) family;
Tie1; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie1 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. No specific ligand has been
identified for Tie1, although the angiopoietin, Ang-1,
binds to Tie1 through integrins at high concentrations.
In vivo studies of Tie1 show that it is critical in
vascular development.
Length = 297
Score = 26.5 bits (58), Expect = 2.3
Identities = 10/37 (27%), Positives = 20/37 (54%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
L++ + F + G++Y+ +HRDL N+L+
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152
>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 1.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 1 (Ror1); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror kinases are expressed in many
tissues during development. Avian Ror1 was found to be
involved in late limb development. Studies in mice
reveal that Ror1 is important in the regulation of
neurite growth in central neurons, as well as in
respiratory development. Loss of Ror1 also enhances the
heart and skeletal abnormalities found in Ror2-deficient
mice.
Length = 283
Score = 26.5 bits (58), Expect = 2.4
Identities = 15/54 (27%), Positives = 25/54 (46%)
Query: 27 SDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
SD T L + + QI G++Y+ S +H+DL N+L+ +K
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVK 164
>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine
Kinases. Protein Tyrosine Kinase (PTK) family; Tie
subfamily; catalytic (c) domain. The Tie subfamily
consists of Tie1 and Tie2. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie proteins are
receptor tyr kinases (RTKs) containing an extracellular
region, a transmembrane segment, and an intracellular
catalytic domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2, while no specific
ligand has been identified for Tie1. The binding of
Ang-1 to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. In vivo studies of Tie1 show that it is
critical in vascular development.
Length = 270
Score = 26.6 bits (58), Expect = 2.5
Identities = 12/37 (32%), Positives = 21/37 (56%)
Query: 37 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
LS+ + +F + RG+ Y+ +HRDL N+L+
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 145
>gnl|CDD|233622 TIGR01893, aa-his-dipept, Xaa-His dipeptidase. This model
represents a clade of dipeptidase enzymes, many of which
are specific for carnosine (beta-alanyl-histidine). This
enzymes is found broadly in bacteria and at least one
archaeon (Methanosarcina). In most species there is only
one sequence hitting this model, while Bacteroides
thetaiotaomicron, Chlorobium tepidum and Clostridium
perfringens have two each and Fusobacterium nucleatum
has three. These may indicate that there is a broader
substrate range than just carnosine in these (and other)
species. 8/19/03 GO terms added [SS].
Length = 477
Score = 26.2 bits (58), Expect = 3.4
Identities = 18/61 (29%), Positives = 28/61 (45%), Gaps = 5/61 (8%)
Query: 33 KYQRLSNDHICYFLYQI-LRGLKYIHSANVLHRDLKPSN-LLLNTTCDLKFFFYFFFSFF 90
KY++ + + YQI L+GLK HS +H+ +N L+ +LK F S
Sbjct: 187 KYEKFTKN---EEGYQISLKGLKGGHSGADIHKGRANANKLMARVLNELKENLNFRLSDI 243
Query: 91 F 91
Sbjct: 244 K 244
>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein
Tyrosine Kinases, Apoptosis-associated tyrosine kinases
1 and 3. Protein Tyrosine Kinase (PTK) family;
Apoptosis-associated tyrosine kinase 1 (Aatyk1) and
Aatyk3; catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Aatyk1 and Aatyk3 are
members of the Aatyk subfamily of proteins. Aatyk3 is a
receptor kinase containing a transmembrane segment and a
long C-terminal cytoplasmic tail with a catalytic
domain. Aatyk1 has a similar domain arrangement but
without the transmembrane segment and is thus, a
cytoplasmic (or nonreceptor) kinase. The expression of
Aatyk1 (also referred simply as Aatyk) is upregulated
during growth arrest and apoptosis in myeloid cells.
Aatyk1 has been implicated in neural differentiation,
and is a regulator of the Na-K-2Cl cotransporter, a
membrane protein involved in cell proliferation and
survival, epithelial transport, and blood pressure
control. The function of Aatyk3 is still unknown.
Length = 269
Score = 26.1 bits (57), Expect = 3.6
Identities = 12/34 (35%), Positives = 17/34 (50%)
Query: 47 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+I GL ++H N +H DL N LL +K
Sbjct: 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140
>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen and stress-activated
kinase. Serine/Threonine Kinases (STKs), Mitogen and
stress-activated kinase (MSK) subfamily, N-terminal
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MSK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MSKs contain an
N-terminal kinase domain (NTD) from the AGC family and a
C-terminal kinase domain (CTD) from the CAMK family,
similar to 90 kDa ribosomal protein S6 kinases (RSKs).
MSKs are activated by two major signaling cascades, the
Ras-MAPK and p38 stress kinase pathways, in response to
various stimuli such as growth factors, hormones,
neurotransmitters, cellular stress, and pro-inflammatory
cytokines. This triggers phosphorylation in the
activation loop (A-loop) of the CTD of MSK. The active
CTD phosphorylates the hydrophobic motif (HM) in the
C-terminal extension of NTD, which facilitates the
phosphorylation of the A-loop and activates the NTD,
which in turn phosphorylates downstream targets. MSKs
are predominantly nuclear proteins. They are widely
expressed in many tissues including heart, brain, lung,
liver, kidney, and pancreas. There are two isoforms of
MSK, called MSK1 and MSK2.
Length = 288
Score = 25.9 bits (57), Expect = 4.0
Identities = 10/46 (21%), Positives = 27/46 (58%)
Query: 29 SHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
+H + + + + ++ +I+ L ++H +++RD+K N+LL+
Sbjct: 94 THLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139
>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine
Kinase, Tropomyosin Related Kinase C. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase C
(TrkC); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. TrkC is a member of the
Trk subfamily of proteins, which are receptor tyr
kinases (RTKs) containing an extracellular region with
arrays of leucine-rich motifs flanked by two
cysteine-rich clusters followed by two
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. Binding of TrkC
to its ligand, neurotrophin 3 (NT3), results in receptor
oligomerization and activation of the catalytic domain.
TrkC is broadly expressed in the nervous system and in
some non-neural tissues including the developing heart.
NT3/TrkC signaling plays an important role in the
innervation of the cardiac conducting system and the
development of smooth muscle cells. Mice deficient with
NT3 and TrkC have multiple heart defects. NT3/TrkC
signaling is also critical for the development and
maintenance of enteric neurons that are important for
the control of gut peristalsis.
Length = 291
Score = 25.7 bits (56), Expect = 4.8
Identities = 11/26 (42%), Positives = 16/26 (61%)
Query: 48 QILRGLKYIHSANVLHRDLKPSNLLL 73
QI G+ Y+ S + +HRDL N L+
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLV 156
>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family. This family
consists of bacterial antibiotic resistance proteins,
which confer resistance to various aminoglycosides they
include: aminoglycoside 3'-phosphotransferase or
kanamycin kinase / neomycin-kanamycin phosphotransferase
and streptomycin 3''-kinase or streptomycin
3''-phosphotransferase. The aminoglycoside
phosphotransferases inactivate aminoglycoside
antibiotics via phosphorylation. This family also
includes homoserine kinase. This family is related to
fructosamine kinase pfam03881.
Length = 238
Score = 25.6 bits (56), Expect = 4.8
Identities = 10/30 (33%), Positives = 14/30 (46%)
Query: 45 FLYQILRGLKYIHSANVLHRDLKPSNLLLN 74
L L L ++H DL P NLL++
Sbjct: 151 RLLAALLALLPALPLVLVHGDLHPGNLLVD 180
>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine
Kinases, Apoptosis-associated tyrosine kinases. Protein
Tyrosine Kinase (PTK) family; Apoptosis-associated
tyrosine kinase (Aatyk) subfamily; catalytic (c) domain.
The Aatyk subfamily is also referred to as the lemur
tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1
(Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Aatyk proteins are mostly receptor tyr kinases (RTKs)
containing a transmembrane segment and a long C-terminal
cytoplasmic tail with a catalytic domain. Aatyk1 does
not contain a transmembrane segment and is a cytoplasmic
(or nonreceptor) kinase. Aatyk proteins are classified
as tyr kinases based on overall sequence similarity and
the phylogenetic tree. However, analysis of catalytic
residues suggests that Aatyk proteins may be
multispecific kinases, functioning also as
serine/threonine kinases. They are involved in neural
differentiation, nerve growth factor (NGF) signaling,
apoptosis, and spermatogenesis.
Length = 269
Score = 25.6 bits (56), Expect = 5.5
Identities = 12/53 (22%), Positives = 22/53 (41%), Gaps = 8/53 (15%)
Query: 28 DSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+ + QR++ + GL ++H A+ +H DL N L +K
Sbjct: 96 MAQKDVLQRMACEVAS--------GLLWLHQADFIHSDLALRNCQLTADLSVK 140
>gnl|CDD|218977 pfam06293, Kdo, Lipopolysaccharide kinase (Kdo/WaaP) family. These
lipopolysaccharide kinases are related to protein
kinases pfam00069. This family includes waaP (rfaP) gene
product is required for the addition of phosphate to O-4
of the first heptose residue of the lipopolysaccharide
(LPS) inner core region. It has previously been shown
that WaaP is necessary for resistance to hydrophobic and
polycationic antimicrobials in E. coli and that it is
required for virulence in invasive strains of S.
enterica.
Length = 206
Score = 25.4 bits (56), Expect = 5.9
Identities = 11/30 (36%), Positives = 16/30 (53%)
Query: 46 LYQILRGLKYIHSANVLHRDLKPSNLLLNT 75
+ R + +H A V H DL N+LL+T
Sbjct: 124 WRAVGRLIARMHRAGVNHTDLNAHNILLDT 153
>gnl|CDD|240172 cd05151, ChoK, Choline Kinase (ChoK). The ChoK subfamily is part of
a larger superfamily that includes the catalytic domains
of other kinases, such as the typical
serine/threonine/tyrosine protein kinases (PKs), RIO
kinases, actin-fragmin kinase (AFK), and
phosphoinositide 3-kinase (PI3K). It is composed of
bacterial and eukaryotic choline kinases, as well as
eukaryotic ethanolamine kinase. ChoK catalyzes the
transfer of the gamma-phosphoryl group from ATP (or CTP)
to its substrate, choline, producing phosphorylcholine
(PCho), a precursor to the biosynthesis of two major
membrane phospholipids, phosphatidylcholine (PC), and
sphingomyelin (SM). Although choline is the preferred
substrate, ChoK also shows substantial activity towards
ethanolamine and its N-methylated derivatives. Bacterial
ChoK is also referred to as licA protein. ETNK catalyzes
the transfer of the gamma-phosphoryl group from CTP to
ethanolamine (Etn), the first step in the CDP-Etn
pathway for the formation of the major phospholipid,
phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK
shows specific activity for its substrate and displays
negligible activity towards N-methylated derivatives of
Etn. ChoK plays an important role in cell signaling
pathways and the regulation of cell growth.
Length = 170
Score = 25.3 bits (56), Expect = 6.1
Identities = 15/55 (27%), Positives = 25/55 (45%), Gaps = 8/55 (14%)
Query: 25 EYSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVL-----HRDLKPSNLLLN 74
E+ + + S+ L +I + LK +HS+ + H DL P N LL+
Sbjct: 71 EFIEGSELLTEDFSDPEN---LEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122
>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase
[Signal transduction mechanisms].
Length = 204
Score = 25.3 bits (56), Expect = 6.2
Identities = 8/19 (42%), Positives = 14/19 (73%)
Query: 56 IHSANVLHRDLKPSNLLLN 74
+H A ++H DL SN++L+
Sbjct: 108 LHKAGIVHGDLTTSNIILS 126
>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine
Kinase, Tropomyosin Related Kinase A. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase A
(TrkA); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. TrkA is a member of the
Trk subfamily of proteins, which are receptor tyr
kinases (RTKs) containing an extracellular region with
arrays of leucine-rich motifs flanked by two
cysteine-rich clusters followed by two
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. Binding of TrkA
to its ligand, nerve growth factor (NGF), results in
receptor oligomerization and activation of the catalytic
domain. TrkA is expressed mainly in neural-crest-derived
sensory and sympathetic neurons of the peripheral
nervous system, and in basal forebrain cholinergic
neurons of the central nervous system. It is critical
for neuronal growth, differentiation and survival.
Alternative TrkA splicing has been implicated as a
pivotal regulator of neuroblastoma (NB) behavior. Normal
TrkA expression is associated with better NB prognosis,
while the hypoxia-regulated TrkAIII splice variant
promotes NB pathogenesis and progression. Aberrant TrkA
expression has also been demonstrated in non-neural
tumors including prostate, breast, lung, and pancreatic
cancers.
Length = 280
Score = 25.3 bits (55), Expect = 6.7
Identities = 12/38 (31%), Positives = 20/38 (52%)
Query: 36 RLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 73
+L+ + QI G+ Y+ S + +HRDL N L+
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
>gnl|CDD|237913 PRK15119, PRK15119, undecaprenyl-phosphate
alpha-N-acetylglucosaminyl 1-phosphate transferase;
Provisional.
Length = 365
Score = 25.0 bits (55), Expect = 7.6
Identities = 12/32 (37%), Positives = 14/32 (43%), Gaps = 3/32 (9%)
Query: 70 NLLLNTTCDLKFFFYFFFSFFFHFTVHDVTKK 101
NLL +T + F FS F F V KK
Sbjct: 2 NLLTMST---ELISIFLFSTLFLFFARKVAKK 30
>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine
Kinase, Apoptosis-associated tyrosine kinase 2. Protein
Tyrosine Kinase (PTK) family; Apoptosis-associated
tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Aatyk2 is
a member of the Aatyk subfamily of proteins, which are
receptor kinases containing a transmembrane segment and
a long C-terminal cytoplasmic tail with a catalytic
domain. Aatyk2 is also called lemur tyrosine kinase 2
(Lmtk2) or brain-enriched kinase (Brek). It is expressed
at high levels in early postnatal brain, and has been
shown to play a role in nerve growth factor (NGF)
signaling. Studies with knockout mice reveal that Aatyk2
is essential for late stage spermatogenesis. Although it
is classified as a tyr kinase based on sequence
similarity and the phylogenetic tree, Aatyk2 has been
characterized as a serine/threonine kinase.
Length = 268
Score = 25.2 bits (55), Expect = 7.7
Identities = 15/55 (27%), Positives = 24/55 (43%), Gaps = 8/55 (14%)
Query: 26 YSDSHRTKYQRLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLK 80
+S QR++ C +I G+ ++H N LH DL N L + +K
Sbjct: 93 RRNSQLLLLQRMA----C----EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVK 139
>gnl|CDD|172308 PRK13770, PRK13770, histidinol dehydrogenase; Provisional.
Length = 416
Score = 25.2 bits (55), Expect = 7.7
Identities = 10/45 (22%), Positives = 21/45 (46%)
Query: 6 DQITIEIRHSTKESLVSFREYSDSHRTKYQRLSNDHICYFLYQIL 50
D + + + + ++S + Y +S + Q+L CY +Y L
Sbjct: 67 DTLDEKTKQALQQSYERIKAYQESIKQTNQQLEESVECYEIYHPL 111
>gnl|CDD|215599 PLN03140, PLN03140, ABC transporter G family member; Provisional.
Length = 1470
Score = 25.2 bits (55), Expect = 8.9
Identities = 9/17 (52%), Positives = 13/17 (76%), Gaps = 2/17 (11%)
Query: 80 KFFFYFFFSF--FFHFT 94
KFF+++F SF F +FT
Sbjct: 1326 KFFWFYFISFFSFLYFT 1342
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.332 0.143 0.445
Gapped
Lambda K H
0.267 0.0807 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 5,023,797
Number of extensions: 408177
Number of successful extensions: 1210
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1189
Number of HSP's successfully gapped: 351
Length of query: 101
Length of database: 10,937,602
Length adjustment: 67
Effective length of query: 34
Effective length of database: 7,965,884
Effective search space: 270840056
Effective search space used: 270840056
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.2 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (22.0 bits)
S2: 53 (24.0 bits)